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The thesis examines the regulation of neuronal nitric oxide synthase (nNOS)
mRNA expression in magnocellular neurosecretory neurones under physiological
circumstances including pregnancy, hyperosmotic challenges and prolonged
stimulation of the axons of the magnocellular neurones, and the functional role of
nitric oxide (NO) in regulating oxytocin and vasopressin neuronal activities, and the
release of oxytocin. The studies have included measurement ofmRNA expression by
in situ hybridization, in vivo electrophysiological studies combined with
intrasupraoptic nucleus retrodialysis, Fos immunocytochemistry studies, and
functional studies involving measurement of oxytocin secretion.
Expression of nNOS mRNA in the magnocellular neurones in the supraoptic
(SON) and paraventricular nuclei (PVN) has been confirmed to be regulated in
response to chronic osmotic stimuli, suggesting an important involvement of NO in
this situation. It has been demonstrated that an induction of this gene is not a rapid
response since an increase ofNOS gene expression in the magnocellular neurones in
the SON and PVN has been found at 6 h after acute hypertonic saline intraperitoneal
injection, but not at 4 h after injection.
Neuronal activity of oxytocin and continuously firing vasopressin neurones in
the SON was inhibited by local application ofNO donor, and was increased by local
administration of NOS inhibitor. Nitric oxide donor inhibited neuronal activity of
phasic vasopressin neurones, while NOS inhibitor did not alter neuronal activities of
these neurones. Blocking the central production of NOS by NOS inhibitor enhanced
the expression of Fos in the magnocellular neurones in the SON and PVN following
high doses, but not low doses of hypertonic saline. In addition, inhibition of NOS
potentiated the release of oxytocin evoked by electrical stimulation of the axons of
the magnocellular neurones. Furthermore, prolonged electrical stimulation of the
axons of the magnocellular neurones for 2 h produced a down-regulation of nNOS
mRNA expression in the magnocellular neurones in the SON. Thus NO, generated in
Abstract vi
an activity-dependent manner, appears to act as a feedback inhibitor of oxytocin
release at the cell bodies and the terminals of oxytocin neurones. However, although
NOS expression is up-regulated in conditions of chronic demand for oxytocin, the
present experiments indicate that this does not reflect a coupling of spike activity to
increased NOS mRNA expression.
In experiments in virgin rats, central administration of NO donor attenuated
the release of oxytocin in response to acute intraperitoneal hypertonic saline and
systemic administration of NOS inhibitor potentiated oxytocin release induced by
acute intraperitoneal hypertonic saline but not cholecystokinin. Blocking the central
production of NO with NOS inhibitor further enhanced the release of oxytocin in
response to acute intraperitoneal and intravenous hypertonic saline. In contrast, in
experiments in 21-day pregnant rats, systemic administration of NOS inhibitor was
unable to enhance the release of oxytocin evoked by acute intraperitoneal and
intravenous hypertonic saline. Furthermore, down-regulation of nNOS mRNA
expression in the magnocellular neurones in the SON was found in 22-day pregnant
rats, which was followed by an increase in the expression of nNOS mRNA in the
magnocellular neurones in the SON during parturition. These results indicate a
functional down-regulation of the influence of central released NO on the
responsiveness of oxytocin neurones to osmotic stimulation during late pregnancy.
The decrease in NOS activity in late-pregnancy may release the magnocellular
secretory system from this inhibition, making the oxytocin system more excitable at
this time.
The thesis provides new information on the mechanism by which NO
influences oxytocin secretion. Nitric oxide exerts a predominantly inhibitory effect
on the magnocellular oxytocin and vasopressin neurones in the SON and may serve
within a negative feedback loop to control the production and release of oxytocin.
Neuronal NOS gene has been shown to be a late response gene and an increase of
nNOS mRNA expression does not reflect a direct coupling to spike activity. The
endogenous NOS system has a potent restraining influence on oxytocin neurone
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excitability. A functional down-regulation of this system in the magnocellular
neurosecretory system occurs at the end of pregnancy, which may play a key role in
the osmoresponsiveness of oxytocin neurones during late pregnancy.
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Nitric oxide (NO), a simple diatomic molecule, has long been known as an
atmospheric pollutant arising from automobile exhaust, aircraft emissions and
industrial fumes (Johnson et al., 1992). The first reports of endogenous formation of
NO in mammalian cells appeared in 1987 (Ignarro et al., 1987; Palmer et al., 1987).
This molecule has since been implicated in a diverse number of physiological
systems and pathophysiological states. In medicine, NO-generating substances (e.g.
glyceryl trinitrate) have been used for their vasodilating actions in the management of
angina pectoris for many years.
In the cardiovascular system, endogenous NO was identified as endothelium-
derived relaxing factor (EDRF) (Ignarro et al., 1987; Palmer et al., 1987), which is
released from the endothelial cells when stimulated by a variety of vasodilator
substances such as acetylcholine, bradykinin and adenosine triphosphate (ATP),
causing relaxation of the underlying smooth muscle (Furchgott and Zawadzki, 1980).
Nitric oxide also inhibits platelet aggregation (Azuma et al., 1986; Bredt et al.,
1991b) and adhesion (Radomski et al., 1987).
In the immune system, NO is responsible for the tumoricidal and bactericidal
actions of macrophages. Nitric oxide is produced by activated macrophages, which
contributes to their cytotoxic action by inhibiting the cell proliferation that is
necessary to raise the effectiveness of immune responses. Nitric oxide is a non¬
specific effector capable of killing or inhibiting the growth of many pathogens and
tumor cells (for reviews see Nathan and Hibbs, 1991).
Considerable evidence has indicated that NO is also a novel type of
neurotransmitter in the peripheral and central nervous systems. Nitric oxide is unlike
classical neurotransmitters that are stored in synaptic vesicles, released by exocytosis
upon membrane depolarization, and act at receptor proteins on adjacent neuronal
membranes. Nitric oxide is a lipophilic molecule with a very short half-life that
readily diffuses across cellular membranes, and is not stored in synaptic vesicles or in
association with the plasma membrane. Instead, NO is synthesized on demand and
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diffuses out of neurones and into target cells, where it interacts with specific
molecular targets. The putative receptor for NO is iron in the heme of soluble
guanylate cyclase (sGC), which can influence guanosine 3', 5'-monophosphate
(cGMP) formation (for reviews see Bredt and Snyder, 1992).
In the peripheral nervous system, NO generated in response to non-
adrenergic, non-cholinergic (NANC) neurotransmission has been implicated in the
relaxation of the corpus cavernosum smooth muscle of the penis, inducing penile
erection (for reviews see Argiolas and Melis, 1995). Nitric oxide released from
NANC neurones also causes gastric relaxation, intestinal peristalsis, and sphincter
relaxation, inducing gastrointestinal motility (Lefebvre, 1997; Li and Rand, 1990).
Nitric oxide may also act to regulate renal sympathetic nerve activity (Sakuma et al.,
1992).
In the central nervous system, the existence of NO was first suggested by the
observation of Garthwaite et al. in 1988 (Garthwaite et al., 1988) that dissociated
cerebellar neuronal cultures released a factor with properties resembling NO, as well
as by the demonstration of NO forming activity in the brain (Bredt and Snyder, 1989;
Knowles et al., 1989). Possible functions for NO as a neurotransmitter are suggested
by the localization of the enzyme responsible for NO formation, nitric oxide synthase
(NOS) in the brain (Bredt et al., 1991a; Bredt et al., 1990; Vincent and Kimura,
1992), which is now known to be identical to nicotinamide adenine dinucleotide
phosphate (NADPH) diaphorase (Dawson et al., 1991; Hope et al., 1991). It has been
proposed that NO may be a messenger in the brain that can contribute to both
retrograde and anterograde signalling at the synapse (for reviews see Garthwaite and
Boulton, 1995).
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1.1 Mechanism of NO production
1.1.1 Biosynthesis of NO
Nitric oxide is composed of one atom each of nitrogen and oxygen, and is
called a radical gas because of its characteristics as an uncharged molecule with an
unpaired electron. Nitric oxide can diffuse freely across membranes, and is highly
reactive, with a very short half-life of less than 30 s. After release, NO decays
spontaneously into nitrite (NO2) (Ignarro, 1990; Ignarro et al., 1993). Nitric oxide is
synthesized by nitric oxide synthase (NOS), a cytochrome (CYT) P450-like structure
(Bredt et al., 1991b), in an unusual reaction that converts the semi-essential amino
acid L-arginine and oxygen to Nffl-hydroxyl- L-arginine first (Stuehr et al., 1991) and
then into L-citrulline and NO (Fig. 1). The precise biosynthetic pathway is still not
clear, but it involves electron oxidation of the guanidino nitrogen of L-arginine to
NO. This reaction requires molecular oxygen and the guanidine nitrogen of L-
arginine as the substrates, nicotinamide adenine dinucleotide phosphate (NADPH) as
electron donor, and flavin adenine dinucleotide (FAD), flavin mononucleotide
(FMN), tetrahydrobiopterin (H4B), heme and Ca2+/calmodulin as cofactors. Electrons
donated by NADPH are transported by FAD and FMN to heme when calmodulin
(CaM) is bound to the enzyme (Fig. 2). Tetrahydrobiopterin is essential for the
coupling of NADPH-dependent 02 activation to NO synthesis. Finally, an atom of
oxygen binds with the terminal guanidine nitrogen of L-arginine to form NO (for
reviews see Mayer and Hemmens, 1997).
H
H,N COO HLN COO HLN COO
L-Arginine Nm-Hydroxy-L-arginine L-Citrulline Nitric oxide




Reductase domain Oxygenase domain
Figure 2. Schematic representation of NO synthesis by NOS. When calmodulin
(CaM) is not bound to the enzyme (top), electrons, donated by NADPH, do not flow
to the oxygenase domain and are accepted by cytochrome c and other electron
acceptors. In the presence of CaM (bottom), L-arginine is converted into NO and L-
citrulline. 'Coupled' NO synthesis requires H4B, a co-factor whose function in NO
synthesis is not entirely clear. Abbreviations: CaM, Calmodulin; Cyt c, cytochrome
oxidase; FAD, Flavin adenine dinuceleotide; FMN, Flavin mononucleotide;
NADPH, nicotinamide adenine dinucleotide phosphate; H4B, tetrahydrobiopterin.
(From Iadecola, 1997)
1.1.2 Classification of NOS subtypes
In mammalian cells, several NOS isoforms exist, which share significant
sequence similarity and which contain conserved putative cofactor binding sites (Fig.
3). The sequences differ at the N-terminal extension, which appears not to be
essential for catalysis, and which probably functions in the intracellular localization
of the enzyme. There are two distinct categories of NOS, classified as either Ca2+-
dependent (constitutive NOS or cNOS) or Ca2+-independent (inducible NOS or
iNOS) (Nathan, 1992). Constitutive NOS and iNOS exist as dimeric and tetrameric
complexes respectively. Each unit contains two identical domains with four
L-Arginine
HOOC- NADPH FAD FMN Heme
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prosthetic groups (FAD, FMN, H4B and heme). The C-terminal reductase domain
contains binding motifs for FAD, FMN and NADPH, and N-terminal oxygenase
domain contains the consensus sequences for H4B, the heme binding site and the
potential phosphorylation sites. The reductase and oxygenase domains are linked by a
calmodulin binding site which facilitates electron transfer from NADPH and the
flavins to the heme group during NO production.
Both categories of NOS are strictly dependent on calmodulin (CaM), which
triggers the electron flow between the reductase and oxygenase domains. Calmodulin
binds just at the N-terminal side of the reductase domain. An important difference
between cNOS and iNOS is that cNOS synthesizes NO only when the intracellular
Ca2+ concentration is elevated and calmodulin is bound to the enzyme (Fig. 2),
whereas iNOS produces NO continuously and independently of intracellular Ca2+.
Calmodulin is bound to inducible NOS, and is fully active at resting cellular levels of
calcium (30-70 nM) (Abu-Soud and Stuehr, 1993). By contrast, constitutive NOS
only binds calmodulin at stimulated intracellular concentrations of Ca2+. Thus,
constitutive NOS, calmodulin binding and activation respond to physiological
changes in Ca2+. Consequently, constitutive NOS produces NO in small and highly
regulated bursts that are well suited for the molecular messenger function of NO
(Garthwaite and Boulton, 1995). In contrast, iNOS produces large amounts of NO
continuously for long periods, a feature that is responsible for the cytotoxicity of NO
(Gross and Wolin, 1995).
The cNOS isoform does not require new protein synthesis, whereas iNOS is
transcriptionally regulated (Xie et al., 1992). Three isoforms of NOS are named after
the tissue in which they were first purified and cloned, neuronal NOS (nNOS or type
I), macrophage or immunological NOS (iNOS or type II), and endothelial NOS
(eNOS or type HI) (Griffith and Stuehr, 1995). These isoforms are encoded by three
distinct genes and are regulated by diverse signaling pathways. Across species, amino
acid sequences of NOS isoforms are more than 90% conserved for nNOS and eNOS,
and are more than 80% identical to iNOS. The eNOS and nNOS isoforms are
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constitutively expressed and regulated by Ca2+/calmodulin, whereas iNOS is not
normally expressed but is inducible in many cell types by selected immunological
stimuli (Nathan, 1992; Nathan and Xie, 1994). Recent evidence has suggested that
the level of expression of eNOS and nNOS can be subject to up- and down-
regulation (Kadowaki etal., 1994; Sessa etal., 1994; Uematsu etal., 1995; Weiner et
al., 1994).
The classification of the NOS family, summarized in Table 1, is based on
physical and biochemical characteristics, and prototypical locations. Indeed, nNOS is
not only expressed in brain and spinal cord but also expressed in skeletal muscle
(Kobzik et al., 1994) and the airway epithelium (Kobzik et al., 1993; Kowalski et al.,
1998). eNOS, originally found in vascular endothelial cells, is also found in platelets
(Radomski et al., 1990) and certain neuronal populations in the brain (Dinerman et
al., 1994). In addition, iNOS, while mainly expressed in macrophages, appears also
to be present constitutively in bronchial epithelium (Kobzik et al., 1993).
PDZ Heme CaM FMNJ. A » A.A * FAD NADPF
nNOS
Heme CaM FMN FAD NADPF
eNOS
He in e CaM FMN FAD NADPF
iNOS
Figure 3. Schematic alignment of the NOS proteins. nNOS has a unique amino-
terminal PDZ motif. Binding sites: CaM, Calmodulin; FMN, flavin adenine
mononucleotide; FAD, flavin adenine dinucleotide; nNOS, neuronal NOS; eNOS,
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1.1.3 Synaptic function of NO
Although NO was first identified as the EDRF, it is now clear that the brain is
the primary source of NO in the body, and the major isoform present in the
hypothalamus is nNOS (Bhat et al., 1996). Depending on the location of the enzyme,
the activity of nNOS is coupled to one of two main types of physiological stimuli:
postsynaptic neurotransmitter receptor stimulation leading to Ca2+ influx or
mobilization, and action potentials in presynaptic nerves eliciting Ca2+ influx
through voltage-sensitive Ca2+ channels (Garthwaite and Boulton, 1995).
Postsynaptically, the activity of nNOS is tightly regulated by Ca2+ through the
binding of the ion to calmodulin. At resting cytoplasmic Ca2+ concentrations (<100
nM), calmodulin is largely free of Ca2+ and so does not bind to nNOS. The binding of
glutamate to TV-methyl-D-aspartate-type receptors (NMDA) leads to postsynaptic
Ca2+ influx, which would activate nNOS resulting in the formation of NO
(Garthwaite and Boulton, 1995). After formation at presynaptic or postsynaptic sites,
NO diffuses out to act on neighbouring cellular elements. Thus, NO can operate as an
intercellular messenger, which represents a potential line of communication from
postsynaptic to presynaptic elements, and vice versa, as well as between presynaptic
fibers or postsynaptic structures (Garthwaite, 1991).
In contrast to eNOS, nNOS does not associate directly with membranes, but is
associated with membranes by the amino-terminal, which possesses a PDZ domain
(postsynaptic density protein of 95 kDa, Drosophila discs large protein and Zonal
occludens protein l)(Fig. 3). Synaptic localization is regulated by the amino terminus
of nNOS, which encodes a PDZ protein motif as shown in Fig. 3 (Brenman et al.,
1996). PDZ domains are modular protein motifs implicated in signal transduction in
neurones and other cells (Sheng, 1996). Indeed, the PDZ domain of nNOS appears to
link the synthase to protein complexes at the postsynaptic density that contain
NMDA receptors. The NR2 subunit and certain NR1 splice forms of the TV-methyl-D-
aspartate (NMDA) receptor contain a carboxy-terminal tSXB motif (where S is
serine, X is any amino acid, and V is valine) that can interact with the PDZ domain
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of the postsynaptic density protein of 95 kDa, PSD-95 (Kornau et al., 1995).
Neuronal NOS binds via its N-terminal PDZ domain to PSD-95 through a PDZ-PDZ
binding interface (Brenman et al., 1996). PSD-95 can mediate the assembly of a tight
ternary complex containing nNOS and NMDA receptor subunits. This
macromolecular complex probably underlines the particular sensitivity of nNOS to
activation of the NMDA type of glutamate receptor.
1.2 NO signal transduction
To mediate a signal between cells, most molecules (e.g. hormones and
neurotransmitters) act through specific protein receptors associated with the
membranes. By contrast, NO diffuses from the cell that generates it and into target
cells (Table 2). Because of its chemical reactivity, there may be multiple targets for
NO. The best-characterized "receptor" of NO is iron, contained in certain proteins as
a heme group or as an iron-sulphur complex. Nitric oxide exerts its effects by binding
to iron-containing enzymes and either activating or inactivating the enzymes. When
NO binds to the iron in the heme group of soluble guanylate cyclase (sGC), the
enzyme is activated and catalyses the formation of cyclic guanosine 3', 5'-
monophosphate (cGMP) which then activates other cellular processes (Bredt and
Snyder, 1989; Garthwaite et al., 1989; Johns, 1991). Like sGC, cyclooxygenase
(COX) is a heme-containing enzyme that can directly bind NO, and NO may serve as
an activator for the synthesis of prostaglandins from arachidonic acid in a cGMP-
independent manner (Rettori et al., 1993; Rettori et al., 1992; Salvemini et al., 1996).
When NO binds to iron-sulfur centers of nonheme-containing enzymes, it causes a
loss of enzyme activity (Nathan, 1992). Nitric oxide also potently enhances
adenosine diphosphate (ADP) ribosylation of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) by attaching an ADP-ribose group to it, thereby blocking
the production of adenosine triphosphate from glycolysis (Brune et al., 1994; Brune
and Lapetina, 1989; Kots et al., 1992; Zhang and Snyder, 1992).
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Soluble guanylate cyclase (sGC)/cGMP
Soluble guanylate cyclase (sCG) exists as a heterodimer composed of a and (3
subunits (Schmidt et al., 1993). Three a and [3 subunit isoforms (al-3, (31-3) and
subunit splice variants have been identified (Garbers, 1992). Although each subunit
contains the cyclase domain located within the carboxy-terminus and the heme-
binding domain located at the amino-terminus, the catalytic activity apparently
depends on both subunits together with the presence of Mg2+ (Murad, 1994). Only
one molecule of heme is bound per sGC molecule at the heme binding site co¬
ordinated with a histidine residue (His 105) and cysteine residues (Cys 78, Cys 214)
of the (3 subunit. Nitric oxide appears to activate sGC by interaction with the heme
group (Schmidt et al., 1993) and rapidly forms a nitrosyl-heme complex with sGC
which may induce a conformational change of sGC that reveals the catalytic site to
gaunosine 5'-triphosphate (GTP) (Traylor and Sharma, 1992). The enzymatic
reaction of sGC is then stimulated, and GTP is converted into the second messenger
cGMP (Humbert et al., 1990; Schmidt, 1992; Schmidt et al., 1993; Stone and
Marietta, 1994). Regulation of physiological events by cGMP is accomplished by
interaction of the nucleotide with target proteins, including cGMP-gated ion
channels, cGMP-dependent protein kinases and cGMP-regulated cyclic nucleotide
phosphodiesterases (Garthwaite, 1991; Garthwaite and Boulton, 1995; Lincoln and
Cornwell, 1993; McDonald and Murad, 1996). This means that cGMP can alter cell
function through protein phosphorylation or through mechanisms indirectly related to
protein phosphorylation. Cation channels of retinal photoreceptor cells are gated by
9-4-
binding of cGMP that allows Ca entry the cells, which is important for visual
transduction (Finn et al., 1996). cGMP activation of cGMP-dependent protein kinase
may be involved in reduction of Ca2+concentration, via Ca2+sequestration and
extrusion, by phosphorylating and activating Ca2+-ATPase or components associated
with the transporter (Lincoln and Cornwell, 1993; Schmidt et al., 1993) causing
smooth muscle relaxation and platelet inhibition. cGMP can also control the
breakdown of itself and another nucleotide, cAMP, by stimulating or inhibiting
specific subtypes of cyclic nucleotide phosphodiesterases (PDEs). cGMP-inhibited
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PDE has been found to enhance cAMP-mediated relaxation of smooth muscle and
platelet inhibition (Lincoln and Cornwell, 1993). cGMP-stimulated PDE-induced
reduction in cAMP levels has been found to suppress Ca2+ in hippocampal pyramidal
neurones (Doerner and Alger, 1988). Termination of signal transduction by
hydrolysis of cGMP to GMP depends on the GMP-specific PDEs.
It has thus been proposed that sGC is the main target for NO in the brain
(Bredt and Snyder, 1994). The al and [31 subunits of sGC are widely distributed in
most neurones throughout the brain, with different levels of expression. Both
subunits are expressed markedly in the glomerular layer of the olfactory bulb, dorsal
and ventral striatum, and several regions in the brainstem (Furuyama et al., 1993).
Interestingly, low levels of expression of GC mRNA have been demonstrated in the
hypothalamus (Matsuoka et al., 1992). There is a paucity of cGMP in the supraoptic
nucleus (SON) and the paraventricular nucleus (PVN) in non-stimulated rats
(Southam and Garthwaite, 1993). Cyclic GMP localizes within a dense fibre network
in both the PVN and SON and also in small cells, perhaps astrocytes in the SON,
rather than being present in the magnocellular neurones (Bredt et al., 1990). It has
been reported recently that NO potently regulates hypothalamic cGMP levels (Bhat et
al., 1996). The release of cGMP from the posterior pituitary has been reported
following depolarization (O'Dea et al., 1978; Vale and Hope, 1982) and from the
SON following osmotic stimulation (Carter and Murphy, 1989). More recently, it has
been proposed that heme-containing enzymes other than guanylate cyclase, such as
cyclo-oxygenase, may be targets for NO in the hypothalamus (Rettori et al., 1993;
Rettori etal., 1992).
In general, NO-producing neurones seem unlikely to be influenced by
released NO because the high concentration of intracellular calcium necessary to
trigger NO release prevents the activation of the sCG. Therefore, NO release from
one cell type will act on sGC in another cell type in a paracrine function within a
volume delimited by the half-life and diffusion of NO (approximately 200 pm),
causing elevation of intracellular cGMP (Southam and Garthwaite, 1993; Wood and
Garthwaite, 1994). This hypothesis may not apply to magnocellular neurones of the
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PVN and SON, which express high levels of both the al and (31 subunits of sGC
(Furuyama et al., 1993). Therefore, the released NO from a stimulated neurone may
activate sGC within the same neurone and any neighbouring magnocellular neurones
in a paracrine and autocrine function.
Table 2. Molecular targets of NO
Interaction sites or
modification types
Target molecules Functional consequences
Heme Soluble guanylyl cyclase











activation of IRF to regulate iron metabolism
Inhibition of glycolysis
Inhibition of respiratory chain
Iron loss and lipid peroxidation















Activation, causing NF-kB translocation
Activation of p56lck
NO carrier activity
Vasodilation and antiplatelet activities












Deamination DNA Mutations and strand breaks, PARS activation
Abbreviations: IRF, iron-responsive factor; complex I & II, NADH-succinate oxidoreductase and
NADPH-ubiquinone oxidoreductase; NMDA, IV-methyl-D-aspartate; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; NF-kB, nuclear factor kB, a transcription factor; t-PA, tissue-type
plasminogen activator; ONOO", peroxynitrite; LDL, low density lipoproteins; PARS, poly (ADP-
ribose) synthetase. (From Zhang and Snyder, 1995)
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1.3 Molecular biological features of neuronal NOS (nNOS)
Neuronal NOS (nNOS), originally isolated from rat (Bredt et al., 1990) and
porcine cerebellum (Mayer et al., 1990), is also expressed in skeletal muscle (Nakane
et al., 1993) and pulmonary epithelium (Asano et al., 1994). Neuronal NOS in the
brain is mostly soluble, and migrates with a molecular mass of 150-160 kDa on SDS-
polyacrylamide gel electrophoresis (Bredt et al., 1990; Mayer et al., 1990).The
cDNAs encoding nNOS have been cloned from rat (Bredt et al., 1991b), mouse
(Ogura et al., 1993) and human brains (Nakane et al., 1993). The cDNA sequences of
rat and human nNOS predict proteins of 160 and 161 kDa, respectively, which is in
good agreement with the purification results. Neuronal NOS seems to be a highly
conserved enzyme between species; 93% amino acid identity exists between the rat
and human species (Nakane et al., 1993). The human nNOS gene is localized to
chromosome 12 (Marsden et al., 1993).
Although nNOS is constitutively expressed in various cells, expression of
nNOS is subject to regulation as suggested by a number of recent observations. In
particular, nNOS gene expression has been reported to be up-regulated in various
brain areas by estrogen (Ceccatelli et al., 1996; Weiner et al., 1994), water
deprivation (Ueta et al., 1995b), chronic salt loading (Kadowaki et al., 1994; Villar et
al., 1994b), lactation (Ceccatelli and Eriksson, 1993; Luckman et al., 1997), stress
(Calza et al., 1993), axotomy (Verge et al., 1992), hypophysectomy (Villar et al.,
1994a), gonadectomy (Ceccatelli et al., 1993), and occlusion of the middle cerebral
artery (Zhang et al., 1994). Conversely, down-regulation of nNOS gene expression
has been reported following food deprivation (O'Shea and Gundlach, 1996; Ueta et
al., 1995a). Thus, nNOS expression can be regulated under some circumstances, but
the molecular mechanism of this regulation remains to be elucidated.
Little information is available on the regulation of nNOS expression. One of
the interesting features of the nNOS genes is that nNOS mRNA transcripts are highly
diverse, originating from different first exons spliced to a common second exon. At
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least two alternatively spliced transcripts of human and murine nNOS genes and at
least three alternatively spliced transcripts of the rat nNOS gene arising from
alternative splicing promoters and differing in their 5'-untranslated regions have been
described (Brenman et al., 1996; Min et al., 1997; Xie et al., 1995). The use of
multiple alternative promoters in conjunction with alternative splicing may allow
spatial and temporal regulation of transcription of the nNOS gene. The putative
promoter regions of human nNOS contains consensus sequences that encode putative
functional domains for the binding of several transcription factors, such as activator
protein 2 (AP-2), acute-phase reactants, nuclear factor 1 (NF-1) and NFkB, providing
a possible means of transcriptional regulation of the nNOS gene in response to
physiological or pathological perturbations (Hall et al., 1994). Neuronal NOS might
also be regulated post-transcriptionally by altered mRNA stability and post-
translationally by modulation of protein stability of protein phosphorylation (Nathan
and Xie, 1994). Post-translational modifications might provide a powerful
mechanism for down-regulation of NOS activity. Enhanced phosphorylation of
nNOS decreases nNOS catalytic activity that might be a useful strategy for
neuroprotection (Dawson et al., 1993).
1.4 The magnocellular neurosecretory system
The magnocellular neurosecretory system plays major roles in body fluid
homeostasis maintenance, in parturition, in milk ejection during lactation, and in
stress responses. This system originates from the magnocellular neurones of the
supraoptic (SON) and paraventricular hypothalamic nuclei (PVN) of the
hypothalamus where oxytocin and arginine vasopressin are synthesized and stored in
neurosecretory granules, in separate neurones. The neurosecretory granules are then
transported along axons that project through the pituitary stalk and terminate within
the posterior lobe of the pituitary gland (Brownstein et al., 1980). In response to
appropriate stimuli, action potentials arise as a result of synaptic input to the cell
bodies and are transmitted down the axons, causing exocytosis of the neurosecretory
granules by triggering an influx of calcium into the nerve terminals. Either oxytocin
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or vasopressin is then released from the nerve terminals into the general circulation
(Hatton, 1990). The amount of release has been shown to correlate with the
frequency and pattern of the action potentials (see Bicknell & Leng, 1981 and
Renaud & Bourque, 1991 for reviews).
Oxytocin and vasopressin are structurally related nonapeptide hormones,
differing at only two amino acid residues. Oxytocin and vasopressin mediate their
physiological roles through interaction with specific G-protein coupled receptors
(oxytocin, vasopressin Via, Vib and V2), which have been classified on the basis of
both the second messenger system coupled to the receptors and the affinity of a series
of vasopressin and oxytocin analogues with enhanced selectivity for a certain
receptor type, and by sequencing of their genes. Vasopressin Via receptors are found
in liver and smooth muscle cells from blood vessels. V|b and V2 receptors are found
in adenohypophysis and kidney, respectively while oxytocin receptors are found in
uterus and mammary gland. Vasopressin Via and oxytocin receptors are also
localized in discrete brain nuclei (Barberis and Tribollet, 1996). Recently,
vasopressin V)b receptor mRNA has been detected in the kidney, thymus, lung,
spleen, uterus and breast, and in numerous areas of the rat brain (Lolait et al., 1995).
Molecular cloning has confirmed that vasopressin and oxytocin receptor subtypes are
members of the seven-transmembrane domain, G-protein-coupled receptor (GPCR)
(Kimura et al., 1992). Oxytocin appears to act through a single receptor that signals
through the phosphoinositol pathway, while vasopressin effects are mediated by two
classes of receptors linked to separate transduction systems. Vasopressin V] receptors
signal vascular muscle contraction by means of the phosphoinositol pathway,
whereas vasopressin V2 receptors utilize the cyclic AMP system to produce the
antidiuretic effect in renal tubules.
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1.4.1 Morphology of the magnocellular neurosecretory system
The PVN contains both large (magnocellular) and small (parvocellular)
neurones. There are eight distinct subdivisions within the PVN, three of which are
magnocellular and the rest are parvocellular (Swanson and Kuypers, 1980). The
anterior and medial parts of the magnocellular division contain primarily oxytocin
neurones. The posterior part of the nucleus, the largest subdivision, consists of two
distinct populations located in the medial and the lateral areas (Hatton et al., 1976).
Oxytocin neurones are primarily found in the medial area, and vasopressin neurones
in the lateral area. The SON contains only large (magnocellular) neurones: oxytocin
neurones are mainly located posterodorsally and vasopressin neurones are mainly
located posteroventrally (Swaab et al., 1975; Vandesande et al., 1975). The
magnocellular neurones of the SON and PVN each have between one to five and one
to three simple dendrites, respectively, together with one axon arising directly from
the soma or from a primary dendrite (Armstrong et al., 1982; Armstrong et al., 1980;
Swanson and Kuypers, 1980). Almost all of the axons project to the posterior
pituitary gland. Some axons display collateral branches, most of which terminate in
the hypothalamus close to the SON and PVN (Hatton et al., 1985; Mason et al.,
1984). Some vasopressin-synthesizing neurones, originating from the parvocellular,
not the magnocellular neurones of the PVN, project to the median eminence
(Vandesande et al., 1977), the brain stem and spinal cord (Buijs, 1978; Kannan and
Yamashita, 1983) instead of to the neural lobe of the pituitary gland. In the SON,
most of the dendrites course ventrally toward the ventral glial lamina along the base
of the nucleus, where they form a layer of dendritic bundles, intermingled with glial
cell bodies and glial processes (Randle et al., 1986).
Although oxytocin and vasopressin are predominantly released directly into
the systemic circulation, the central release of oxytocin and vasopressin has also been
reported. Oxytocin and vasopressin are released by exocytosis from the axonal
swellings (Nordmann and Dayanithi, 1988), the axonal collaterals (Hatton et al.,
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1985; Mason et al., 1984) and the dendrites of magnocellular neurones in response to
various stimuli (Ludwig, 1998; Pow and Morris, 1989).
1.4.2 Afferent pathways to the magnocellular neurosecretory system
The magnocellular neurosecretory system receives inputs from several
forebrain regions including the olfactory bulb, the amygdala, the septum and
structures associated with the lamina terminalis of the third ventricle which include
the subfornical organ (SFO), the organum vasculosum of the lamina terminalis
(OVLT) and the median preoptic nucleus (MnPO) (Hatton, 1990; Sawchenko and
Swanson, 1983). The SFO and OVLT, so-called "circumventricular organs", lack an
effective blood-brain barrier and are characterized by the presence of dense
vascularization and the outer membranes of the endothelial cells that line blood
vessels in these regions possess fenestrations. These areas send direct efferent
projections to the magnocellular neurosecretory system (Fig. 4) (Armstrong et al.,
1996; Sawchenko and Swanson, 1983). The SFO and OVLT also have indirect
connections with the magnocellular neurones via synapses in an intervening nucleus,
the MnPO (Oldfield et al., 1991b; Oldfield et al., 1991c). The SFO, OVLT and
MnPO have been suggested to contain osmoreceptors, which participate in the
control of osmoregulatory hormone release (Bourque et al., 1994). Angiotensin II
may mediate an excitatory input from the SFO to the SON (Jhamandas et al., 1989)
and the anteroventral third ventricle region (AV3V) region (Tanaka et al., 1987). The
SFO sends an angiotensinergic input that evokes a predominantly excitatory effect on
vasopressin neurones (Jhamandas et al., 1989; Renaud, 1996). The MnPO exerts a
GABAa receptor-mediated inhibition of supraoptic neurones in the rat (Nissen and
Renaud, 1994; Renaud et al., 1993). Glutamatergic innervation and GABAergic
afferents from the OVLT to the SON exert excitatory and inhibitory influences,
respectively (Renaud et al., 1993; Yang et al., 1994).
Noradrenergic inputs from the brainstem to the magnocellular nuclei arise
from the Al cell group of the ventrolateral medulla (VLM), and the A2 cell group of
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the caudal part of the nucleus tractus solitarii (NTS). The A6 cells of the locus
coeruleus also innervate the PVN, but predominantly the parvocellular division
(Sawchenko and Swanson, 1982). The A1 and A2 cells send afferent inputs to both
parvocellular and magnocellular neurones of the PVN and to the SON. The terminals
anterogradely labelled from A1 pathways are preferentially concentrated around
vasopressin neurones in the SON, primarily on their dendrites (Shioda et al., 1992),
while the anterogradely labelled fibers from A2 cells innervate oxytocin neurones of
the SON (Cunningham and Sawchenko, 1988). Some A2 cells also send a direct
projection to the neurohypophysis (Garten et al., 1989). The supraoptic oxytocin and
vasopressin neurones are excited after stimulation of the A2 cells (Raby and Renaud,
1989). Non-noradrenergic cells in the NTS project to the Al cell group (Sawchenko
and Swanson, 1982). The NTS appears to mediate activation of oxytocin neurones
directly, whereas stimuli that activate vasopressin neurones are likely to be indirectly
mediated via a non-noradrenergic projection to the Al cells and then to the
vasopressin neurones (Raby and Renaud, 1989). Afferent inputs from baroreceptors,
stretch receptors, chemoreceptors and gastrointestinal distention are conveyed in the
vagus nerves and glossopharyngeal nerves to the NTS (Cunningham and Sawchenko,
1991). Activation of chemoreceptors may activate a cholinergic pathway from the
NTS to the Al cells, resulting in stimulation of vasopressin release. Activation of
baroreceptors and stretch receptors may activate GABA neurones in the NTS that
innervate the Al cells, resulting in inhibition of vasopressin release (Bisset and
Chowdrey, 1988). The caudal NTS also receives direct information from the area
postrema (McKinley et al., 1990). Signals from the vaginal and uterine distention
receptors, somatic sensory receptors and nociceptors are carried to the Al cell group
and the caudal NTS via the dorsal horn of the spinal cord (Menetrey and Basbaum,
1987; Menetrey et al., 1983) by way of the spinoreticular and spinosolitary tracts,
respectively.
Figure4.Schematicillustrationoflectedn ralpathwayssubs rvingosmoregul tion.Abbreviat :a.c ,nte i rco missure;M PO medianpr opticnucleus;NTS,ucleustractussoli ari ;o. .pt cch smOVLTrganumvas ulo ulamiter i liPBN parabrachialnucleus;PP,posteriorituita y;VN,par ventricularnu lSFOsubfornic lo g nOpraopt cVLM ventrolateralmedulla;ZI,zonaincert .(Fr mBourqua ,1994)
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1.4.3 Co-localization of neuroactive substances within the magnocellular
neurosecretory system
Oxytocin and vasopressin are typically synthesized and secreted by separate
magnocellular neurones (Mohr et al., 1988; Vandesande et al., 1975; Young and
Lightman, 1992). Exceptionally, under strong stimulation, the expression of oxytocin
and vasopressin and their mRNAs can be found to be co-localized in some
magnocellular neurones of the SON and PVN (Kiyama and Emson, 1990; Trembleau
et al., 1993).
In the magnocellular neurones of the SON and PVN, not only oxytocin and
vasopressin, but also a wide variety of messenger molecules have been found to co-
localize. Vasopressin neurones primarily express tyrosine hydroxylase, galanin,
dynorphin, angiotensin II, Leu-enkephalin and peptide histidine-isoleucine, and to a
minor extent CCK, Met-enkephalin and thyrotropin-releasing hormone, whereas
oxytocin neurones mainly contain CCK, Met-enkephalin and corticotropin-releasing
factor (CRF), and to a minor extent galanin, dynorphin, Leu-enkephalin and
thyrotropin-releasing hormone (Brownstein and Gainer, 1977; Brownstein and
Mezey, 1986; Brownstein et al., 1980; Meister et al., 1990b; Mezey and Kiss, 1985;
Sawchenko et al., 1984; Vanderhaeghen et al., 1981; Villar et al., 1990). In addition,
vasopressin has been found to co-localize with nitric oxide synthase (NOS) (Calka
and Block, 1993b; Sanchez et al., 1994; Torres et al., 1993), and oxytocin also
coexists with NOS (Miyagawa et al., 1994; Sanchez et al., 1994; Torres et al., 1993)
in the magnocellular neurones of the SON and PVN.
Regulation of coexisting peptide or mRNA levels within magnocellular
neurones may be influenced by several systemic challenges known to target oxytocin
and vasopressin synthesis and secretion (Lightman and Young, 1987; Meister et al.,
1990a; Sherman et al., 1986). Salt-loading is the best challenge that up-regulates
several mRNAs of co-localized peptides, including vasopressin (Herman et al., 1991;
Lightman and Young, 1987), oxytocin (Lightman and Young, 1987), dynorphin
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(Lightman and Young, 1987; Sherman et al., 1988), CCK (Sherman et al., 1988),
tyrosine hydroxylase (Young, EI et al., 1987), galanin (Meister et al., 1990a) and
nitric oxide synthase (Kadowaki et al., 1994).
1.4.4 Electrophysiology of the magnocellular neurones
The stimulus-secretion coupling at the axon terminals of magnocellular
neurones depends upon the electrical activity of these neurones. The amount of
release correlates with the frequency and pattern of the action potentials (Bicknell
andLeng, 1981;Renaud and Bourque, 1991).
Electrical stimuli applied to the neural stalk evoke action potentials in the
axons of magnocellular neurones, which are propagated antidromically to the cell
bodies (Leng, 1981). These antidromic action potentials have been used to identify
putative neurosecretory neurones in vivo (Poulain and Wakerley, 1982; Renaud and
Bourque, 1991). In the rat, the majority of both oxytocin and vasopressin neurones
fire in a slow, irregular pattern under conditions of low demand for neurohypophysial
hormones. One of two patterns of activity, either regular continuous firing or phasic
bursting, in which silent pauses punctuate prolonged bursts, has been revealed under
certain stimulation in vivo (Poulain and Wakerley, 1982). The former pattern is
strongly associated with oxytocin neurones and the latter with vasopressin neurones.
However, there have been exceptions reported, particularly in lactating rats, when the
continuous firing pattern is periodically interrupted by a brief (<5 s) high-frequency
bursts of activity immediately preceding periodic milk ejections (Lincoln and
Wakerley, 1974). This profile is associated with oxytocin neurones only. Oxytocin
and vasopressin neurones are best distinguished in vivo by their firing patterns
following gastric, cardiovascular and suckling stimuli. The firing rate of vasopressin
neurones is unaffected by suckling. In response to haemorrhage or osmotic
stimulation, the firing rate of vasopressin cells is increased and eventually they adopt
a phasic bursting pattern of activity, while oxytocin neurones display a continuously
elevated firing rate under these conditions (Brimble and Dyball, 1977; Poulain et al.,
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1977). The electrical activity of single neurones in the SON, identified antidromically
as projecting to the posterior pituitary, can be identified as oxytocin neurones by
virtue of their continuous firing pattern, and by their excitatory response to
intravenously injected cholecystokinin (Renaud et al., 1987) and identified as
vasopressin neurones by their phasic firing pattern, and by their inhibitory response
to intravenously injected phenylephrine (Harris, 1979).
In vitro, oxytocin and vasopressin neurones can be distinguished by their
different responses to certain neurochemicals (or stimuli), and by the presence of
phasic bursting mostly correlated with vasopressin neurones (Armstrong et al., 1994;
Cobbett et al., 1986). The continuous firing pattern is often associated with both cell
types (Andrew and Dudek, 1984; Armstrong et al., 1994). The membrane properties
of oxytocin and vasopressin neurones are generally similar in vitro. Depolarizing
after-potentials (DAPs) are more often exhibited by, but are not exclusive to,
vasopressin neurones (Armstrong, 1995). However, its presence is not a signature for
cell type (Armstrong et al., 1994). The summation of DAPs supports a plateau
potential underlying the burst of phasic firing activity in magnocellular neurones
(Andrew and Dudek, 1984). Furthermore, oxytocin and vasopressin neurones can be
distinguished by their different membrane responses to sustained outward
rectification (Stern and Armstrong, 1995). The sustained outward rectification is
present only in oxytocin neurones.
1.4.5 Physiological and pharmacological regulation of neurohypophysial
hormone release
1.4.5.1 Cholecystokinin
The polypeptide cholecystokinin (CCK), in particular the C-terminal
octapeptide (CCK26-33 or CCK8), has a wide distribution throughout the brain and
spinal cord as well as in the gut (Hokfelt et al., 1991; Hokfelt et al., 1988). CCK is
expressed highly in the magnocellular neurosecretory system, and is co-localized
General Introduction 24
mainly with oxytocin and to a minor extent with vasopressin (Meister et al., 1990b;
Vanderhaeghen et al., 1981). Systemic administration of CCK selectively induces
oxytocin release into the circulation in a dose-dependent manner (Verbalis et al.,
1986a), while vasopressin release is unaffected or inhibited (Blackburn and Leng,
1990). This release is in accordance with a rapid but transient increase in the
electrical activity of the oxytocin neurones and unresponsiveness or inhibition in the
activity of the vasopressin neurones (Renaud et al., 1987; Ueta et al., 1993). These
responses to systemic CCK have been used to identify and differentiate between the
oxytocin and vasopressin neurones in in vivo electrophysiological studies. Oxytocin
has also been found to be released within the SON in response to either systemic or
central CCK administration (Neumann et al., 1994).
Two distinct types of CCK receptor, CCKA and CCKB, are present in both the
central nervous system and peripheral tissues (Hill et al., 1987). CCKA receptors are
predominantly located in the periphery, but are also present in the area postrema and
the NTS, whereas CCKB receptors are found mainly in the brain (Crawley et al.,
1991; Menetrey et al., 1984). Though CCKB receptors are present in the SON and
PVN (Gaudreau et al., 1983), the excitation of oxytocin cells by systemic
administration of CCK appears to be a consequence of peripheral actions, since CCK
poorly penetrates the blood-brain barrier. Systemic administration of CCK has been
shown to activate neuronal activity as determined by Fos protein expression in the
area postrema and in sensory parts of the dorsal vagal complex (Monnikes et al.,
1997), catecholaminergic neurones in the Al and A2 cell groups (Luckman, 1992;
Luckman et al., 1993; Rinaman et al., 1995) and oxytocin neurones (Hamamura et
al., 1991; Verbalis et al., 1991). The administration of a selective CCKA antagonist,
but not a selective CCKB antagonist, abolishes CCK-induced excitation of oxytocin
neurones (Luckman et al., 1993). Administration of a CCKA receptor antagonist, but
not of a CCKb antagonist, blocks oxytocin release following CCK, while it also
prevents CCK-induced Fos protein expression in the SON, PVN, area postrema and
dorsal vagal complex (Luckman et al., 1993; Miller et al., 1993). Thus, systemic
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CCK acts on CCKA receptors located either on gastric vagal afferent fibers, or in the
area postrema.
Systemic CCK also induces noradrenaline release in the dorsal region of the
SON where oxytocin neurones predominate (Kendrick et al., 1991; Onaka et al.,
1995b). The CCK-induced oxytocin release is not abolished by destruction of the so-
called AV3V region, which includes the OVLT and the MnPO (Blackburn and Leng,
1990). However, this response is abolished by gastric vagotomy (Verbalis et al.,
1986a) and attenuated by destruction of the area postrema (Carter and Lightman,
1987). Thus, the actions of systemically administered CCK on oxytocin neurones are
mediated by vagal afferents or through the area postrema to the NTS.
Systemic administration of CCK, gastric distention from feeding, and
nauseants such as lithium chloride, copper sulphate and apomorphine, all selectively
release oxytocin in rats (McCann et al., 1989; Renaud et al., 1987; Verbalis et al.,
1986a; Verbalis et al., 1986b) and produce a parallel inhibition of gastric motility and
food intake (McCann et al., 1989). These latter effects are not mediated by the
peripheral release of oxytocin and may be relayed by the central oxytocinergic
projection from the PVN to the dorsal motor nucleus of the vagus (Flanagan et al.,
1992a; Flanagan et al., 1992b; Olson et al., 1992).
1.4.5.2 Pregnancy and parturition
Oxytocin has a physiological role in both parturition and milk-ejection, or
milk let-down, but there is little evidence for a major role of vasopressin in such
conditions. The release of oxytocin is enhanced by two reflex mechanisms. The first
is associated with tactile stimulation of the nipple during suckling, the milk-ejection
reflex. The second is associated with stretch receptors in the lower genital tract,
particularly the uterine cervix during the expulsion stage of parturition, the Ferguson
reflex (see Leng et al., 1999 for reviews).
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Oxytocin gene expression in the SON and PVN is increased (Crowley et al.,
1993; Schriefer, 1991; Zingg and Lefebvre, 1988; Zingg and Lefebvre, 1989) or
unchanged (Brooks, 1992; Douglas et al., 1998; Spinolo et al., 1992) during
pregnancy, possibly reflecting the counteraction between inhibitory actions of
progesterone and the stimulating action of relaxin.
During pregnancy, an up-regulation of GABAa subunit receptor mRNA
expressed in oxytocin neurones of the SON and PVN has been revealed, followed by
down-regulation on the day of parturition (Fenelon and Herbison, 1996). High
concentrations of progesterone, secreted from the corpus luteum, have been found in
early pregnancy and this persists until shortly before the end of pregnancy. Parturition
is associated with a relative increase in circulating oestrogen levels against a
background of falling levels of progesterone. Progesterone is essential for
establishing and maintaining pregnancy in mammals, as progesterone receptor
antagonist can induce preterm labour (for reviews see Garfield et al., 1998b). One of
its functions includes maintenance of uterine quiescence by decreasing uterine
sensitivity to oxytocin (Burgess et al., 1992). Furthermore, in ovariectomized rats,
administration of progesterone inhibits oxytocin neurone electrical activity (Negoro
et al., 1973). It has been shown recently that progesterone inhibits oxytocin binding
to oxytocin receptors in vitro (Grazzini et al., 1998).
A peptide hormone relaxin, produced from the ovary, is present throughout
the second half of pregnancy until term (Sherwood et al., 1980) to prepare the birth
canal for parturition and sensitizing the uterus to oxytocin. The plasma concentration
of oxytocin is elevated and sustained throughout pregnancy (Douglas et al., 1993),
which may arise from the actions of ovarian relaxin upon the SFO and OVLT
(Geddes and Summerlee, 1995; McKinley et al., 1997). Systemic administration of
relaxin increases the electrical activity of oxytocin and vasopressin neurones and
increases oxytocin and vasopressin secretion (Parry et al., 1994; Way and Leng,
1992), while ovariectomy during pregnancy decreases oxytocin secretion (Way et al.,
1993). However, these effects are either reduced or not observed in late-pregnant rats
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(Parry et al., 1994). The excitation of vasopressin neurones by relaxin results in
antidiuresis causing plasma volume expansion and a decrease in plasma osmolality in
order to satisfy the increased vascular needs of the developing placenta and foetus.
These changes are maintained by a comparable reduction in osmotic thresholds for
drinking and neurohypophysial hormone release (Barron et al., 1985; Durr et al.,
1981; Koehler et al., 1993). Despite this decrease in the set-point for osmoregulation
and volume homeostasis, there is no change in sensitivity of the magnocellular
neurosecretory system to osmotic stimulation in late pregnancy (Durr et al., 1981;
Koehler et al., 1993). This new balance is reflected in the sustained hyponatremia
and hypervolemia of pregnancy. However, a reduction of the osmoresponsiveness of
the oxytocin system has also been reported, indicating no change in the osmotic
threshold for oxytocin release in late pregnancy (Russell et al., 1992).
Two distinct opioid mechanisms regulate oxytocin secretion (Russell et al.,
1993), while there is no significant action of either morphine treatment or of
endogenous opioids on vasopressin secretion. Functional K-and p.-receptors are
present on the cell bodies and dendrites of oxytocin neurones, but only K-receptors
are present at the nerve terminals. Therefore, both p.- and K-receptor agonists can act
centrally to inhibit oxytocin neurones but only K-receptor agonists (and not p,-
agonists) can act at the secretory terminals (Bicknell et al., 1988). Met-enkephalin,
which is co-secreted with oxytocin, is a 5-receptor agonist, but extended forms of
Met-enkephalin are active at neurohypophysial K-receptors (Leng et al., 1994). At the
neural lobe, oxytocin secretion is restrained by co-secreted opioid peptides including
dynorphin (released by both vasopressin and oxytocin terminals) and Met-enkephalin
(released by oxytocin terminals), acting through K-receptors (Leng et al., 1994; Zhao
et al., 1988). This appears to be principally an auto-inhibitory mechanism. In mid-
pregnancy, oxytocin secretion is powerfully restrained by this auto-inhibition
(Douglas et al., 1993; Russell et al., 1995), which may contribute to the
accumulation of oxytocin stores in the neural lobe in advance of parturition. By the
end of pregnancy oxytocin nerve terminals become desensitized to endogenous
opioid restraint, which may contribute to the high secretion of oxytocin during
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parturition. At this time, a separate endogenous opioid system, acting upon jll-
receptors, actively restrains the electrical activity of oxytocin neurones (Douglas et
al., 1995; Russell et al., 1995). Oxytocin release within the supraoptic and
paraventricular nuclei is elevated during parturition as well as during suckling, but
not during late pregnancy. Intranuclear oxytocin release is unrestrained by
endogenous opioids during parturition. This intranuclear release of oxytocin may act
by local positive-feedback stimulation of oxytocin neurones to excite further
oxytocin release in the brain and into blood during both parturition and lactation
(Neumann et al., 1993).
Systemic and central administration of morphine, an opioid agonist, delays
the course of established parturition, with the delay accompanied by reduced plasma
oxytocin levels and overcome by treatment either with naloxone, a non-selective
opioid antagonist, or by infusion of oxytocin (Bicknell et al., 1988). Evoked oxytocin
release is potentiated by naloxone in late pregnancy, before and during parturition but
not in virgin rats (Hartman et al., 1986). The process of parturition is hastened by
administration of naloxone. Thus, an endogenous opioid mechanism inhibiting
oxytocin release appears to be active during late pregnancy, immediately before and
during parturition. This mechanism does not operate earlier in pregnancy or during
normal lactation and is not seen in virgin rats (Leng et al., 1988).
On the last day of pregnancy, increased local production of prostaglandin by
the uterus and decreased production of progesterone have been shown. The fall in
progesterone removes both a restraining influence on the oxytocin neurones and an
inhibitory effect on uterine tone, and also results in increased oxytocin receptor
expression in the uterus. It is likely that local prostaglandin, but not oxytocin, is a
physiological trigger for parturition. Mice lacking the gene encoding the receptor for
prostaglandin F are unable to deliver normal fetuses at term (Sugimoto et al., 1997).
Parturition is initiated when prostaglandin interacts with the prostaglandin receptor in
ovarian luteal cells to induce luteolysis. After corpus luteum collapse, a positive-
feedback loop between the uterus and the hypothalamic oxytocin system is
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established. Local prostaglandin production triggers uterine contractions, which
excite the oxytocin neurones. The released oxytocin triggers further prostaglandin
production and further uterine contraction (for reviews see Leng & Brown, 1997).
Oxytocin is secreted in response to stretching of the uterine cervix and hastens
expulsion of the fetus and the placenta. Oxytocin stimulates uterine contractions by
action on the uterine oxytocin receptors. A dual action of oxytocin appears in the
uterus, a uterotonic action on myometrium and a prostaglandin-releasing action on
endometrial/decidual cells (Chan, 1980).
The expression of oxytocin receptors has been demonstrated in the uterus,
mammary gland, pituitary and brain including the ventromedial hypothalamus, the
bed nucleus of the stria terminalis, the ventral pallidum, the paraventricular nucleus,
and the dorsal part of the supraoptic nucleus (Adan et al., 1995). A marked increase
of oxytocin receptor density is found in the endothelium and myometrium at term
pregnancy and reaches a maximum during labour (Alexandrova and Soloff, 1980;
Fuchs et al., 1982). The level of oxytocin receptor mRNA at the cervix also increases
at term with a further marked increase at parturition (Fuchs et al., 1996). An
increased sensitivity of the myometrium to oxytocin has been established at term that
could be the result of both up-regulation of oxytocin receptors and an increase in the
fraction of receptors coupled to signal transduction components (Strakova and Soloff,
1997).
Oxytocin is important for the normal progress of parturition to increase the
contractility of the uterus near term, although observations of transgenic mice lacking
oxytocin have demonstrated that parturition can proceed in the absence of oxytocin
(Nishimori et al., 1996; Young, III et al., 1996). During parturition, as during
suckling, bursts of activity of oxytocin neurones becomes highly synchronized, and
these bursts are correlated with abdominal contractions and pup delivery in conscious
rats (Summerlee, 1981). The pulsatile release of oxytocin from the pituitary gland is a
consequence of bursting activity of oxytocin neurones that is important for advancing
the progress of parturition. Background secretion of oxytocin is also increased during
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the expulsive phase (Higuchi et al., 1985; Higuchi et al., 1986a). Oxytocin is also
released within the SON and PVN during parturition, which may act by local positive
feedback stimulation of oxytocin neurones to excite further oxytocin release in the
brain and into blood (Neumann et al., 1993).
The process of parturition appears to involve the contractions of the uterus
induced by oxytocin release, causing movement of fetuses along the uterus to the
cervix, and also the contractions of abdominal muscles to expel the foetus from the
birth canal, which requires the integrity of the pelvic nerves. An increase of oxytocin
secretion from the neurohypophysis during parturition is probably in response to
afferent inputs arising from the uterus and cervix that are carried from the brainstem
in part by noradrenergic fibres from the nucleus tractus solitarii (NTS) (Antonijevic
et al., 1995; Menetrey and Basbaum, 1987; Menetrey et al., 1983), some of which
project directly to the oxytocin neurones. They are also activated by uterine
contractions, not just by the distention of the birth canal that results from fetal
expulsion (Douglas et al., 1995). Destruction of the pelvic nerve which projects to
the NTS or the NTS itself is associated with a prolonged duration of labour (Higuchi
et al., 1986b; Higuchi et al., 1987).
1.4.5.3 The milk-ejection reflex
Oxytocin is essential for suckling-induced milk-let down in lactation. In the
absence of oxytocin, particularly in transgenic 'oxytocin-knockout' mice, milk
ejection does not occur (Nishimori et al., 1996; Young, m et al., 1996). Oxytocin
(and vasopressin) mRNA expression is increased in the SON during lactation (Zingg
and Lefebvre, 1988), and the plasma concentrations of oxytocin, induced by suckling,
become higher than normal (Higuchi et al., 1985; Meyer et al., 1987). Oxytocin
released from the neurohypophysis acts at oxytocin receptors on the myoepithelium
which surround the alveoli to promote contractions in the mammary gland causing
milk let-down.
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In the lactating rat, suckling evokes periodic bursting activity (high frequency
bursts of spikes) in the oxytocin neurones at intervals of 1-10 min (Wakerley and
Lincoln, 1973). These bursting activities occur synchronously in most or all oxytocin
neurones of the SON and PVN (Belin and Moos, 1986; Belin et al., 1984), leading to
the release of a bolus of oxytocin into the circulation that is large enough to produce
contraction of the mammary myoepithelial cells and to cause milk ejection.
Central administration of oxytocin enhances the frequency of occurrence and
the amplitude of bursts (Freund-Mercier and Richard, 1984) whereas an oxytocin
antagonist has the opposite effect (Lambert et al., 1993). Moreover, local release of
oxytocin has been reported to occur within the PVN and SON during the milk-
ejection reflex (Landgraf et al., 1992; Moos et al., 1989a). It has thus been speculated
that oxytocin release within the hypothalamus is necessary for the bursting activity of
oxytocin neurones and their excitability, which exerts a facilitatory role and provides
a positive feedback signal to promote bursting of the whole oxytocin neurone
population (Freund-Mercier and Richard, 1984; Freund-Mercier and Richard, 1981;
Lambert et al., 1993). These bursting activities are accompanied by structural
plasticity of exclusively the oxytocin neurones involving a further increase in
membrane apposition and increased numbers of double synapses which may
contribute to the synchronized electrical activity in oxytocin neurones (Hatton and
Tweedle, 1982; Theodosis et al., 1986). An enlargement of oxytocin neurone
nucleoli in the PVN during lactation has also been reported (Russell, 1983).
As well as the magnocellular nuclei, certain limbic structures, including in
particular the bed nucleus of the stria terminalis and the ventrolateral septum, may
play an important part in the central action of oxytocin on the milk-ejection reflex. In
lactating rats, oxytocin excites neurones in these structures in vitro (Ingram et al.,
1990; Ingram and Moos, 1992) and also facilitates the bursting activity of oxytocin
neurones (Moos et al., 1991; Moos and Richard, 1989b).
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1.4.5.4 Osmoregulation
Vasopressin plays a critical role in maintaining body fluid and electrolyte
balance by promoting water reabsorption by the kidney (Abramow et al., 1987). In
the rat, however, oxytocin also contributes to sodium balance and mediates
natriuresis (Conrad et al., 1993; Verbalis et al., 1991). Indeed, the release of oxytocin
and vasopressin is regulated by changes in plasma osmolality (Dunn et al., 1973;
Negoro et al., 1988; Verbalis et al., 1986). Therefore, the concerted osmotic control
of vasopressin and oxytocin secretion represents a powerful osmoregulatory response
in the rat to regulate body fluid balance and counteract ionic disturbance in rats
through the effects of diuresis and natriuresis (Bourque et al., 1994).
At the physiological osmotic set-point, approximately 295 mosm/kg in rats
(Dunn et al., 1973), both vasopressin and oxytocin neurones tend to display slow (2-3
Hz) irregular firing (Poulain and Wakerley, 1982), consistent with the presence of
low, but detectable, plasma concentrations of vasopressin and oxytocin. Under
resting conditions, these low levels of vasopressin and oxytocin in the blood are
sufficient to contribute to basal antidiuresis (Conrad et al., 1993; Verbalis et al.,
1991) and natriuresis (Dunn et al., 1973), respectively. A reduction in plasma
osmolality by systemic administration of water or hypotonic saline inhibits
magnocellular neurones (Brimble and Dyball, 1977) and suppresses oxytocin and
vasopressin release (Rosella-Dampman et al., 1987; Strieker and Verbalis, 1986),
which promotes compensatory sodium retention and water excretion. Elevation in
plasma osmolality without changes in blood volume by systemic hypertonicity, in
contrast, dramatically increases the firing rate and eventually induces a phasic
bursting pattern of activity of putative vasopressin neurones (Poulain et al., 1977),
and also increases the firing rate of oxytocin neurones which in these cases fire
continuously rather than in bursts (Brimble and Dyball, 1977; Poulain et al., 1977).
Systemic administration of hypertonic saline also enhances the release of oxytocin
and vasopressin (Brimble and Dyball, 1977; Dunn et al., 1973; Landgraf et al.,
1988), which promotes sodium excretion and water retention. In addition, there is
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enhanced release of oxytocin and vasopressin within the SON following systemic
administration of hypertonic saline (Ludwig et al., 1994a). Direct administration of
hypertonic saline into the SON or PVN via a microdialysis probe evokes oxytocin
and vasopressin release within the SON and PVN (Hattori et al., 1990; Landgraf and
Ludwig, 1991; Ludwig et al., 1994b) as well as into the blood (Hattori et al., 1990).
In addition, dehydration produced by salt-loading (giving a 2% sodium chloride in
place of drinking water) or water deprivation results in an increased plasma sodium
concentration or osmolality which, in turn, elevates plasma oxytocin and vasopressin
concentrations (Balment et al., 1980; Jones and Pickering, 1969; Van Tol et al.,
1987) and depletes the neural lobe (George, 1976; Jones and Pickering, 1969; Van
Tol et al., 1987). Since substitution of hypertonic saline with small permeant
molecules such as mannitol causes a similar activation without any change in
extracellular sodium, oxytocin and vasopressin neurones are activated in response to
an increase in plasma osmolality rather than an increase in plasma sodium
concentration (Brimble et al., 1978).
The osmosensitive sites are located centrally and possibly also peripherally to
regulate sodium and water balance in a manner that maintains the osmotic pressure of
the extracellular fluid near an ideal set-point (Bourque et al., 1994). Peripheral
osmoreceptors may be located in the region of the hepatic portal vein, a strategic site
for early detection of systemic osmolality changes from ingested foods and fluids.
Osmosensitive information derived from peripheral osmoreceptors is transmitted to
the central regions that participate in the control of osmoregulatory reflexes (Fig. 4),
the NTS and the VLM, via the hepatic branch of the vagus nerve (King and
Baertschi, 1992; Kobashi et al., 1993). The NTS and VLM send direct projections to
magnocellular neurones of the SON and PVN (Day et al., 1984; Raby and Renaud,
1989). The osmosensitive information appears to be relayed to a number of rostral
structures including the MnPO (Saper and Levisohn, 1983), the zona incerta and the
parabrachial nucleus (Kobashi et al., 1993; Yamashita et al., 1980).
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Changes in systemic osmolality are detected centrally within forebrain
structures associated with the lamina terminalis including the OVLT, MnPO and
SFO (McKinley et al., 1996). Alterations in plasma tonicity or in the concentrations
of blood-borne hormones which play a role in blood volume and electrolyte
homeostasis, including angiotensin n, atrial natriuretic peptide and relaxin can be
detected by neurones in the SFO and OVLT (McKinley et al., 1996). Neurones in the
SFO and OVLT possess many binding sites for angiotensin II (McKinley et al.,
1990). The AT] subtype of the angiotensin receptor is the specific membrane receptor
for angiotensin II in the SFO and OVLT (Lenkei et al., 1997). ATI receptors are
directly involved in the osmotically induced release of vasopressin (Hogarty et al.,
1994). Neurones in the SFO that project to the SON and PVN are activated, as
identified by Fos expression, after systemic osmotic stimulation (Oldfield et al.,
1994). Thus, angiotensin II, generated both peripherally and centrally, may play an
important role in the osmotic control of vasopressin release by acting at the SFO and
AV3V.
Neurones in the SFO, MnPO, OVLT are also activated, as identified by Fos
expression, after systemic osmotic stimulation (Oldfield et al., 1994; Oldfield et al.,
1991a) and water deprivation (McKinley et al., 1994). Some of the activated
neurones, particularly in the OVLT, project to magnocellular neurones in the SON
(McKinley et al., 1994; Oldfield et al., 1994). In addition, destruction of the
anteroventral third ventricle region (AV3V) region, which includes the OVLT and
MnPO, attenuates the increase in plasma oxytocin concentration in response to
hypertonic injection (Blackburn et al., 1987), produces deficits in osmotically
regulated vasopressin release (Chiaraviglio and Perez, 1984), disturbs the ability to
excrete sodium during water deprivation (Bealer et al., 1983b), attenuates natriuresis
response to hypertonicity (Bealer, 1983a; McKinley et al., 1992), disrupts drinking
response to systemic administration of angiotensin and hypertonic saline (Lind and
Johnson, 1982), and produces deficits in the pressor responses to angiotensin II,
leading to progressive accumulation of sodium (Bealer, 1982; Hartle and Brody,
1984), suggesting that osmotic control of most osmoregulatory responses is achieved
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through central pathways originating from neurones located within these structures,
particularly the OVLT. Furthermore, it has been suggested that some neurones of the
OVLT are intrinsically osmoresponsive. Increase in the osmolality of the superfusion
media by addition of NaCl or mannitol prompts a depolarization of OVLT neurones
that project to the SON in vitro (Nissen et al., 1993) and also increases the firing
frequency of neurones in the OVLT (Vivas et al., 1990). In addition, local hypertonic
stimulation of the OVLT excites magnocellular neurones in the SON and PVN in
vivo (Honda et al., 1987). From intracellular recording experiments, hyperosmotic
stimulation of the OVLT in vitro has been shown to evoke an increase in the
frequency of spontaneous excitatory postsynaptic potentials (EPSPs) and in the firing
rate of neurones in the SON (Richard and Bourque, 1992; Richard and Bourque,
1995). Therefore, it is likely that osmoresponsive neurones located within the OVLT
that project to the magnocellular system are essential for osmoregulation of oxytocin
and vasopressin release.
The SON and PVN lie inside the blood-brain barrier, but are densely
vascularized with a large capillary surface area. In these areas, changes of osmotic
pressure of the extracellular fluid in these regions closely match that of the plasma.
Oxytocin and vasopressin neurones respond directly to changes in osmotic pressure
(Mason, 1980; Oliet and Bourque, 1993). Both continuous-firing and phasic-firing
neurones in the SON are activated in response to application of hypertonic saline to
the immediate neighbourhood of neurones in the SON by microtap in vivo (Leng,
1980). In addition, intracellular recordings of neurones in the SON in vitro have
shown that hypertonic solutions cause direct membrane depolarization (Abe and
Ogata, 1982; Bourque, 1989; Mason, 1980). These intrinsic responses result from
changes in the activity of mechanosensitive cation channels (Oliet and Bourque,
1993; Oliet and Bourque, 1996). These channels are inactivated when the cell
membrane is stretched due to cell swelling caused by hypotonicity, thereby
hyperpolarizing the neurone. In contrast, hyperosmotic stimulation causes cell
shrinking, resulting in an enhancement of a voltage-independent inward cationic
current, and provokes membrane depolarization.
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Indeed, intrinsically generated changes in membrane potential in
magnocellular neurones may be subthreshold for spike discharge during osmotic
stimulation (Bourque et al., 1994). An increase in firing rate is provoked by osmotic
stimulation of the OVLT from a selective modulation in the frequency of
glutamatergic EPSPs (Richard and Bourque, 1995). In addition, an acute electrolytic
lesion of the AV3V silences all neurones in the SON. Neurones are not
spontaneously active and are not excited by hypertonic stimuli, however, an increase
of neuronal activity in response to hypertonic stimuli is restored by local application
of glutamate (Leng et al., 1989; Leng et al., 1988; Russell et al., 1988). It is likely
that the intrinsic osmosensitivity of magnocellular neurones combines with
osmotically regulated excitatory synaptic drive, derived from osmosensitive neurones
in the OVLT, to modulate the firing rate of magnocellular neurones, which in the rat,
contributes to the regulation of natriuresis and diuresis through effects of oxytocin
and vasopressin (Bourque et al., 1994). Therefore, the sensitivity of the
neurohypophysial responses to osmotic stimuli in vivo requires concurrent activation
of intrinsic and extrinsic mechanisms in osmoregulation.
1.5 Distribution of neuronal nitric oxide synthase
Nitric oxide is a highly reactive and readily diffusible substance, and it has
proved difficult to localize NO in tissue and measure NO formation directly (Bredt &
Snyder, 1992). The sites of action of NO in brain tissue are therefore preferably
localized by the identification of the synthesizing enzyme NOS, by using NADPH-
diaphorase histochemistry, immunohistochemistry with antibodies to nNOS, and/or
in situ hybridization with antisense probes complementary to nNOS mRNA (Beesley,
1995; Bredt et al., 1991a; Bredt et al., 1990; Dawson et al., 1991; Vincent and
Kimura, 1992). These methods detect an enzyme associated with the NOS molecule,
the NOS molecule and NOS mRNA, respectively.
The NADPH-diaphorase histochemical technique is based on the presence of
an enzyme that can catalyze the NADPH-dependent conversion of a soluble
tetrazolium salt, the best known is nitroblue tetrazolium, to an insoluble, visible
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formazan. This establishes that NOS catalytic activity, which requires NADPH, is
responsible for the NADPH-diaphorase histochemical activity. The distribution of
NOS neurones appears identical to that of neurones staining for NADPH-diaphorase
(Bredt et al., 1991a; Dawson et al., 1991), and purified brain NOS has NADPH-
diaphorase activity (Hope et al., 1991). The NADPH-diaphorase staining is found in
the soma, in the cytoplasm but not in the nucleus, in the dendrites, axons and
terminal fields. The NADPH-diaphorase localizes in the nuclear envelope, inner and
outer membranes of mitochondria, Golgi apparatus, and endoplasmic reticulum in
both oxytocin and vasopressin neurones in the SON and astrocytes (Calka et al.,
1994).
NADPH-diaphorase containing neurones are distributed throughout the brain,
particularly in the olfactory bulb, the basal forebrain, the medulla, the hypothalamus,
the striatum, the hippocampus, the cerebellum, the visual system and the cortex
(Bruhwyler et al., 1993; Vincent and Kimura, 1992). In the hypothalamus NADPH-
diaphorase staining has been found, especially in the SON and PVN, the OVLT, the
preoptic nucleus, the lateral hypothalamic area, the ventromedial and dorsomedial
nuclei, the arcuate nucleus and various parts of the mammillary region (Vincent and
Kimura, 1992; Yamada et al., 1996). Neuronal NOS (nNOS) is the major nitric oxide
synthase isoform in the hypothalamus (Bhat et al., 1996).
High concentrations of nNOS, nNOS mRNA and the electron donor for the
enzyme reaction, NADPH are present in the magnocellular neurones in the SON and
PVN as well as the posterior pituitary gland (Bredt et al., 1990; Pasqualotto et al.,
1991; Pow, 1992; Sagar and Ferriero, 1987; Vincent and Kimura, 1992). The
posterior pituitary receives a widely distributed NO innervation, which originates in
the magnocellular neurosecretory system (Vanhatalo and Soinila, 1995).
It has been shown that nNOS and NADPH-diaphorase are co-localized with
neurotransmitters and the messenger molecules in the SON and PVN. Co-
localization of NADPH-diaphorase with vasopressin (Calka and Block, 1993b;
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Sanchez et al., 1994; Torres et al., 1993), oxytocin (Miyagawa et al., 1994; Sanchez
et al., 1994; Torres et al., 1993), somatostatin (Alonso et al., 1992), angiotensin II
(Calka and Block, 1993a), dynorphin (Murakami, 1994), CRF (Siaud et al., 1994)
and Met-enkephalin (Murakami, 1994) in the neurosecretory nuclei has been
reported. Neuronal NOS protein also coexists with oxytocin, CCK and galanin in the
SON, and with enkephalin, oxytocin and CRF in the PVN (Yamada et al., 1996).
1.6. Role of NO in biological functions integrated within the magnocellular
neurosecretory system
1.6.1 The role of NO in the regulation of neurohypophysial hormone secretion
The hypothesis that NO may play a role in osmoregulation has been led by the
study of Sagar and Ferriero in 1987 (Sagar and Ferriero, 1987). They found an
increase in NADPH-diaphorase staining in rat posterior pituitary gland after 8-days
of salt loading. Up-regulation of NOS mRNA expression has also been found in the
PVN and SON after chronic salt loading (Kadowaki et al., 1994; Villar et al., 1994b).
Dehydrated rats also show an increase of NADPH-diaphorase activity and NOS
mRNA in both the PVN and SON (O'Shea and Gundlach, 1996; Pow, 1992; Ueta et
al., 1995b). Furthermore, an involvement of NO under chronic hyperosmotic
stimulation is suggested in studies in mice and rats with inherited diabetes insipidus.
Homozygous (di/di) mice have nephrogenic diabetes insipidus and do not respond to
vasopressin that is secreted in increased amounts, while homozygous Brattleboro
(di/di) rats have hypothalamic diabetes insipidus and a deficiency in the secretion of
vasopressin (Valtin et al., 1965). An increase in the amount of nNOS protein in the
PVN and SON but not in the OVLT, MnPO and SFO of female homozygous (di/di)
mice and homozygous Brattleboro (di/di) rats has been reported (Wang and Morris,
1996). In addition, up-regulation of nNOS mRNA expression in the SON and PVN
has recently been reported in female homozygous Brattleboro (di/di) rats (Yamamoto
et al., 1997). After hypophysectomy, up-regulation of NOS mRNA expression has
been revealed in magnocellular neurones in the SON and PVN (Villar et al., 1994a).
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Furthermore, NO appears to be involved in the plasticity of ultrastructural changes in
the neurohypophysis in response to hypertonic saline, since the contact between the
basal lamina and the membrane of axon terminals in neurohypophysis of rats injected
with the NOS inhibitor A^-nitro-L-arginine methylester (L-NAME) and hypertonic
saline was less than those of rats that received hypertonic saline alone. Rats receiving
both L-NAME and hypertonic saline also had more axonal profiles enclosed within
neurohypophysial astrocytes than rats received hypertonic saline alone (Beagley and
Cobbett, 1997). These anatomical findings are complemented by functional studies.
Increases in NO-forming activity in the posterior pituitary have been reported after
chronic osmotic stimulation (Kadowaki et al., 1994; Pow, 1994).
The NOS system in the PVN and SON can also be modulated by non-
osmotic-stimuli, such as hypotension, haemorrhage and hypovolemia. Isotonic
hypovolemia, induced by polyethylene glycol (PEG) without changes of plasma
[Na+], resulting in increased nNOS mRNA expression in the SON and PVN (Ueta et
al., 1998), accompanied by dense staining for NADPH-diaphorase in the PVN and
SON. Increased expression of Fos protein in NADPH-diaphorase-positive cells has
been reported in the SON and the magnocellular and the medial parvocellular parts in
the PVN after PEG-induced hypovolemia (Ueta et al., 1998). In addition, Fos
expression in NADPH-diaphorase positive neurones in the SON and PVN is
increased in hypotensive conscious rats following haemorrhage and sodium
nitroprusside infusion (Petrov et al., 1995). Furthermore, nNOS mRNA expression is
increased in the caudal ventrolateral medulla, dorsal medulla, and hypothalamus,
primarily in the PVN (both parvo- and magnocellular divisions) and SON of
spontaneously hypertensive rats (Plochocka-Zulinska and Krukoff, 1997).
It has been demonstrated that central blockade of NOS by i.e.v.
administration of the NOS inhibitor A^-monomethyl-L-arginine (L-NMMA) to rats
deprived of water for 24 h increased the plasma concentration of oxytocin, but not
vasopressin (Summy-Long et al., 1993), and attenuated drinking and decreased
glucose utilization in the SFO and MnPO (Kadekaro et al., 1994). In conscious rats,
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central administration of L-NAME further enhanced oxytocin release, but not
vasopressin, in response to a painful stimulus (needle prick), isotonic saline, and
moderate, but not strong, hypertonic stimulation (Kadekaro et al., 1997). Central
administration of either the NO donor 5-nitroso-A-acetyl-penicillamine (SNAP) or
the NO precursor L-arginine increased the basal release of vasopressin in conscious
rats (Ota et al., 1993). Intracerebroventricular administration of L-NAME increased
plasma concentration of vasopressin and oxytocin in normovolaemic rats, and further
enhanced increased oxytocin release, but not vasopressin, in response to hemorrhage
(Kadekaro et al., 1998). Central administration of L-NAME potentiated basal release
of oxytocin and vasopressin in conscious rats. In rats i.e.v. administered with
angiotensin II and L-NAME, plasma concentration of oxytocin, but not vasopressin,
was significantly greater than in rats that received either angiotensin II or L-NAME
alone. Furthermore, Angiotensin Il-induced water intake was attenuated by L-NAME
(Liu et al., 1997). In conscious rabbits, the basal release of vasopressin was increased
by i.v. infusion of either L-NAME or sodium nitroprusside (SNP). Infusion of
L-NAME did not alter increased vasopressin release in response to i.v. infusion of
either hypertonic saline or SNP (Goyer et al., 1994). In pentobarbital anaesthetised
rats, the basal release of vasopressin was increased after i.e.v. injection of L-arginine
and was decreased after i.e.v. injection of L-NAME. Central administration of
L-NAME also reduced vasopressin release in response to hypotension induced by
SNP (Cao et al., 1996). Systemic administration of the NOS inhibitor A^-nitro-L-
arginine (L-NNA) enhanced oxytocin and vasopressin release in salt-loaded rats, but
not in normallly hydrated rats (Kadowaki et al., 1994). It is clear that NO has an
inhibitory effect on the release of oxytocin, whereas the effect of NO on vasopressin
release remains controversial.
In in vitro studies, KCl-evoked vasopressin release from rat hypothalamic
explants comprising the PVN and SON was attenuated by L-arginine and the NO
donors, sydnonimine-1 (SIN-1) and SNP. The effect of L-arginine was reversed by
the presence of L-NMMA, and reduced by the NO scavenger hemoglobin (Yasin et
al., 1993). A transient increase of basal release of vasopressin from posterior
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pituitary explants was found after incubation of the glands with L-NAME and
hemoglobin. L-arginine (but not D-arginine) reduced the stimulatory influence of
L-NAME on both vasopressin and oxytocin release (Lutz-Bucher and Koch, 1994).
Furthermore, SIN-1 also reduced KCl-stimulated vasopressin release. Nitric oxide
may regulate the release of oxytocin and vasopressin by acting on either the cell
bodies in the SON and PVN or their nerve terminals in the neurohypophysis.
In in vitro electrophysiological studies, an inhibitory effect of NO on neuronal
activity of both phasic and non-phasic neurones in the rat SON has been shown, as
SNP and L-arginine inhibited neuronal activity, whereas L-NAME and hemoglobin
enhanced neuronal activity of the SON neurones (Liu et al., 1997). Nitric oxide may
control SON neurons through NMDA receptors via a cGMP-independent pathway,
since the NO donors SNP and isosorbide dinitrate suppressed NMDA-evoked
depolarization, whereas the NO scavenger hemoglobin and the NOS inhibitor L-NNA
enhanced NMDA-evoked depolarization. Furthermore, L-NNA also attenuated an
NMDA-driven increase in intracellular concentration of cGMP (Cui et al., 1994).
It has been recently found that NO preferentially potentiates GABAergic
synaptic inputs into SON neurones without influencing glutamatergic inputs via
cGMP-independent mechanisms, since application of SNAP increased the frequency,
but not the amplitude, of spontaneous inhibitory postsynaptic currents (IPSPs)
recorded from the SON neurones, representing presynaptic GABA release, while
SNAP had no effect on excitatory postsynaptic currents (EPSPs), representing
presynaptic glutamate release (Ozaki et al., 1999). Hemoglobin and L-NNA did not
alter spontaneous IPSPs. The SNAP-evoked IPSPs were reduced by hemoglobin,
indicating that the effect of SNAP was mediated through NO. Furthermore,
application of a membrane-permeant analog of cGMP, 8-bromo cGMP, inhibited
both the amplitude and the frequency of the IPSPs and EPSPs, suggesting that the
action of NO on IPSCs in the SON may be mediated via cGMP-independent
mechanisms. Hence, NO increases GABA release by acting at presynaptic terminals
of GABAergic neurones rather than by a direct effect on SON neurones. In the rat
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PVN magnocellular neurones, spontaneous IPSPs were evoked by SNAP, bubbled
NO solution or L-arginine while spontaneous IPSPs were not altered by the NOS
inhibitor L-NAME. However, NMDA-evoked IPSPs were attenuated by either
L-NAME or by GABAa receptor antagonists, indicating that NO potentiated GABA
inputs via postsynaptic as well as presynaptic mechanisms (Bains and Ferguson,
1997b). Furthermore, parvocellular neurones, but not magnocellular neurones, in the
PVN are depolarized by bath application of NO, SNAP and L-arginine, and also by
bath application of a membrane-permeant cGMP analogue, 8-bromo-cGMP (Bains
and Ferguson, 1997a). Taken together, NO may exert a predominantly inhibitory
action on SON and PVN neurones via presynaptic as well as postsynaptic
mechanisms.
In the SFO neurones, an inhibitory effect of NO on neuronal activity has been
found to be mediated by cGMP (Rauch et al., 1997). Nitric oxide derived from SNP
inhibited the spontaneous electrical activity of the SFO neurones. Application of 8-
Bromo-cGMP mimicked the inhibitory effect of SNP. Furthermore, firing rate of
SNP-sensitive neurones in the SFO was suppressed by L-arginine and increased by
L-NMMA. It has been reported recently that that hyperosmotic stimuli directly
influence glutamatergic excitatory synaptic inputs to the neurones in the SON in vitro
by an action on the presynaptic terminals, as the frequency of the spontaneous EPSPs
induced by application of hypertonic saline was almost completely blocked by both a
non- N-methyl-D-aspatate (NMDA) antagonist and a non-selective glutamate
antagonist, but not altered by an NMDA antagonist (Inenaga et al., 1997).
1.6.2 Involvement of NO in pregnancy and parturition
In late-pregnant and parturient rats, but not in mid-pregnant rats, a decrease of
the density and number of NADPH-diaphorase-positive cells in the SON and PVN
and a reduction in the NOS enzyme activity in the posterior pituitary has been
reported (Okere and Higuchi, 1996a). By contrast, an increase in the number of cells
showing dense staining for NADPH-diaphorase increase in the SON and PVN has
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been demonstrated in mid-pregnant (Popeski et al., 1999) and in late-pregnant rats
(Popeski et al., 1999; Woodside and Amir, 1996). Other authors have reported an
increase in NOS protein and NOS mRNA expression in the hypothalamus obtained
from 20 day pregnant rats, assessed by western blot and northern blot, respectively
(Xu et al., 1996). However, an increase in NOS mRNA expression in the SON, the
PVN and the lamina terminalis has not been revealed in 15 day pregnant rats
(Luckman et al., 1997). Central administration of a NO donor in parturient rats
significantly delays the progress of parturition and inhibits the expression of maternal
behaviour (Okere et al., 1996b), which can be restored by central administration of
oxytocin. Systemic administration of a NO donor prolongs the duration of parturition
probably by interfering with foetal expulsion, while a NOS inhibitor has no effect
(Okere et al., 1996b).
Down-regulation of the NOS system in the brain in late pregnancy and during
parturition is consistent with observed changes in the uterine NOS system (Natuzzi et
al., 1993; Sladek et al., 1993; Yallampalli et al., 1994; Yallampalli et al., 1993).
Staining for NADPH-diaphorase present in multiple uterine structures increases
during pregnancy and decreases during parturition (Natuzzi et al., 1993). Uterus NOS
activity decreases in parturient rats (Natuzzi et al., 1993) and rabbit (Sladek et al.,
1993). In addition, the uterus posses an L-arginine-NO relaxation system, which
inhibits contractility during pregnancy but not during labour. During pregnancy, but
not during labour, NO generated from the utems inhibits the spontaneous
contractility of the uterus, causing substantial relaxation, which can be reversed by
administration of a NOS inhibitor and soluble guanylate cyclase (Yallampalli et al.,
1993). In women in pre-term labour, a NO donor glyceryl trinitrate continuously
delivered by transdermal patches is effective in suppression of uterine contractions
and in prolonging gestation (Lees et al., 1994). Furthermore, uterine NO and cGMP
formation are low in virgin rats, substantially increased during pregnancy, and
decreased during labour and immediately postpartum. The uterine production of NO
and cGMP is inhibited by oestrogen (Yallampalli et al., 1994). The NO-cGMP
system also exists in the human uterus, NO produced locally inhibits spontaneous
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contractility of the uterus. The relaxation responsiveness to NO is elevated during
pregnancy and decreased during labour (Buhimschi et al., 1995). Thus, the uterine
NOS system is up-regulated during pregnancy to maintain uterine contractile
quiescence, and down-regulated in late pregnancy and during parturition. A rise in
estrogen at term is thought to inhibit NO and cGMP generation from this system,
increase uterine contractility and facilitate the initiation of labour. In contrast to
findings of Yallampalli and colleagues, an increase in the calcium-dependent NOS
activity (nNOS and eNOS) measured indirectly by citrulline production has been
found in various tissues following treatment with oestrogen, but not progesterone, in
pregnant guinea pigs (Weiner et al., 1994), which suggests that the changes in NOS
expression and activity are mediated by oestrogen. In addition, NADPH-diaphorase
staining in the SON and PVN is increased following chronic oxytocin infusion in
oestrogen-implanted rats and by manipulation of ovarian steroid hormones involving
administration of chronic oestrogen and progesterone, which followed by
progesterone withdrawal to mimick the hormonal milieu of late pregnancy in
ovariectomized rats (Popeski et al., 1999).
1.6.3 Involvement of NO in lactation
During lactation, nNOS mRNA expression is increased in both magnocellular
and parvocellular neurones in the PVN (Ceccatelli and Eriksson, 1993). The number
of cells that show dense staining for NADPH-diaphorase also increases in the SON
and PVN (Popeski et al., 1999). The increase in NOS mRNA expression appears to
occur mainly in oxytocin neurones rather than vasopressin neurones as shown by
double in situ hybridization (Luckman et al., 1997). In addition, NOS mRNA
expression is increased in the SFO, MnPO and OVLT (Luckman et al., 1997).
Central administration of a NO donor but not a NOS inhibitor causes a disruption of
milk transfer from lactating rats to their pups after a 12 h period of separation (Okere
et al., 1996). In vivo electrophysiological studies have reported that central
administration of a NO donor or L-arginine disrupts, whereas a NOS inhibitor
permits, the milk-ejection associated bursts of oxytocin neurones, as well as the
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magnitude of milk-ejection bursts, without altering mammary gland sensitivity.
Systemic administration of a NO donor inhibits the contraction of the mammary
gland myoepithelial cells, since NO abolishes intramammary pressure in response to
oxytocin or electrical stimulation of the neurohypophysial stalk in anaesthetized
lactating rats (Okere et al., 1996). In conscious lactating rats, central administration
of NO donor inhibits Fos expression, in the PVN, SON, periventricular and preoptic
nuclei while a NOS inhibitor attenuates Fos expression in the PVN of urethane-
anaesthetized rats (Okere et al., 1999). Other authors have reported that systemic
administration of L-NAME potentiates Fos expression in the SON and PVN induced
by oxytocin i.v. infusion in conscious lactating rats (Woodside and Popeski, 1999).
1.7 c-fos immediate early gene product as a marker of neuronal activity
The expression of the immediate early gene c-fos and its protein product Fos
has been widely used as a marker of neuronal activity (Hughes and Dragunow, 1995;
Kaczmarek and Chaudhuri, 1997). The basal level of c-fos mRNA and Fos
expression are relatively low in most cell types (Cohen and Curran, 1989). Following
stimulation, transcription of c-fos is induced rapidly and transiently, and Fos is
translated (Morgan and Curran, 1988). In neurones, Fos is synthesized following
depolarization and voltage-gated enhancement of Ca2+ influx (Morgan and Curran,
1986). Once synthesized in the cytosol, Fos goes through extensive post-translational
modifications, including phosphorylation and translocation back to the nucleus,
where it influences the expression of the late-response genes. Fos is associated with
Jun, another protein product of the immediate early gene c-jun, through the leucine
zipper domain to form a dimerized complex. The Fos-Jun heterodimer represents one
form of transcription factor, activator-protein 1 (AP-1), which selectively binds to the
consensus sequence 5'-TGACTCA-3', known as the AP-1 binding site, in the
promoter region of the target genes to regulate transcription (Curran and Morgan,
1987; Sonnenberg et al., 1989). Fos can also recognize and bind to other DNA
sequences, one of which is 5'-TGACGTCA-3' known as CRE (cAMP response
element) which differs by only one base from AP-1 (Macgregor et al., 1990). CRE is
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present in the promoter region of the vasopressin gene (Mohr and Richter, 1990). The
regulatory effects of Fos heterodimers appear rather complex in vivo, ranging from
activation to repression of transcription. Fos itself acts as a negative regulator of its
own promoter, to repress transcription of c-fos gene (Konig et al., 1989; Sassone-
Corsi et al., 1988; Wilson andTreisman, 1988).
Fos is reliably produced following synaptic activation, allowing its use for
showing the activation of magnocellular neurones under a variety of stimulated
conditions such as systemic administration of hypertonic saline (Ceccatelli et al.,
1989; Sharp et al., 1991; Xiong and Hatton, 1996), dehydration (McKinley et al.,
1994; Oldfield et al., 1994), systemic administration of CCK (Luckman, 1992;
Onaka et al., 1995a) and parturition (Luckman, 1995; Luckman et al., 1993).
Hypertonic stimuli, dehydration and parturition are not specific to either cell types,
whereas CCK activates only oxytocin neurones. Interestingly, suckling in the
lactating rat, a potent stimulus for oxytocin neuronal activation and oxytocin release,
is not inefficient in inducing Fos expression (Fenelon et al., 1993). In addition,
antidromic stimulation of oxytocin and vasopressin neurones, that does not cause
transynaptic activation, is unable to induce Fos (Luckman et al., 1994).
In response to hypertonicity, Fos expression is induced in the SON and PVN
in parallel with enhanced release of oxytocin and vasopressin from the
neurohypophysis (Sharp et al., 1991; Verbalis et al., 1995). Prolonged hypertonic
stimulation by chronic salt loading has been found to up-regulate the expression of
oxytocin and vasopressin mRNA in the SON and PVN (Lightman and Young, 1987).
Intraperitoneal injection of hypertonic saline induces Fos-immunoreactivity in the
SON, PVN and structures associated with the lamina terminalis of the third ventricle,
including the SFO, OVLT and MnPO (Ceccatelli et al., 1989; Giovannelli et al.,
1990; Giovannelli et al., 1992) with a corresponding up-regulation of c-fos mRNA
expression in these areas (Hamamura et al., 1992). Although the pattern of neuronal
activity induced by hypertonic saline may determine the expression of Fos, the
precise role of activity in induction of Fos is questionable.
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1.8 Aims
The experiments were undertaken to investigate the role of NO in the
magnocellular neurosecretory system. We were particularly interested in exploring
changes of nNOS mRNA expression in the magnocellular neurones, as this has been
thought to be involved in the major events known to regulate the release of oxytocin
such as hyperosmotic stimulation, salt-loading, pregnancy and parturition. In
particular, we wished to test the following hypotheses:
1. Nitric oxide, produced by oxytocin neurones, is a negative-feedback
inhibitor of oxytocin secretion by its actions in the supraoptic nucleus and/or at the
posterior pituitary?
2. This action is particularly important in osmoregulation? To test these
hypotheses we undertook a series of experiments to study the role of the NO system
in the regulation of oxytocin release; both in response to osmotic stimuli, and in
response to other, non-osmotic stimuli. We used CCK as a stimulus for oxytocin
secretion which activates oxytocin neurones through a different pathway to that
through which osmotic stimuli activate oxytocin neurones.
3. Changes in this pathway underlie the altered osmoreceptiveness of





Adult female Sprague-Dawley rats weighing 250-350 g (Bantin & Kingman,
UK) were used throughout this work. Rats were housed up to five per cage under
standard conditions (12:12 h dark-light cycle, ambient temperature 20 ± 1°C). Food
(standard breeder diet, Bantin & Kingman, UK) and water were available ad libitum,
except where otherwise specified. Rats were acclimatised in the MFAA unit for 1-2
weeks after arrival before use in experiments or being mated.
To obtain pregnant rats, adult female rats were caged individually with a stud
male in mesh floored breeder cages. If a vaginal plug of semen appeared on the
underlying tray the next morning then that day was designated as day 0 of pregnancy.
After mating, rats were housed separately until the day of experiment. The number of
pups was counted post mortem and data were excluded if less than four pups were
found.
2.2 Non-recovery catheterization of the femoral vessels
To withdraw serial blood samples for determination of oxytocin and sodium
concentration the left femoral artery and vein were catherised. A sufficient number of
catheters (approximately 5-15 cm in length, OD 0.75 mm, size 3FG, Portex Ltd.,
Kent, UK) were prepared prior to surgery. The leading edges of catheters were
trimmed to 45° to ease insertion and connected to 1 ml plastic syringes (Steriseal
poly-vu syringes, Worcestershire, UK) filled with heparinised saline. Heparinised
saline (50 IU/ml) was prepared by a 1:100 dilution of a 5000 units/ml heparin
solution (Multiparin, CP Pharmaceutical Ltd., Wrexham, UK) in isotonic saline
solution (Steriflex No. 1, FL (manufacturing) Ltd., England, UK).
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Surgery
On the day of experiment, rats were intraperitoneally injected with urethane
(1.25 g/kg ethyl carbamate, 25% w/v solution, Sigma Chemical Company Ltd.,
Dorset, UK) which usually produced a sufficient level of anaesthesia by checking
withdrawal reflex that occurs in response to a noxious and usually painful stimulation
of the skin or subcutaneous tissues and muscle. If necessary, supplement doses were
given. Rats were placed in the supine position and an incision (approximately 1-2
cm) made just below the second inguinal nipple. The sheath which encapsulates the
femoral artery, vein and nerve was exposed and gently opened for several
millimetres. The femoral artery and vein were then separated from each other and the
femoral nerve by blunt dissection. Two ligatures (EP 1 suture silk, Davis and Geek,
Hampshire, UK) were then placed around the vessels. The first ligature was placed as
distal from the inguinal ligament as possible and tightened to occlude the vessel. A
loose ligature (half-hitch) was then formed but left several millimetres approximately
to the first ligature and a small clamp was placed over the vessel as close to the
ligament as possible. The vessel was then semi-transected with fine scissors between
the two ligatures. The tip of the catheter was inserted into the vessel and pushed
forwards in the direction of the ligament, this being facilitated by opening the
incision with fine forceps. The loose ligature was then tied round the vessel and
catheter to prevent blood loss while simultaneously advancing the catheter into the
vessel. The clamp was then removed and the catheter lay below the vessel until the
tip of the catheter lied below the inguinal ligament. If blood was easily drawn back
along the catheter, the ligature was then tied and two further ligatures were applied to
secure the catheter. Once catheters for both vessels were in place, the surgical wound
was closed with 2-3 stitches using suture silk (EP3, Davis and Geek, UK).
To infuse hypertonic saline solution i.v., the right femoral vein was




To determine the oxytocin concentration, 300 (0,1 blood samples were taken
via a femoral arterial catheter into 1 ml heparinised syringes, then transferred into
pre-numbered 1.5 ml eppendorf tubes and immediately centrifuged at 13,000 RPM
for 2-3 minutes (Micro Centaur, MSE, UK). Plasma samples (approximately 150 (0,1)
were separated from the blood cells, aliquoted into separate eppendorf tubes and
stored at -20°C until assay for oxytocin concentration. The remaining blood cells
were resuspended in 150 jal isotonic saline solution to equal the amount of plasma
removed. This solution was then returned to the rat as quickly as possible via the
femoral vein catheter.
To measure sodium concentration at the same time, a further 300 fil of blood
was taken from the femoral artery and treated in the same manner as above. Plasma
samples were aliquoted into separate eppendorf tubes for oxytocin concentration
measurements and sodium concentration measurements before frozen storage (4°C).
2.3 Intracerebroventricular (i.e.v.) infusion
To allow central drug administration into the right lateral ventricle,
implantation of intracerebroventricular cannulae was performed on urethane
anaesthetised rats. The scalp was shaved and the head of the rat was placed in a
stereotaxic frame. A longitudinal midline incision through the skin was made with a
scalpel. The dorsal surface of the skull was exposed by retracting the underlying
tissue and scraping away the periosteum. A 1 mm diameter hole was drilled at the
following co-ordinates: 1.6 mm right lateral, 0.6 mm caudal from Bregma for
insertion of a 22-gauge stainless steel guide cannula (Plastics One, USA). The i.e.v.
guide cannula (length 4.5 mm) was brought down vertically through the hole so the
tip was 3.5 mm below the surface of the skull. Two additional holes (1.2-1.3 mm
diameter) were drilled on either side of the midline lateral to the cannula placement
for insertion of 2 stainless steel screws (3.2 mm x 10 BA). Dental cement (Simplex
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Rapid, Associated Dental Products Ltd., Swindon) was then poured over the stainless
steel screws and around the guide cannula to a depth of approximately 3 mm to hold
the guide cannula in place. A cap was inserted into the guide cannula until the start of
the experiment. After the implantation of the cannulae, all rats were allowed to rest
for at least 2 h before the experiment was performed.
Before the experiment, an infusion cannula (28-gauge, length 5.5 mm, tip 4.5
mm below the surface of skull) was introduced into the right lateral ventricle via the
guide cannula. Solutions were administered through the infusion cannula via a
polythene tube (1.0 mm o.d., 0.5 mm i.d., Portex, R&J Wood, Paisley, UK)
connected to a 100 pi gas tight microsyringe (Hamilton, Sigma, UK).
2.4 Dorsal approach to the pituitary stalk
On the day of experiment, rats were anaesthetised with urethane and their left
femoral vein and artery cannulated for blood sampling. The head of the rat was
placed in a stereotaxic frame and the skull exposed and levelled by ensuring that
bregma and lambda were in the same horizontal plane. A 1 mm diameter guide hole
was drilled on the midline, 0.3 mm caudal to Bregma. A concentric stimulating
electrode (SNEX-100X, Clarke Electromedical Instruments, England, UK) was
placed down the guide hole until it reached the base of the skull. The electrode was
then lifted by about 0.1 mm to locate the electrode in the neural stalk of the pituitary
gland. After that, the stimulator (Grass stimulator) was set to deliver trains of
biphasic pulses (20 Hz, 10 s on 10 s off, 1 mA peak to peak) for 2 h. Blood samples
were collected before and after stalk stimulation in order to check the effectiveness of
stalk stimulation. Data were excluded from experiments of stalk stimulation if
plasma concentration of oxytocin was not increase following stalk stimulation.
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2.5 Intra-supraoptic nucleus retrodialysis
In 1997, Ludwig and Leng developed the intra-supraoptic nucleus
microdialysis technique combined with in vivo extracellular recording to investigate
the effect of local drug application on the activity of oxytocin and vasopressin
neurones. This technique was used in this thesis to deliver drugs directly to specific
areas of the brain.
The microdialysis probe
An in-house designed U-shaped dialysis probe consisting of a 1.3 mm U-
shaped dialysis fibre (molecular weight cut-off 5 kDa, 0.2 mm o.d., 3 mm total
membrane length, Spectra/Por RC Hollow Fibers®, Spectrum Med. Inc., Houston,
TX, USA) glued with cyanoacrylate adhesive on to the ends of two pieces of parallel
side-by-side 24-gauge stainless steel tubing (approximately 1.5-2 cm length) which
were connected to a syringe pump via polythene tubing (0.8 mm o.d., 0.4 mm i.d.;
Portex).
The microdialysis probe was perfused at 3 pl/min with artificial cerebrospinal
fluid (aCSF; pH 7.2, composition (mM): NaCl, 138; KC1, 3.36; NaHC03, 9.52;
Na2HP04, 0.49; urea, 2.16; MgCl2, 1.18) or with aCSF including a drug (see
experiment). As the dialysis membrane is semipermeable and the concentration of
drug in the dialysate higher than in the tissue, the membrane allows the passage of
the drug into the extracellular compartment.
Recovery rate of vasopressin with these probes has been estimated previously
as 1.60% in vitro (Landgraf and Ludwig, 1991) and 0.5% in vivo when implanted
into the lateral septum (Engelmann et al., 1992). In vitro recovery of oxytocin has
also been estimated as 1.99% for [3H] oxytocin and 1.62% for [125I] oxytocin
(Neumann etal., 1993).
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The ventral surgical approach
(Set up by Dr. Mike Ludwig)
Under urethane anaesthetised conditions, a femoral vein and the trachea of
female Sprague-Dawley rats were cannulated. The pituitary stalk and the right SON
were exposed by a transpharyngeal approach described previously (Leng and Dyball,
1991). Briefly, animals were laid supine in a stereotaxic frame. An incision was made
through the lower jaw between the lower incisors. The tongue was retracted ventrally
through the split jaw until the entire soft palate and epiglottis was clearly visible, and
secured with a retractor anchored to the frame. The lower incisors were pulled apart
to give clear access to the soft palate. The soft palate was removed using a cautery
probe to expose the posterior pharyngeal wall. The hard palate (approximately 3 mm)
was then removed with a dental drill. At the rostral end of the pharynx, the
presphenoid and basisphenoid bones and a venous sinus within the basi-sphenoid
bone were revealed. The sinus appeared as a purple smudge across the sphenoid bone.
To expose the neural stalk that lies beneath the sinus, a shallow hole was
made at the midline about 2 mm caudal to the sinus. The hole was filled with bone
wax to prevent blood leakage from the sinus and drilling was continued caudally
further down and rostrally, packing it with bone wax at regular intervals until an
opaque colour was clearly seen in the sinus. After the cavity reaches the sinus, it was
then drilled deeper. The last thin layer bone was gently and carefully removed using
fine forceps and a minute spatula with a slightly hooked end formed from a
disposable needle. The rostral adenohypophysis and the neural stalk were then
exposed.
To expose the right supraoptic region, the lateral wing of the palatine bone
and medial pharyngoid plate were cleared of muscle, and drilled away to expose the
trigeminal nerve. The SON lies laterally to the suture between the pre-sphenoid and
basi-sphenoid bones. The trigeminal nerve was removed from this region with two
pairs of fine forceps. The venous sinus, which runs alongside the sphenoid bone, was
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then compressed rostrally and caudally with small pledgets of tissue wedged against
the sphenoid bone. The supraoptic region was identified by the density of vasculature
that is often visible beneath the dura.
After removal of the dura with fine scissors, an in-house designed U-shaped
dialysis probe (described previously) was bent to position the loop of the membrane
flat onto the exposed ventral surface of the brain on the ventral glial lamina of the
SON. A glass micropipette (filled with 0.15 M NaCl, 20-40 MQ resistance, GC150F-
10, 1.5 mm O.D, 0.86 mm I.D., borosilicate glass capillaries, Clarke Electromedical
Instruments) was introduced into the centre of the loop of the dialysis membrane. A
stimulating electrode (SNEX-200X, Clarke Electromedical Instruments) was placed
on the neural stalk of the pituitary gland and set to deliver single matched biphasic
pulses (1 ms duration, <1 mA peak to peak) for antidromic identification of SON
neurones. Electrical stimuli applied to the neural stalk evoke action potentials in the
axons at a constant latency following the stimulus. These evoked spikes are
propagated antidromically to the cell bodies, and the latency reflects the conduction
velocity and length of the axon.
2.6 Oxytocin Radioimmunoassay
The radioimmunoassay (RIA) that was used throughout this work was
modified from a previous study (Higuchi et al., 1985). The oxytocin content in
unextracted plasma samples from individual rats could be determined by using
antibodies to a synthetic oxytocin-bovine serum albumin (b.s.a.) conjugate which
was raised in the rabbit and purified by Higuchi and his co-workers. Specificity of the
anti-oxytocin antibody was determined by Higuchi et al. (1985) by comparing the
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inhibition of the binding of I-labelled oxytocin to antibody with arginine-
vasopressin, arginine-vasotocin, and melanocyte-stimulating hormone-release
inhibiting factor. The cross-reactivity of these peptides is less than 0.005%.
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This antibody (Higuchi rabbit anti-oxytocin antibody) was added to solutions
containing either duplicate aliquots of rat plasma (containing unknown concentration
of oxytocin) or triplicate aliquots of known concentrations of standard oxytocin in a
assay buffer. Mixtures were left to incubate for 24 h to reach equilibrium. A fixed
amount of l25I-oxytocin (calculated to contain approximately 6-8,000 cpm) was then
added to all tubes and left for 48 h incubation. The amount of 125I-oxytocin bound to
the rabbit anti-oxytocin antibody was inversely proportional to the concentration of
oxytocin in the standard or plasma sample. The rabbit anti-oxytocin-I25I-oxytocin
conjugate was then precipitated out of solution using a second antibody (Donkey
anti-rabbit gammaglobulin). To further aid precipitation and visualisation, a
suspension of white Pansorbin cells was added prior to centrifugation. The
supernatant was then aspirated and the radioactivity of the precipitates was measured
with a gamma counter. Oxytocin concentration of the unknown samples was
determined by comparing the unknown precipitate radioactivity to precipitate
radioactivity of known standard oxytocin contents.
2.6.1 Materials
Assay Buffer
The assay buffer was prepared in distilled water and contained:
0.025% w/v Sodium Dihydrogen Orthophosphate 2-hydrate (NaH2P04.2H20
AnalaR, BDH Ltd, Poole Dorset, UK)
0.119% w/v Disodium Hydrogen Orthophosphate (Na2HP04 AnalaR, BDH)
0.1% w/v Sodium Azide (NaN2 AnalaR, BDH)
0.5% w/v Bovine Serum Albumin (BSA RIA grade, Sigma)
Standard Oxytocin
Standard oxytocin obtained from the National Institute for Biological
Standards and controls (Herts, UK) was dissolved in assay buffer to make a desired
concentration (50 ng/ml), aliquoted and kept in a -20°C freezer.
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First Antibody Buffer
First antibody buffer was an assay buffer containing normal rabbit serum
(SAPU, Lanarkshire, Scotland, UK) at a dilution of 1:400 to aid the precipitation of
the anti-oxytocin-12<T-oxytocin conjugate. This dilution was the lowest concentration
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of normal rabbit serum that produced the highest percentage of binding of ~ I-
oxytocin in the precipitates and was determined from trial assays containing
standards diluted in buffer and rat plasma. Total binding of assays was 40.76 ± 2.15
% of the total count of radioactivity.
First Antibody Solution
Rabbit anti-oxytocin antibody THF-3 was kindly donated by Dr. T. Higuchi
and stored at -20°C (diluted 1:200 in assay buffer). The final dilution used in assays
was 1:200,000 (1 pl/ml) in first antibody buffer. Anti-oxytocin serum at this dilution
bound 40-50% of the 125I-labelled oxytocin.
Second Antibody
Donkey anti-rabbit gammaglobulin (A-PPT1; IDS, Tyne and Wear, UK) was
stored at 4°C. The dilution used in assays was 1:25 in assay buffer.
Lyophilised l25I-Oxytocin
Lyophilised l25I-oxytocin (New England Nuclear, Boston, MA) was
resuspended in distilled water aliquoted and stored at -20°C. A concentration
calculated to give 3.7 KBq/ml radioactivity in assay buffer was found to give
between 6,000-8,000 cpm/50 p.l/min when counted by a gamma counter (LKB-
Wallac 1272 Clinigamma with a single detector consisting of a Nal crystal in a 3"
aluminium tube of wall thickness 0.25 mm, Wallac Oy, Finland).
Standardised Pansorbin Cells
Standardised pansorbin cells (10% w/v in phosphate buffer containing 0.1%
w/v sodium azide, Novabiochem (UK) Ltd, Nottingham, UK) stored at 4°C. The
dilution added to assays was 1:25 in assay buffer.
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2.6.2 Methodology
To quantify the unknown oxytocin concentration of experimental rat plasma
samples, a standard curve of precipitate radioactivity against known standard
oxytocin concentration was compiled. On the first day of assay, serial double
dilutions (in assay buffer) of a stock oxytocin aliquot were made to produce a range
of concentrations from 2.4-2,500 pg/ml.
Three other standards were also prepared for construction of the curve and
assessing the sensitivity and binding of the assay: -
TC, contained an aliquot of l25I-oxytocin only, to determine total count of
radioactivity added,
NSB, contained l25I-oxytocin and second antibody but no first antibody or
unlabelled oxytocin, to determine non specific binding of radioactivity,
BO, contained aliquots of 125I-oxytocin trace, first and second antibody but no
unlabelled oxytocin, to determine the maximum percentage binding of radioactivity.
On the day of assay, plasma samples were removed from the freezer as
required, thawed to 4°C and centrifuged for 1-2 min at 13,000 RPM before being
aliquoted into the appropriate tubes. The assay was performed in pre-numbered 0.75
ml polystyrene tubes (LP2 tubes, Luckman Ltd, Sussex, UK). Standards were assayed
in triplicate. Intra-assay, inter-assay standards and rat plasma samples were assayed
in duplicate.
Day 1
The experimental procedure for the addition of reagents to the appropriate
tubes was as follows:
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TC Nothing
NSB 50 |iil assay buffer, 50 pi first antibody buffer
BO 50 pi assay buffer, 50 pi first antibody solution
Standards 50 pi first antibody solution, 50 pi standard
Samples: 50 pi first antibody solution, 50 pi plasma sample
Solution was mixed well, covered with aluminium foil and kept overnight at 4°C.
Day 2
50 pi of 125I-oxytocin was added to all tubes, mixed well, recovered in foil
and kept at 4°C for 2/3 days.
Day 4/5
50 jlxI of second antibody solution was added to all tubes except TC, mixed
well, re-covered in foil and kept at 4°C for 24 h.
Day 5/6
50 pi of standardised pansorbin cells was added to all tubes except TC. Five
minutes later, all tubes were centrifuged at 3,000 rpm at 4°C for 30 min (Minifuge 2,
Heraeus-Christ, GMBH, Osterode, Germany). The supernatant was aspirated and the
radioactivity of each precipitate was measured for 1 -3 min in a gamma counter.
2.6.3 Calculation of radioimmunoassay results
A standard curve of precipitate radioactivity against known standard oxytocin
concentration was constructed automatically by Wallac Ultroterm 2 software.
Oxytocin contents of intra-assay, inter-assay standards and rat plasma samples were
then extrapolated from the standard curve.
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Assay Sensitivity
The sensitivity of an assay is the minimum detection limit of an assay. It
provides information about the minimum acceptable sample concentration and was
calculated using the following equation:
TBO- £2xSD)j - NSB
BO-NSB
SD is the standard deviation of the 125I-oxytocin bound in the three BO tubes.
The value obtained from this equation was then compared to the % of BO
radioactivity bound by each standard (2.4-2,500 pg/ml) calculated using the
following equation:
mean standard cpm - NSB
mean BO - NSB
The sensitivity of the assay was taken at the point where the value obtained
using the first equation was greater than those values obtained from the second
equation and converted to a concentration in pg/ml. The assay sensitivity was 3.84 ±
0.66 pg/ml at 93.25 ± 1.10 % of total binding.
Inter- and Intra-assay variation
Known concentrations of standard oxytocin (10, 50, 100, 250 and 500 pg/ml)
were included in each assay run to determine inter- and intra-assay variation.
Duplicates of each intra-assay standards were added at the beginning and at the end
of assays that allowed an intra-assay variation to be determined. The inter-assay
variation could be determined by adding the intra-assay standard solutions of
oxytocin from the previous assay and a comparison between the two assays was
made. The intra-assay and inter-assay coefficients of variation were 13.51 ± 1.97 %
and 16.66 ± 4.06 %, respectively.
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2.7 Fos immunohistochemistry
Fos which is the 380 amino-acid protein product of the immediate early gene
(IEG), c-fos (Curran et al., 1984), can be visualised by immunohistochemistry using
an indirect method (Douglas et al., 1995) and an avidin-biotin complex (ABC)
method (McKinley et al., 1994)). In our methodology, Fos immunoreactivity was
localised by both methods using the N-terminally selected Rabbit Polyclonal anti Fos
{c-fos Ab-2, Oncogene Sciences, Cambridge Bioscience, UK) as a primary antibody.
This antibody was raised against a peptide (SGFNADYEASSSRC) which
corresponds to residues 4 to 17 of human Fos and reacts with human and rodent
cellular forms of Fos (De Togni et al., 1988). This antibody offers a high specificity
with little cross-reactivity with Fos related antigens (FRAs) (Hoffman et al., 1992).
Nuclear immunolabelling was completely blocked by preabsorption of this antibody
with the synthetic 4-17 residues of human Fos but not affected by preabsorption of
the antiserum with the non-immunogenic residues 128-152 (McKinley et al., 1994;
Patronas et al., 1998; Rinaman et al., 1997).
Initially, brain sections were soaked with hydrogen peroxide solution to
deactivate endogenous peroxidase and then incubated in normal sheep serum solution
to preblock nonspecific sites. They were then incubated with a rabbit polyclonal
primary antiserum specific for Fos {c-fos Ab-2) for 48 h, followed by incubation with
a secondary antibody. For the indirect method, the sections were incubated with a
goat anti-rabbit IgG-peroxidase complex for 24 h. For the ABC method, the sections
were incubated with biotinylated goat anti-rabbit IgG for 1 h followed by incubation
for 1 h with Avidin-biotinylated horseradish peroxidase complex (ABC). Finally, the
sections were immersed in a glucose oxidase-nickel diaminobenzidine (DAB)
solution to label peroxidase. Fos immunoperoxidase labelling was clearly
demonstrated in the nucleus as a permanent, dense purple/black colour product




Heparinised saline (5 IU/ml) was prepared by adding 1 ml of a 5000 units/ml
heparin solution (Multiparin, CP Pharmaceutical Ltd., Wrexham, UK) to 1,000 ml
isotonic solution (Steriflex No. 1, FL (manufacturing) Ltd., England, UK).
4% Paraformaldehyde in 0.1 M Phosphate Buffer
4% Paraformaldehyde solution was prepared in double distilled water and
contained:
I.15% w/v Disodium Hydrogen Orthophosphate 2-hydrate (Na2HP04.2H20 AnalaR;
BDH),
0.272% w/v Sodium Dihydrogen Orthophosphate 1-hydrate (NaH2P04.H20 AnalaR;
BDH).
4.0% w/v Paraformaldehyde (CH20; Sigma)
This solution was then adjusted to pH 7.3-7.4 with 1 M HC1 or 1 M NaOH.
Phosphate Buffer (PB)
Phosphate buffer (1 M) was prepared in double distilled water and contained:
II.5% w/v Disodium Hydrogen Orthophosphate 2-hydrate (Na2HP04.2H20 AnalaR;
BDH),
2.72% w/v Sodium Dihydrogen Orthophosphate 1-hydrate (NaH2P04.H20 AnalaR;
BDH).
This solution was then adjusted to pH 7.3-7.4 with 1 M HC1 or 1 M NaOH.
To make 1,000 ml of 0.1 M Phosphate buffer, 100 ml of 1 M phosphate buffer was
added to 900 ml double distilled water.
Washing Solution (PB-T)
Washing solution for the indirect method was 0.1 M Phosphate buffer (pH
7.3-7.4) containing 0.3% v/v Triton X-100 (iso-Octylphenoxypolyethoxyethanol,
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BDH). Washing solution for the ABC method was 0.1 M Phosphate buffer (pH 7.3-
7.4) containing 0.2% v/v Triton X-100 (BDH).
Preincubation Buffer
Preincubation buffer was a washing solution containing 1% v/v Normal
Sheep Serum (SAPU, Lanarkshire, Scotland, UK).
Hydrogen Peroxide Solution
Hydrogen peroxide solution was 0.1 M phosphate buffer (pH 7.3-7.4)
containing:
0.3% w/v Hydrogen Peroxide (H2O2 AnalaR; BDH)
20% v/v Methanol (CH3OH AnalaR; BDH).
Primary Antibody
Rabbit Polyclonal anti Fos (c-fos Ab-2, Oncogene Sciences) was diluted
1:1,000 in preincubation buffer.
Secondary Antibody
Secondary antibody for the indirect method was goat anti-rabbit IgG-
peroxidase complex (PI 1000, Vector, UK) diluted 1:1000 in 0.1 M PB containing
0.3% Triton X-100 (BDH) and 1% Normal sheep serum (SAPU).
Secondary antibody for the ABC method was made in PB-T and contained
1 % v/v biotinylated anti-rabbit immunoglobulin and 3% v/v normal goat serum
(Vectastain Elite ABC Kit rabbit IgG's, Vector Laboratories, Peterborough, UK).
Avidin-biotinylated horseradish peroxidase complex (ABC)
ABC solution was made in PB-T and contained:
2% v/v Avidin DH
2% v/v Biotinylated horseradish peroxidase
(Vectastain Elite ABC Kit rabbit IgG's, Vector Laboratories)
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This solution was left to incubate for at least 30 minutes prior to use.
Acetate Buffer (0.2 M)
Acetate buffer (0.2 M) was made in double distilled water and contained:
1.64% w/v Sodium Acetate Anhydrous (CH3COONa; BDH).
This solution was then adjusted to pH 6.0 using acetic acid.
Glucose Oxidase-Ni DAB Solution
Glucose oxidase-Ni DAB solution contained:
0.4% w/v Glucose (C6Hi206 AnalaR; BDH)
0.08% w/v Ammonium Chloride (NH4CI AnalaR; BDH)
0.003% w/v Glucose Oxidase (b-D-glucose: oxygen 1-oxidoreductase; EC 1.1.3.4,
O(CHOH) 4CHCH2OH, type VII-S from Aspergillus niger, Sigma)
2.5% w/v Di-Ammonium Nickel (II) Sulphate 6-Hydrate ((NH4) 2S04NiS04.6H20
AnalaR; BDH)
0.025% Diaminobenzidine (DAB) (3,3',4,4'-Tetraaminobiphenyl, tetrahydrochloride,
C12H14N4.4HCI; Sigma)
To make up 100 ml of glucose oxidase-Ni DAB solution, nickel sulphate,
glucose and ammonium chloride were dissolved in 50 ml of 0.2 M acetate buffer and
DAB was dissolved in 50 ml of double distilled water. After that, nickel solution and
DAB solution were mixed well and filtered. The glucose oxidase was added
immediately prior to use.
Stop Solution
Stop Solution (0.1 M Acetate Buffer) was made by diluting 0.2 M acetate
buffer with an equal volume of double distilled water.
Chrome Alum Gelatine
Chrome alum gelatine solution was made in double distilled water and
contained:
1 % w/v gelatine powder (BDH)
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0.1% w/v chromic potassium sulphate (Chromium (III) potassium dodecahydrate,
CrK(S04)2.12H20, BDH)
2.7.2 Methodology
In our methodology, an indirect method and an ABC method were used for
Fos immunohistochemistry and both were performed with gentle agitation on a
rotational shaker (R100/TW, Luckman Ltd., Sussex, UK).
2.7.2.1 Indirect method
After decapitation, rat brains were removed from the skulls, covered with
powdered dry ice until frozen and then stored at -70°C. Frozen brains removed from
a -70°C freezer were sectioned coronally (15 Jim thickness) through the level of the
SON and PVN, which corresponded to the stereotaxic atlas of Paxinos and Watson
(1982), on a cryostat at optimal temperature (-12 to -16°C). Sections were thaw-
mounted onto chrome alum gelatine subbed slides (4 sections per slide) and kept in
slide boxes stored in a -70°C freezer. Marker slides for orientation were collected
every ninth section and counterstained with toluidine blue.
Day 1
After warming up to room temperature, slides were selected and the sections
were framed using PAP pens (Bayer Diagnostics, Hampshire, UK). The slides were
placed in racks and the sections fixed in 4% paraformaldehyde in 0.1 M PB (pH 7.3)
for 30 min and then washed in 0.1 M PB (2x5 min, 1x10 min). Endogenous
peroxidase was then deactivated with hydrogen peroxide solution for 15 min and
washed off with washing solution for 15 min. Non-specific staining was then blocked
by preincubation buffer containing 0.3% Triton X-100, 1% normal sheep serum in
0.1 M PB for 1 h. Excess liquid was drained off and the slides were placed in flat
slide boxes containing filter paper soaked with 0.1 M PB. An excess of primary
antibody solution containing Ab-2 Fos antibody at 1:1,000 diluted in preincubation
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buffer was pipetted onto each section on all slides. The slide boxes were sealed and
the sections incubated for 48 h at 4°C. Additional primary antibody solution was
applied to prevent drying out of the solution the next morning and early on day 3.
Day 3
Excess primary antibody was washed out using washing buffer containing
0.3% Triton X-100 in 0.1 M PB (8x5 min). After draining off any excess liquid, the
slides were replaced in the flat slide boxes. An excess of secondary antibody
solution, goat anti-rabbit peroxidase complex, was pipetted onto sections and
incubated in the sealed slide boxes for 24 h at 4°C.
Day 4
Early the next morning, additional secondary antibody solution was applied as
required. The sections were washed in PB-T (2x10 min) and rinsed with 0.1 M
acetate buffer for 2 min. The sections were then incubated with the glucose oxidase-
Ni DAB solution for approximately 10 min. Progress of the reaction was followed by
viewing under a light microscope. Once the reaction had worked and some nuclei
appeared black, the reaction was terminated with stop solution for 5 min, and then a
rinse with PB for 5 min to prevent excessive background developing. The sections
were then dehydrated through serial concentrations of ethanol (70%, 90%, 95%,
100% and 100%) and then into xylene. The slides were finally coverslipped using
DPX mountant (BDH).
2.7.2.2 Avidin-biotin complex (ABC) method
Rats were deeply anaesthetised with sodium pentobarbitone (Saggatal, Rhone
Merieux Ltd., Essex, UK) at a dose of 50 mg/kg, i.p.. An incision was made through
the abdomen just below the rib cage. The thoracic cavity was opened by making two
horizontal cuts through the rib cage and the cut thoracic wall was then folded
headward to expose the heart. A blunt 23-guage hypodermic needle connected to a
perfusion pump (Minipuls 2, Gilson, Anachem House, Luton, UK) via polythene
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tubing filled with heparinised saline was quickly inserted upward through the apex of
the left ventricle, passed through the aortic valve and the tip of the needle located in
the ascending aorta. The needle was then clamped in place with a hemostat across the
ventricle. Rats were perfused with 30 ml of heparinised saline at a flow rate of 10
ml/min. Immediately after starting the pump, the right atrium was cut to allow an
escape route for the blood and perfusion fluid. After the atrium effluent was clear,
rats were perfused with 250-300 ml of fixative (4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.3-7.4) at a flow rate of 10 ml/min. The brains were removed
and post-fixed in fixative overnight at 4°C. Brains were then transferred into 30%
sucrose in fixative overnight and stored in 30% sucrose in 0.1 M PB at 4°C for 24 h
or until the brains sank.
Day 1
Sections (50 |im thickness) were cut on a sledge microtome equipped with a
freezing platform throughout the brain area of interest (SON and PVN). Free-floating
sections from each brain were collected in a petri dish containing 0.1 M PB and then
washed (4x15 min) in washing solution (0.2% Triton X-100 in 0.1 M PB). [Triton X-
100 is a detergent that increases tissue impregnation.] Endogenous peroxidase was
then deactivated with hydrogen peroxide solution for 15 min and washed off with
washing solution (3x10 min). Non-specific staining was then blocked by
preincubation buffer containing 1% normal sheep serum for 30 min. After that the
sections were incubated in Ab-2 Fos antibody (Rabbit polyclonal; Oncogene
Sciences, Cambridge Bioscience, UK), at 1:1,000 diluted in preincubation buffer, for
48 h in 7 ml labelled plastic bottles (Bijou container, Sterilin) at 4°C.
Day 3
Excess Ab-2 Fos antibody was washed off from the sections with PB-T (3x10
min). Fos immunoreactivity was visualised by the avidin-biotin peroxidase
technique. To localise the antibody-antigen complex, sections were incubated in
secondary antibody solution (1% biotinylated anti-rabbit immunoglobulin and 3%
normal goat serum in PB-T) for 1 h at room temperature. After that, the sections were
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washed in PB-T (3x10 min) and then left to incubate in ABC complex solution (2%
Avidin DH and 2% Biotinylated horseradish peroxidase in PB-T) at room
temperature for 1 h. The sections were washed in PB-T (2x10 min). After that the
sections were rinsed with 0.1 M acetate buffer for 5 min. They were then incubated
with the glucose oxidase-Ni DAB solution for approximately 10 min. Progress of the
reaction was followed by viewing under a light microscope. Once the reaction had
worked and some nuclei appeared black, the reaction was terminated by replacing the
glucose oxidase-Ni DAB solution with stop solution for 5 min, and then a rinse with
PB for 5 min to prevent excessive background developing. The sections were then
mounted onto the chrome alum gelatine subbed slides in serial order and left to dry
overnight. The sections were then dehydrated through serial concentrations of ethanol
(70%, 90%, 95%, 100% and 100%) and then into xylene. Slides were finally
coverslipped using DPX mountant (BDH).
Quantitative Analysis
The slides were coded by covering identifying numbers with masking tape
and assigned random numbers before quantification to prevent bias. The sections
were viewed under a light microscope (xlO objective, Wang 6000 series microscope)
and Fos positive nuclei were counted in the SON and PVN on both the left and right
sides. The animal mean for each region and the group means ± SEM were then
calculated.
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2.8 In situ Hybridization
In situ hybridization histochemistry (ISH) has become a powerful technique
for the detection and localisation of specific messenger ribonucleic acids (mRNA)
within morphologically preserved cells or tissue preparations (Lewis et al., 1985). In
our methodology the expression of neuronal nitric oxide synthase (nNOS) and
oxytocin gene was demonstrated within fixed brain tissues using chemically
synthesized oligonucleotide probes as described previously (Kadowaki et al., 1994;
Luckman et al., 1997). These probes comprised short single stranded DNA sequences
(ssDNA) complementary to designated sequences of nNOS mRNA (Bredt et al.,
1991b) and oxytocin mRNA (Ivell and Richter, 1984). Their small sizes (45 bases for
nNOS probe and 25 bases for oxytocin probe) give them good penetration properties,
which is considered to be one the main factors for successful in situ hybridization.
nNOS and oxytocin probes were labelled using terminal deoxynucleotidyl transferase
(TdT) with either [a-35S]dATP (Davies et al., 1995; Kishimoto et al., 1993) or
digoxigenin-dUTP (Lewis et al., 1990), respectively.
Brain sections were fixed with paraformaldehyde solution to reduce the
activity of tissue nucleases and preserve the structure of native mRNA without
disrupting tissue morphology. The sections were washed in phosphate buffer saline
solution, acetylated in triethanolamine solution containing acetic anhydride in order
to reduce non-specific DNA binding to charged particles. The sections were then
dehydrated through a series of ethanol solutions (70%, 80%, 95%, 100%),
delipidated in chloroform to improve probe access, and rehydration in 95% ethanol.
They were then hybridized for 17 h at 37°C in hybridization buffer containing the
35S-labelled nNOS probes (100,000 dpm/p.1) or the DIG-labelled oxytocin probes (2
fmol/fil). The slides were then washed stringently in 1 x SSC at 55°C, which is
important to remove unhybridized probe. The slides for radioactive in situ
hybridization were rinsed in ammonium acetate to remove salts and then in 70%
ethanol. After air drying, they were exposed to autoradiographic film for 3 weeks
followed by dipping in emulsion for 4 weeks. The film and emulsion dipped slides
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were photographically developed and fixed. Film autoradiography provides
information on the intensity of the hybridization signals and the regional distribution
of nNOS mRNAs while photographic emulsion provides information concerning the
cellular localization of nNOS mRNA transcripts.
The slides for non-radioactive in situ hybridization were taken from 1 x SSC
for immunological detection. They were incubated in blocking solution for 30 min
and covered with anti-DIG-alkaline phosphatase solution (1:500) for 1 h. The slides
were then left to incubate with colour reaction solution overnight. The non¬
radioactive hybridization signal for oxytocin mRNA was clearly shown in the
cytoplasm as a brown colour product, which allowed localization of oxytocin mRNA
transcripts with cellular resolution.
2.8.1 Oligonucleotide Probes
Oligonucleotide probes must be species specific and only recognise a
designed mRNA sequence especially for gene family homologies such as oxytocin
(Ivell and Richter, 1984) and vasopressin (Land et al., 1982) which contain extensive
sequence similarities. The stability of the hybridized sequences is determined by the
probe length, GC:AT ratio, the number of mismatched base pairs and by temperature
and salt concentration during the hybridization washes (Lewis et al., 1985).
2.8.1.1 Antisense Oxytocin oligonucleotides
Antisense oxytocin oligonucleotides were obtained from Oswel DNA
Service, Department of Chemistry, University of Edinburgh. They were prepared by
an automatic DNA synthesiser and partially purified by gel filtration and dissolved in
distilled water (16 OD units per ml or 0.2 pmole/ml). The sequence of the antisense
oxytocin oligonucleotide, complementary to bases 912-936 of oxytocin mRNA (Ivell
and Richter, 1984) (MW=9555), is shown below:
5'- CTC GGAGAA GGC AGA CTC AGG GTC G -3'
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2.8.1.2 Antisense neuronal Nitric oxide synthase (nNOS) oligonucleotides
Three 45-mer antisense nNOS oligonucleotides (070, 071 and 073) which
correspond to rat nNOS sequence (Bredt et al., 1991b) were kindly donated by Dr
S.M. Luckman from the Babraham Institute, Cambridge, UK. They were dissolved in
distilled water (33 ng/jLtl or ~2 pmol/|al).
nNOS 070 (complementary to bases 223-267 of nNOS mRNA (5'-noncoding region),
MW= 16900)
The sequence of antisense nNOS 070 oligonucleotide is shown below:
5'- AGA GTT CTG TCG CCT CTG TCT TGA CGT CAA CTT GGC GTC ATC TGC -3'
nNOS 071 (complementary to bases 4714-4758 nNOS mRNA (3'-noncoding region),
MW=17102)
The sequence of antisense nNOS 070 oligonucleotide is shown below:
5'- AGG CAG AGC AGG GCC ACT CGG TTC AGC CGT GTG TGT CCG AAT TTA -3'
nNOS 072 (complementary to bases 1662-1706 of nNOS mRNA, MW=16946)
The sequence of antisense nNOS 070 oligonucleotide is shown below:
5'- CCT TTG TTG GTG GCA TAC TTG ACA TGG TTA CAG ATG TAG TTG AAC -3'
2.8.2 Materials
1. Slides
Slides were soaked in strong cleaning solution overnight, washed with tap
water throughout the day, rinsed 3 times in autoclaved deionised double distilled
water (adddH20), dipped in 80% alcohol to degrease and left to dry in a 37°C oven.
Slides were then coated with chrome-alum gelatine and baked in a 37°C oven
overnight. Coated slides were stored in clean dry slide boxes with silica gel packets.
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2. Glassware and plasticware
All glassware was baked at 200°C for 12 h, and all plasticware was wrapped
with tinfoil and then autoclaved.
3. Solutions
All solutions were made in DEPC-treated H2O, except for Tris buffer and T/E
buffer.
Diethyl pyrocarbonate treated water (DEPC-treated H?Q)
0.1% v/v Diethyl pyrocarbonate (DEPC, Sigma), inhibitor of RNAses, was
added to the deionized double distilled water.
Strong Cleaning Solution
200 g potassium dichromate was dissolved in 2000 ml distilled water and
then 200 ml concentrated sulphuric acid was added while the flask was immersed in
cold water.
Chrome Alum Gelatine
Chrome alum gelatine solution was made in DEPC-treated H20 and
contained:
1% w/v gelatine powder (BDH)
0.1% w/v chromic potassium sulphate (Chromium (III) potassium dodecahydrate,
CrK(S04)2.12H20, BDH)
0.2 M Phosphate Buffer Saline Solution (PBS)
Stock A: 0.2 M Na2HP04 stock solution was made in DEPC-treated H20 and
contained:
3.56% w/v Disodium Hydrogen Orthophosphate 2-hydrate (Na2HP04.2H20 AnalaR;
BDH),
1.7% w/v Sodium Chloride (NaCl AnalaR; BDH)
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Stock B: 0.2 M NaH2P04H20 stock solution was made in DEPC-treated H20 and
contained:
2.76% w/v Sodium Dihydrogen Orthophosphate 1-hydrate (NaH2P04.H20 AnalaR;
BDH).
1.7% w/v Sodium Chloride (NaCl AnalaR; BDH)
To make 1,000 ml of 0.2 M Phosphate buffer, 190 ml of Stock B was added to 810
ml of Stock A. This solution was then adjusted to pH 1.2-1A with 1 M HC1 or 1 M
NaOH.
0.1 M PBS was made by diluting 0.2 M PBS with an equal volume of DEPC-treated
h2o.
4% Paraformaldehyde in 0.1 M PBS (pH 7.4)
4.0% w/v Paraformaldehyde (CH20; Sigma) was dissolved in 0.1 M PBS and then
adjusted to pH 7.4 with 1 M HC1 or 1 M NaOH.
Triethanolamine (TEA) solution for acetylation
Triethanolamine solution was made in DEPC-treated H20 and contained:
0.25% v/v Acetic anhydride (C4H603, Sigma)
1.332% v/v Triethanolamine (1.12 g/ml Triethanolamine, C6H15NO3, Sigma)
0.877% w/v Sodium chloride (NaCl AnalaR, BDH)
300 m M Ammonium Acetate
2.312% w/v Ammonium acetate (BDH) was dissolved in DEPC-treated H20.
1 M Tris stock solution
12.12 g Trizma-Base (Tris[hydroxymethyl]aminomethane, C4H11NO3, Sigma)
was dissolved in 80 ml adddH20. Concentrated HC1 was added slowly while stirring
until desired pH was reached.
desired pH: Approximate amount of concentrated 1 M HC1
pH 7.4 7 ml
pH 7.6 6 ml
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pH 8.0 4.2 ml
0.5 M EDTA stock solution (pH 8.0)
I.861 g EDTA (ethylenediaminetetraacetic acid, disodium, dihydrate,
CioHuN^OgNai.HiO, Sigma) was dissolved in 40 ml adddEEO. To help dissolve of
this solution 10 M NaOH or 2 g NaOH pellets were added.
adddH20 was then added to make up to 100 ml. The solution was adjusted to pH 8.0
with 1 M HC1 or 1 M NaOH.
0.2 M EDTA (pH 8.0)
4 ml of 0.5 EDTA (pH 8.0) was added to 6 ml adddH20.
Tris/EDTA Buffer (10 mM Tris (pH 7.4) / 1 mM EDTA (pH 8.0))
100 ml of T/E buffer contained:
1 ml 1 M Tris (pH 7.4) stock solution
200 |il 0.5 M EDTA (pH 8.0) stock solution
RNase Buffer (10 mM Tris 8.0, 0.5 M NaCl and 1 mM EDTA)
RNase buffer was made in DEPC-treated H20 and contained:
0.14% w/v Tris 8.0 (Sigma)
2.9% w/v Sodium chloride (NaCl AnalaR, BDH)
0.04% w/v EDTA (ethylenediaminetetraacetic acid, disodium, dihydrate,
CioHi4N2OgNa2.H20, Sigma)
RNase solution (20 |lg/ml)
II.2 (J.1 of RNase A (100 mg/ 7 ml: 100 units/mg RNase enzyme solution A
type XA, Sigma) was added to 8 ml RNase buffer.
Standard sodium citrate (SSC)
20xSSC stock solution was made in DEPC-treated H20 and contained:
17.54% w/v Sodium chloride (NaCl AnalaR, BDH)
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8.82% w/v Tri sodium citrate (Na3C6H507.H20 AnalaR, BDH)
The solution was adjusted to pH 7.0 with a few drops of a ION NaOH.
To make dilutions: lxSSC 50 ml 20xSSC was added to 950 ml DEPC treated H20
2xSSC 100 ml 20xSSC was added to 900 ml DEPC treated H20
4xSSC 200 ml 20xSSC was added to 800 ml DEPC treated H20
Herring sperm single stranded DNA
10 mg single stranded deoxyribonucleic acid (ssDNA, from herring sperm,
Sigma) was dissolved in 1 ml DEPC-treated H20.
Dextran sulphate
50% w/v Dextran sulphate sodium salt (Sigma) was made in DEPC-treated
h2o.
Deionized Formamide
50 ml Formamide (HCONH2, BDH) was added to 5 g of mixed-bed, ion-
exchange resin (AG501-X8(D), Bio-Rad), stirred for 30 minutes at room temperature
and then filtered twice.
Prehybridization buffer
Prehybridization buffer contained all components of a hybridization buffer
except probe and dextran sulphate. 10 ml prehybridization buffer contained:
2 ml 20xSSC
200 |il 50xDenhardt's solution (Sigma)
500 |il 10 mg/ml Herring sperm ss DNA (Sigma)
5 ml Deionized Formamide (BDH)
30 |itl 2-Mercaptoethanol (C2HeOS, Sigma)
2.270 ml DEPC-treated H2Q
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Hybridization Solution
Hybridization solution was made in DEPC-treated H20 and contained:
5 ml 20xSSC
500 jllI 50xDenhardt's solution (Sigma)
1250 pi 10 mg/ml ss DNA (Sigma)
5 ml 50% Dextran sulphate (Sigma)
Hybridization buffer
Hybridization buffer contained:
4700 pi Hybridization solution
5000 pi Deionized Formamide (Sigma)
30 pi 2-mercaptoethanol (Sigma)
The volume of radioactive labelled probe added was calculated to give
100,000 dpm/40 pi of hybridization buffer.
The non-radioactive labelled probe was diluted in hybridization buffer to a
concentration of 2 fmol/pl concentration.
Glycogen-EDTA mixture
200 pi 0.2 M EDTA (pH 8.0) was added to 1 pi 20 mg/ml Glycogen solution
(Boehringer Mannheim).
4 M Lithium Chloride
4 M Lithium Chloride was made by diluting 8 M Lithium Chloride (LiCl for
molecular biology, Sigma) with an equal volume of DEPC-treated H20.
Soaking solution
4xSSC was added to an equal volume of Formamide.
1 M Magnesium Chloride




11.688% sodium chloride (NaCl AnalaR, BDH) was made up in adddH20.
Buffer 1 (100 mM Tris HC1 (pH 7.5), 150 mM NaCl)
100 ml of buffer 1 was made up in adddH20 and contained:
10 ml 1 M Tris HC1 (pH 7.5)
7.5 ml 2 M Sodium Chloride (NaCl AnalaR, BDH)
Blocking solution
Blocking solution was buffer 1 containing 0.1% Triton® X-100 (for
molecular biology, Sigma) and 2% normal sheep serum (SAPU).
Anti-digoxigenin antibody solution
Anti-DIG-alkaline phosphatase (Sheep anti-Digoxigenin alkaline phosphatase
[Fab fragment], Boehringer Mannheim) was diluted 1:500 in Buffer 1 containing 0.1
% Triton® X-100 and 1 % normal sheep serum.
Buffer 2 (100 mM Tris HC1 (pH9.5), 100 mM NaCl, 50 mM MgCl2)
100 ml of buffer 2 was made up in adddH20 and contained:
10 ml 1 M Tris HC1 (pH 9.5)
10 ml 2 M Sodium Chloride
5 ml 1 M MgCl2
Colour substrate solution
Colour substrate solution contained:
45 |il NBT solution (75mg/ml nitroblue tetrazolium salt in dimethylformamide,
Boehringer Mannheim)
35 |il BCIP solution (50 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP),
toluidinium salt in dimethylformamide, Boehringer Mannheim)
2.4 mg Levamisole (Sigma)
10 ml buffer 2
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Buffer 3 (10 mM Tris HC1 (pH 8.1), 1 mM EDTA)
100 ml of buffer 3 was made up in adddH20 and contained:
lml 1 M Tris HC1 (pH 8.1)
200 |il 0.5 M EDTA
2.8.3 Methodology
Tissue preparation
Rat brains were frozen in powdered dry ice immediately after removal. The
brains were wrapped with foil, kept in pre-numbered plastic bags and then stored at -
70°C. The brains were sectioned coronally, in a frozen state, on a cryostat at -12° to -
16°C. Coronal sections (15 |im) through the hypothalamus at the level of the SON
and PVN, guided by Paxinos and Watson (1982), were cut, thaw-mounted onto
chromic acid cleaned chrome alum gelatine subbed slides and then kept in desiccated
slide boxes stored at -70°C. Every ninth section for orientation was collected and
counterstained with toluidine blue.
Brain Paste Standards
Rat brains were dissected and homogenised in 1 ml distilled water containing
a few drops of mineral oil to prevent bubbling. Equal volumes of brain paste
(approximately 1 ml) were transferred to 10 flat bottom tubes. Two microlitres of
adddH20 was added to 2 |itl [a-35S]deoxy-ATP and mixed well. One microlitre of
this solution was taken and added to brain paste standard 1. An equal volume of
dddH20 was then added to the remaining diluted radioactivity and 1 microliter of this
solution was then added to brain paste standard 2. This procedure was followed until
ten serial dilutions of the standards were made. After adding known amounts of
diluted radioactive [a-35S]deoxy-ATP to each tube, the brain paste standards were
mixed well, centrifuged to remove air bubbles, frozen on dry ice and carefully
removed from the tube. After that the standards were fixed onto cryostat chucks with
General Methods 79
Tissue Tek (O.C.T. compound, Miles, USA), sectioned (15 pm thickness) and thaw-
mounted onto slides. Five serial concentrations of [a-35S]deoxy-ATP were placed on
one slide so two sets of slides were needed for the 10 serial concentration sections.
Slides were kept in desiccated slide boxes and stored at -70°C. Two sections from
each standard were also taken into separate scintillation vials containing 3 ml
scintillation fluid (Ultima Gold MR, Packcard Instrument Company, USA) and
radioactivity was counted for 1 min by a scintillation counter (Rackbeta Liquid
Scintillation Counter, LKB, Wallace). The mean disintegrations per minute (dpm)
emitted by each standard was then computed.
Probe Labelling methods
1. V end labelling with ra-35S]deoxy-ATP of Antisense nNOS oligonucleotides
The following was added to an autoclaved eppendorf tube:
3 pi Antisense nNOS oligonucleotide probes (2 pmol/(il nNOS 070, 071 or 072)
5 p,l tailing buffer (Pharmacia Biotech Limited, Herts, UK)
39 pi adddH20
1 pi [oc-^SJdeoxy-ATP (Dupont NEN, New England Nuclear, Boston, MA)
2.1 pi Terminal deoxynucleotidyltransferase (19.2 units/pl TdT, Pharmacia Biotech)
This reaction mixture was incubated for 1 h at 37 °C with gentle agitation.
The reaction was stopped by adding 5 pi of 0.5 M EDTA on ice. To separate labelled
probe from the free label, the mixture was then added along with 500 pi T/E buffer to
a Sephadex G-25 column (NAP® 5 Columns DNA grade, Pharmacia Biotech),
which was equilibrated with 10 ml T/E buffer. T/E buffer was allowed to saturate the
gel bed completely. A further 1 ml T/E buffer was added and the eluted solution was
collected every 3 drops (approximately 100 pi) in pre-numbered eppendorf tubes.
Two 1 pi aliquots of each eluted solution were added to separate scintillation vials
containing 3 ml scintillation fluid (Ultima Gold MV) and then counted for 1 minute
by a scintillation counter (Rackbeta Liquid Scintillation Counter, LKB, Wallace). As
the labelled probe is larger than the free label, then the labelled probe was eluted
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before free label. The tubes containing the labelled probe were identified by the first
peak of detected radioactivity and free label appeared as the second peak. The
incorporation of 35S-dATP was acceptable if the radioactivity was greater than
70,000 cpm/pl.
The known counting efficiency for Ultima Gold is 95% so all counts were
corrected to 100% efficiency. The mean disintegrations per minute (dpm) emitted by
the tubes containing labelled probe were then assumed to represent 100% counting
efficiency, and multiplied by the remaining number of pi of labelled probe.
2. Tailing with DIG-dUTP of Antisense Oxytocin oligonucleotide
The following was added to an autoclaved eppendorf tube.
4 pi 5xReaction buffer (1 M potassium cacodylate, 0.125 M Tris-HCI, 1.25 mg/ml
bovine serum albumin; pH 6.6, Boehringer Mannheim)
4 pi C0CI2 solution (25 mM, Boehringer Mannheim)
1 pi DIG-dUTP (1 mM, Boehringer Mannheim)
0.5 pi Antisense oxytocin oligonucleotide (200 pmol/pl)
1 pi dATP (10 mM in Tris buffer; pH 7.5, Boehringer Mannheim)
8.5 pi adddfUO
1 pi Terminal Transferase (50 units, Boehringer Mannheim)
The reaction mixture was mixed well, centrifuged briefly and then incubated
at 37°C for 15 min. The reaction was stopped by adding 2 pi of the glycogen-EDTA
mixture on ice. The tailed oligonucleotide was purified from the labelling reaction
mixture by ethanol precipitation. This involved adding 2.5 pi of 4 M LiCl and 75 pi
of prechilled (-20°C) 100% ethanol and incubating for at least 30 min at -70°C or 2
hours at -20°C. This solution was then centrifuged (13,000 xg) for 15 min at 4°C, the
supernatant was discarded and the pellet washed with 50 pi ice-cold 70% ethanol and
re-centrifuged (13,000 xg) for 5 min at 4°C. The supernatant was again discarded and
the pellet dried under a vacuum. The dry pellet was dissolved in 200 pi adddH20 and
stored at -20°C.
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To estimate the concentration of the newly labelled probes, a side by side
comparison of the newly DIG-labelled oligonucleotide with a known concentration
of DIG-labelled control oligonucleotide was performed. Serial dilutions of both
probes were prepared and spotted on a piece of Nylon membrane (0.45 (tm pore size,
positively charged (pH 3-10), Boehringer Mannheim). Probes were then fixed to
Nylon membrane by cross-linking with UV light or by baking for 30 min at 120°C.
Subsequently, the membrane was colorimetrically analysed by incubation in a diluted
antibody solution (Anti-DIG-alkaline phosphatase in blocking solution) and a colour
substrate solution. Direct comparison of the intensities of the newly DIG-labelled
oligonucleotide and the DIG-labelled control allowed us to estimate the labelling
yield. Dots that gave the most similar intensities between the newly DIG-labelled
oligonucleotide and the DIG-labelled controls were selected then the dilution factor
was calculated. The concentration of the newly DIG-labelled probe was calculated by
dividing the concentration of DIG-labelled control by the dilution factor.
Prehybridization
Slides were removed from the -70°C freezer and left for 1 h to warm up to
room temperature. The selected slides were placed in racks and fixed in 4%
paraformaldehyde in 0.1 M PBS (pH 7.4) for 30 min, rinsed in 0.1 M PBS and
washed in 0.1 M PBS for 10 min, followed by acetylation in triethanolamine solution
for 10 min to increase tissue permeability. The sections were then dehydrated through
70%, 80%, 95% and 100% ethanol (5 min each), delipidated in chloroform for 10
min and partially rehydrated in 95% ethanol (10 min). After air drying the slides for
radioactive ISH were placed in a humidified chamber containing filter paper soaked
with soaking solution. The slides for the non-radioactive protocol were incubated in
prehybridization buffer for 1 h at 37°C. Prehybridization treatment is carried out to
facilitate probe penetration, to reduce nonspecific annealing or binding of the labelled
probe to proteins or nucleic acids. Excess solution was drained off and then placed in
a chamber containing filter paper soaked with soaking solution.
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To confirm hybridization, control experiments were performed by treatment
of sections with RNase prior to hybridization with the labelled probe to determine
whether this pretreatment abolished the hybridization signal. Control slides treated
with 40 pi RNase (20 |itg/ml) were incubated for 1 h at 37°C in a separate chamber
containing filter paper soaked with RNase buffer to prevent contamination. After
incubation, slides were washed in adddH20, air dried and then placed in a chamber
containing filter paper soaked with soaking solution.
In situ hybridization
1. Radioactive In situ Hybridization
The hybridization procedure for the 35S-labelled nNOS probes was performed
as previously described (Kadowaki et al., 1994). The labelled probe was diluted in
hybridization buffer, such that 40 pi aliquots of buffer diluted probe would contain
100,000 dpm of activity (2,500 dpm/pl). Forty microlitres of hybridization buffer
containing radiolabeled probe (40 pi) was then pipetted onto each section.
Incubation chambers were then sealed and incubated for 17 h at 37°C.
To verify the specificity of the oligonucleotide probe, control experiments
were performed by incubating the sections with a 100-fold molar excess of
•3C
unlabelled oligonucleotide probe in the presence of S-labelled probe to determine
whether 'cold' oligonucleotide probe blocked the signal obtained with labelled probe.
The total amount of the labelled nNOS probe (mole/pl) was calculated then
multiplied by 100 to give the amount of 'cold' nNOS probe to be added to the
hybridization buffer containing labelled probe. Forty microlitres of hybridization
buffer containing radiolabeled probe and 100-fold excess of 'cold' nNOS probe was
then pipetted onto each section. Slides were then incubated for 17 h at 37°C.
General Methods 83
2. Non-radioactive In situ Hybridization
DIG-labelled probes were diluted in hybridization buffer to a concentration of
2 fmol/pl. Prehybridization buffer was drained from the slides and the hybridization
buffer containing DIG-labelled probe (40 pi) was pipetted onto each section.
To check oligonucleotide probe specificity, control experiments were
performed by incubating the sections with 100-fold molar excess of 'cold'
oligonucleotide probe in the presence of DIG-labelled probe. The unlabelled oxytocin
oligonucleotide was diluted in hybridization buffer containing DIG-labelled oxytocin
to a concentration of 200 fmol/pl. Forty microlitres of hybridization buffer containing
2 fmol/pl DIG-labelled oxytocin and 200 fmol/pl unlabelled oxytocin probe was then
pipetted onto each sections. Slides were then incubated for 17 h at 37°C.
Post-hybridization
After hybridization, the excess solution was drained off. The slides were
briefly rinsed three times in lxSSC at room temperature to remove excess buffer and
unhybridized probe, washed three times for 30 min in lxSSC and washed for a
further 1 h in lxSSC at room temperature. The slides from the radioactive in situ
hybridization were air-dried, dipped in 300 mM ammonium acetate, 70% ethanol and
then air-dried. After air-drying, slides were placed in autoradiographic cassettes and
exposed to Hyperfilm-|3max autoradiography film (Amersham, UK) together with
brain paste standards for 3 weeks at 4°C. The exposed film was developed in D19
developer (Kodak) for 5 min, and then fixed (Ilford Hypam rapid fixer, 2x5 min).
After that, the slides were dipped in Ilford G-5 emulsion (Mobberley, Cheshire, UK)
diluted 1:1 with adddlDO for the cellular localization of nNOS mRNA. The
emulsion-coated slides were exposed for a further 4-5 weeks to visualize NOS
cellular signal, and then developed (Kodak D19 developer) for 5 min and fixed
(Ilford Hypam rapid fixer twice 5 min each). The developed sections were
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counterstained with cresyl violet, dehydrated in a graded ethanol series, and
coverslipped in DPX mountant.
The slides from the non-radioactive in situ hybridization were taken from the
final lxSSC wash, washed twice for 10 min with buffer 1 with gentle agitation on a
rotational shaker (R100/TW; Luckman Ltd., Sussex, UK) and then covered with
blocking solution for 30 min at room temperature. The blocking solution was then
decanted and the sections were incubated overnight in an incubation chamber with
anti-DIG antibody solution. After incubation, the sections were then washed twice
with buffer 1 for 10 min followed by buffer 2 for 10 min with gentle agitation. The
sections were then covered with approximately 200 pi of colour substrate solution
and incubated in an incubation chamber overnight in the dark. When the colour had
developed with high resolution and low background, the colour reaction was stopped
by incubating the slides in buffer 3 and then briefly dipped in distilled water. Slides
were then mounted using Aqua-Mount (BDH).
Quantitative Analysis
To prevent bias slides were coded by covering identification numbers with
masking tape and assigned random numbers before quantification. The relative
amount of nNOS mRNA in the brain nuclei of interest was assessed by the silver
grain density of autoradiographic films exposed to the nuclei as viewed under the
light microscope (x5, xlO objective, Wang 6000 series microscope) attached to a
high performance CCD video camera (Cohu). A fixed counting area of a circular
frame was set for each nucleus measurement. Grain areas in the nucleus of interest
and the background from areas immediately outside the nucleus of interest were then
measured and computed by NIH Image analysis system version 1.58 on an Apple
Mcintosh computer. The NIH-Image public domain image processing software
package was developed by Wayne Rasband. The value of silver grain density per unit
area was obtained by subtracting the mean grain area of the background
measurements from each specific nucleus measurement, and dividing by the area
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measurements. Each brain paste standard was measured twice, and corresponding
background measurements, from the area immediately outside brain paste standard,
subtracted. A graph was then plotted of logarithmic radioactivity against grain
density for all the standards. Acceptable grain density values lay on the straight
portion of the curve to eliminate as many variables between each run of ISH as
possible. For each identified brain area, the mean grain density per unit area of each
rat was calculated and the group mean grain density per unit area calculated.
2.9 Statistics
Statistical analysis was performed using the SigmaStat software package on a
P.C. computer. The Kolmogorov-Smirnov test (with Lilliefors'correction) was used
to test data for normality of the estimated underlying population. Parametric tests
were used for comparisons of samples from normally distributed populations. Non-
parametric or distribution-free tests were performed on ranks of the observations,
were used when the populations were not normal. To compare data within a group
the parametric paired r-test and the non-parametric Wilcoxon-Signed Rank test were
used. To compare data between two independent groups the parametric t-test and the
non-parametric Mann-Whitney Rank Sum test were used. For comparisons among
three or more groups, the parametric one way analysis of variance (ANOVA) was
used to compare the effect of a single factor on the mean of two or more groups.
Kruskal-Wallis ANOVA on ranks was the non-parametric test used to compare
effects of a single factor on the rank of two or more groups. The parametric two way
ANOVA was used to compare the effect of two different factors on the means of two
or more groups. To test the effect of treatment with more than one measurement on
the same individuals, the parametric one way repeated measures ANOVA was used
to compare the effect of a single series of treatments. The parametric two way
repeated measures ANOVA was used to compare the effect of two factors where one
or both factors were a series of treatments. The Friedman one way repeated measures
ANOVA on ranks was the non-parametric test to compare the effect of a single series
of treatments. If a significant difference was found, several multiple comparison
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procedures or post-hoc tests, were performed to determine which groups were
different and the size of the difference. Results were considered significantly
different at P< 0.05.
CHAPTER 3
NITRIC OXIDE AND OSMORESPONSIVENESS OF THE OXYTOCIN
SYSTEM IN PREGNANCY
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3.1 Introduction
During late pregnancy in rats, plasma osmolality decreases by approximately
10 mosmol/kgH20, plasma [Na+] decreases by 5.8 mEq/1 while blood volume
expands to nearly twice that of virgin rats (Barron et al., 1985; Barron et al., 1984;
Durr et al., 1981). These changes are maintained by a decrease in the osmotic
threshold for drinking and for the secretion of vasopressin (Barron et al., 1985; Durr
et al., 1981; Koehler et al., 1993). Although the set-point for osmoregulation is
decreased and volume homeostasis is increased, there is no change in the sensitivity
of the magnocellular neurosecretory system to osmotic stimulation in late pregnancy
(Durr et al., 1981; Koehler et al., 1993). By contrast, the osmoresponsiveness of the
oxytocin system in urethane-anaesthetised late pregnant rats has been reported to be
reduced, since i.p. injection of similar amounts of hypertonic saline produced a large
increase of plasma concentration of oxytocin in virgin rats, but not in late-pregnant
rats (Russell et al., 1992). It has also been proposed that, during late pregnancy, the
osmotic sensitivity for oxytocin release is increased, since i.v. infusion of hypertonic
saline after removal of opioid inhibition by naloxone produced a large increase of
oxytocin release in pregnant rats compared to virgin rats (Russell et al., 1992).
Moreover, the studies of Kohler et al. (1993), using s.c. injection of hypertonic
saline, indicate a decrease in the threshold for osmotic stimulation of oxytocin
secretion in pregnancy. Therefore, the hypoosmolality, hyponatremia and
hypervolaemia of pregnancy are perceived as normal by the vasopressin system
enabling retention of water. For oxytocin, which has natriuretic actions, a reduced
threshold implies stimulation of excretion of Na+ at the lower osmolality, which
would deplete body Na+; whereas in pregnancy body fluid volume and Na+ content
are increased. However, the mechanisms responsible for the altered osmoregulation
are obscure.
An endogenous opioid mechanism inhibiting oxytocin release appears to be
active during late pregnancy, since administration of naloxone at this time increases
the plasma concentration of oxytocin and decreases the oxytocin content of the
posterior pituitary (Douglas et al., 1993; Hartman et al., 1986; Leng et al., 1988).
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However, the reduction of the oxytocin secretory response to osmotic stimulation in
late-pregnant rats is independent of endogenous opioids, since naloxone enhanced the
increase in plasma concentration of oxytocin in response to hypertonic saline more in
virgin rats than in pregnant rats (Russell et al., 1992). Naloxone also enhanced the
release of oxytocin evoked by electrical stimulation of the region anterior and ventral
to the third cerebral ventricle (AV3V region) more in virgin rats than in pregnant
rats, suggesting a decreased excitatory coupling of the AV3V input to oxytocin
neurones in pregnancy that was similarly independent of endogenous opioid peptides
(Bull et al., 1994). Thus, an increase in endogenous opioid inhibition of oxytocin
secretion is not responsible for the reduction of osmoresponsiveness of oxytocin
neurones in late pregnancy.
Changes in endogenous NOS in the magnocellular neurosecretory system
have been reported in pregnancy, parturition and lactation. In late-pregnant and
parturient rats, a decrease in the density and number of NADPH-diaphorase-positive
cells in the SON and PVN together with a decrease in the specific activity of NOS in
the posterior pituitary have been found (Okere and Higuchi, 1996a). By contrast,
other authors have reported an increase in NADPH-diaphorase staining in the SON
and PVN in late pregnancy (Popeski et al., 1999; Woodside and Amir, 1996) that
persists into lactation (Popeski et al., 1999). Up-regulation of nNOS protein and
nNOS mRNA expression in the hypothalamus was found on day 20 of pregnancy
(Xu et al., 1996). However, there was no change in NOS mRNA expression in the
SON, PVN and lamina terminalis on day 15 of pregnancy (Luckman et al., 1997).
These observations suggest that the endogenous NOS system may play an important
role in modulating the osmoregulation of the oxytocin neurosecretory system during
pregnancy. Therefore, we tested the hypothesis that changes in the expression of
NOS in oxytocin neurones contribute to the changes in the osmoresponsiveness of
oxytocin neurones during pregnancy.
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3.2 Aims
- To study the role of NO in osmoregulation of oxytocin release in urethane-
anaesthetised virgin rats.
- Does the altered osmoresponsiveness of the oxytocin neurosecretory system
in the pregnant rats reflect a change in the NOS system?
- To investigate the expression of the oxytocin and the neuronal NOS genes in
the hypothalamic magnocellular neurones of rats during pregnancy and parturition.
3.3 Materials and methods
3.3.1 Animals
Experiments were carried out on age-matched female Sprague-Dawley rats
(250-300 g). They were housed under standard laboratory conditions (12:12 h dark-
light cycle, ambient temperature 20 ± 1°C) with free access to food and water.
Pregnant rats were obtained by leaving virgin rats with stud males overnight. Day 0
of pregnancy was determined by the appearance of a vaginal plug of semen that had
been shed into the mating cage on the following morning after mating. The rats were
then housed individually with food and water ad libitum.
3.3.2 Experimental procedure
1. Effect of NOS inhibitor on hypertonic- and CCK-stimulated oxytocin release in
virgin rats
On the day of the experiment, rats were anaesthetised with urethane to allow
cannulation of a femoral vein and artery. The surgical methods are described in
General Methods 2.2.
In the first series of experiments, rats were given either the NOS inhibitor Aw-
nitro-L-arginine (L-NNA, Sigma, 10 mg/kg, i.p.) or isotonic saline. In a second series
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of experiments, rats were given either the NOS inhibitor A^-nitro-L-arginine
methylester.HCl (L-NAME, Sigma, 50 mg/kg, i.p.) or isotonic saline. Both L-NNA
and L-NAME are L-arginine analogues that are competitive with L-arginine in
binding the arginine-binding site of the constitutive NOS. After 4 h, all rats were
intravenously injected with cholecystokinin (CCK, 20 pg/kg, i.v., cholecystokinin-
(26-33)-sulphated; Bachem Ltd, Saffron Walden, Essex, UK) followed by
intraperitoneal injection of hypertonic saline (4 ml/kg 1.5 M NaCl, i.p.). Blood
samples were collected from a femoral artery cannula before and after CCK
administration and hypertonic saline injection and immediately centrifuged. Plasma
O
was then separated and stored at -20 C until assayed for oxytocin by specific RIA as
described previously in General Methods 2.6. The remaining blood cells were
resuspended in isotonic saline at the same volume as the plasma taken and returned
via the left femoral vein. Plasma sodium ([Na+]) concentration in the first and the last
plasma samples was determined using a Corning 455 flame photometer.
2. Effect ofcentral administration ofa NO donor on oxytocin release in virgin rats
A femoral vein and artery of urethane-anaesthetised virgin rats were
cannulated. A 22-gauge stainless steel guide cannula was placed into the right lateral
cerebral ventricle, at the following coordinates: 1.6 mm lateral, 0.6 mm caudal from
Bregma and 4.5 mm below surface of the skull. The guide cannula was held in place
with two stainless screws and dental cement. The cap was inserted into the guide
cannula until the start of the experiment. Following surgery, all rats were left for at
least 2 h before starting of the experiment. For full details of surgery refer to General
Methods 2.3.
Before the experiment, the infusion cannula was introduced into the lateral
cerebral ventricle via the guide cannula. The infusion cannula was connected to a
polythene tube attached to a microsyringe filled either with the NO donor sodium
nitroprusside (SNP, Sigma, 10 nmol/ml) or isotonic saline.
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Rats were given an i.c.v infusion of 25 nmol SNP (10 nmol/fil) or isotonic
saline (5 pi at 2 pl/min followed by 20 pi at 0.7 pl/min) immediately after a
hypertonic saline injection (4ml/kg 1.5 M NaCl, i.p.). Blood samples were taken
from the left femoral artery before and at regular intervals (10 min) during i.c.v.
infusion of SNP or isotonic saline. Blood samples were immediately centrifuged.
O
Plasma was then separated and stored at -20 C until assayed for oxytocin by specific
RIA and measurement of plasma sodium concentration.
3. The effect of NOS inhibitor on hypertonic saline-stimulated oxytocin release in
late pregnancy
A femoral vein and artery of urethane-anaesthetised virgin and 21 day
pregnant rats were cannulated. They were given the NOS inhibitor A^-nitro-L-
arginine (L-NNA, Sigma, 10 mg/kg, i.p.) or isotonic saline. After 4 h the rats received
hypertonic saline (virgin: 4 ml/kg 1.5 M NaCl, i.p., pregnant: 5 ml/kg 2 M NaCl,
i.p.). The volume of hypertonic saline given to late pregnant rats was greater than
virgin rats in order to produce a similar plasma [Na+] between virgin and late
pregnant rats since the reduced plasma [Na+] is found during pregnancy. Intravenous
(i.v.) naloxone (Sigma, 5 mg/kg) was given 40 min after the hypertonic saline
injection. Serial plasma samples were collected from the femoral artery cannula
before and after hypertonic saline and naloxone administration (to investigate the
relationship between the mechanisms of endogenous opioids and nitric oxide), and
O
stored at -20 C until assayed for oxytocin by specific RIA and measurement of
plasma sodium concentration.
4. The effect of NOS inhibitor on oxytocin release following intravenous infusion of
hypertonic saline in late pregnancy
On the experimental day, the left femoral artery and both femoral veins of
virgin and day 21 pregnant rats were cannulated under urethane anaesthesia. All rats
received either A^-nitro-L-arginine (L-NNA, Sigma, 10 mg/kg i.p.) or isotonic saline
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solution 4 h before blood sampling. Hypertonic saline (2.0 ml) was infused through
the right femoral vein for 1 h in virgin and pregnant rats (2.0 M NaCl and 2.6 M
NaCl, respectively). Serial plasma samples were collected from the left femoral
artery before and at regular intervals (10 min) during the infusion, and stored at -
O
20 C until assayed for oxytocin by specific RIA and measurement of plasma sodium
concentration.
5. NOS gene expression in the SON and PVN in pregnancy
Age-matched virgin, 16 day pregnant, 22 day pregnant and parturient rats
were used to study nNOS mRNA expression. Rats were killed by decapitation in the
morning for virgin, day 16 and day 22 of pregnancy. Parturient rats were decapitated
2 h after the birth of the first pup. Their brains were rapidly removed and frozen on
dry ice, stored at -70°C and later processed for study of the expression of nNOS
mRNA by using radioactive in situ hybridization histochemistry.
6. Oxytocin gene expression in the SON and PVN in pregnancy
To study the expression of oxytocin mRNA, age-matched virgin, 22 day
pregnant and parturient rats were used. Virgin and 22 day pregnant rats were killed
by decapitation in the morning. Parturient rats were decapitated 2 h after the birth of
the first pup. Their brains were rapidly removed and placed on dry ice, stored at -
70°C and later processed for study of the expression of oxytocin mRNA by using
non-radioactive in situ hybridization histochemistry.
3.3.3 Radioimmunoassay
The specific radioimmunoassay for oxytocin is described in General Methods
2.6.
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On the day of assay, plasma samples were thawed and centrifuged. Specific
anti-oxytocin antiserum (Higuchi et al., 1985) was added to triplicate aliquots of
standards (ranging from 2.4 to 2500 pg/ml) and duplicate aliquots of plasma samples.
Mixtures were left for 24 h before adding a fixed amount of 125I-oxytocin (between
assayed, approximately 6-8,000 cpm) to all tubes. Mixtures were left for 2-3 days. To
precipitate the first antibody- 125I-oxytocin complex, second antibody (Donkey anti-
rabbit gammaglobulin) was added to all tubes and left for 24 h. To aid visualization
of the precipitate standardized Pansorbin cells (Novabiochem (U.K.) Ltd., 0.1% w/v
solution in phosphate buffer) was added to mixtures prior to centrifugation.
Supernatants were then aspirated. The remaining precipitates were counted in a
gamma counter (LKB-Wallace 1272 Clinigamma). All samples in each experiment
were measured in a single assay in order to avoid interassay variance.
The concentration of oxytocin in the standard or plasma sample was inversely
proportional to the amount of 125I-oxytocin bound to the rabbit anti-oxytocin
antibody. Oxytocin concentration of the unknown samples could be determined by
comparing the unknown precipitate radioactivity to precipitate radioactivity of known
standard oxytocin contents.
3.3.4 In situ Hybridization
The full methodology for in situ hybridization is described in General
Methods 2.8.
Brain sections
Coronal sections (15 pan) through the hypothalamus at the level of the SON
and PVN were cut using a cryostat and thaw-mounted onto gelatin-coated glass
slides. Slides were then stored in desiccated slide boxes at -70°C before in situ
hybridization.
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Probes
Three 45-mer antisense oligonucleotide probes for NOS which were
complementary to bases 223-267 (5'-noncoding region), 4714-4758 (3'-noncoding
region) and 1662-1706 of the rat neuronal NOS (nNOS) sequence (Bredt et al.,
1991b) were used. Probes were labelled at the 3' end with [a-35S]deoxy-ATP (NEN)
using terminal deoxynucleotidyltransferase (Pharmacia).
An antisense oligonucleotide probe for oxytocin which was complementary to
bases 912-936 of oxytocin mRNA (Ivell and Richter, 1984) was used. The probe was
labelled by 3' end tailing with DIG-dUTP using terminal transferase (Boehringer
Mannheim).
In situ hybridization
Sections were fixed at room temperature with 4 % paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for 30 min, then rinsed in 0.1 M PBS and washed in 0.1 M
PBS (10 min), followed by acetylation in triethanolamine solution (0.25% acetic
anhydride in 0.1 M triethanolamine -0.15 M NaCl) for 10 min to increase tissue
permeability. The sections were then dehydrated through 70%, 80%, 95% and 100%
ethanol (5 min each), delipidated in chloroform for 10 min, and partially rehydrated
in 95% ethanol (10 min). After air-drying the slides were placed in the humidified
chamber.
Radioactive in situ hybridization
The sections were hybridized for 17 h at 37°C in hybridization buffer
(4xSSC, 50% formamide, lxDenhardt's solution, 500 [ig/ml sheared salmon sperm
DNA, 10% dextran sulphate and 0.3% mercaptoethanol) containing the "S-labelled
NOS oligonucleotide probes at a concentration of 2500 dpm/pl. After hybridization,
the excess solution was drained. The slides were briefly rinsed three times in lxSSC
at room temperature, washed three times for 30 min lxSSC and were washed for a
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further 1 h in lxSSC at room temperature. The slides were dipped in 300 mM
ammonium acetate, 70% ethanol and then air-dried. The slides were then placed in
autoradiographic cassettes and exposed to Hyperfilm-|3max autoradiography film
(Amersham, UK) together with brain paste standards. The film was left to expose for
3 weeks at 4°C. The films were developed in D19 developer (Kodak) for 5 min, then
fixed (Ilford Hypam rapid fixer, 2x5 min). After that, the sections were dipped in
Ilford G-5 emulsion-coated slides (Mobberley) diluted 1:1 with autoclaved water.
The emulsion-coated slides were exposed for a further 4-5 weeks to visualize NOS
cellular signal, and then developed (Kodak D19 developer) for 5 min and fixed
(Ilford Hypam rapid fixer twice 5 min each). The developed slides were
counterstained with cresyl violet, dehydrated in a graded ethanol series, and
coverslipped in DPX mountant.
Non-radioactive in situ hybridization
The sections were prehybridized with prehybridization buffer for 1 h at 37°C
and then hybridized for 17 h at 37°C in hybridization buffer containing the DIG-
labelled oxytocin probes at a concentration of 200 fmol/pl After hybridization, the
excess solution was drained. The slides were briefly rinsed three times in lxSSC at
room temperature, washed three times for 30 min lxSSC and were washed for a
further 1 h in lxSSC at room temperature. The slides were taken from the final
lxSSC into buffer 1 (100 mM Tris HC1 (pH 7.5), 150 mM NaCl) for 10 min (x2) and
then incubated with blocking buffer (buffer 1 containing 0.1% Triton® X-100 and
2% normal sheep serum) for 30 min. The sections were incubated overnight with
anti-DIG antibody solution (1:500). After incubation, the sections were washed with
buffer 1 (2x10 min), followed by washing in buffer 2 (100 mM Tris HC1 (pH9.5),
100 mM NaCl, 50 mM MgCl2) for 10 min. The sections were then incubated
overnight in the dark with colour substrate solution (buffer 2 containing 340 (tg/ml
nitroblue tetrasolium and 170 fig/ml BCIP). The colour reaction was stopped by
incubating the slides in buffer 3 (10 mM Tris HC1 (pH 8.1), 1 mM EDTA) and then
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briefly dipped in distilled water. The slides were then mounted using Aqua-Mount
(BDH).
Double in situ hybridization
The sections were prehybridized with prehybridization buffer for 1 h at 37°C
and then hybridized for 17 h at 37°C in hybridization buffer containing the DIG-
labelled oxytocin probes at a concentration of 200 fmol/|itl and the 35S-labelled NOS
oligonucleotide probes at a concentration of 2500 dpm/jal. After hybridization, the
excess solution was drained. The slides were briefly rinsed three times in lxSSC at
room temperature, washed three times for 30 min lxSSC and were washed for a
further 1 h in lxSSC at room temperature. The slides were then processed for non¬
radioactive ISH followed by radioactive ISH. The slides were taken from the final
lxSSC into buffer 1 for 10 min (x2) and then incubated with blocking buffer for 30
min. The sections were incubated overnight with anti-DIG antibody solution (1:500).
After incubation, the sections were washed with buffer 1 (2x10 min), followed by
washing in buffer 2 for 10 min. The sections were then incubated overnight in the
dark with colour substrate solution. The colour reaction was stopped by incubating
the slides in buffer 3, briefly dipped in distilled water and then air-dried. The slides
were then placed in autoradiographic cassettes and exposed to Hyperfilm-pmax
autoradiography film (Amersham, UK) together with brain paste standards. The film
was left to expose for 3 weeks at 4°C. The films were developed in D19 developer
(Kodak) for 5 min, then fixed (Ilford Hypam rapid fixer, 2x5 min). After that, the
sections were dipped in Ilford G-5 emulsion-coated slides (Mobberley) diluted 1:1
with autoclaved water. The emulsion-coated slides were exposed for a further 4-5
weeks to visualize NOS cellular signal, and then developed (Kodak D19 developer)
for 5 min and fixed (Ilford Hypam rapid fixer twice 5 min each). The developed
slides were then washed in distilled water and mounted using Aqua-Mount (BDH).
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Quantitative Analysis
The amount of nNOS mRNA in the SON and PVN was assessed by silver
grain density of autoradiographic films of the SON, PVN, SFO and AMG viewed
under the light microscope, x5 and xlO objective. Grain density was quantified by
NIH Image analysis system version 1.58 on an Apple Mcintosh computer. The value
of silver grain density per unit area was obtained by subtracting background
measurements over adjacent tissue from each specific tissue measurement, and
dividing by the area measurements taken. Each brain paste standard was measured
twice, and also corresponding background measurements. A logarithmic relationship
was then plotted for radioactivity against the grain density of the standards.
Acceptable grain density values lay on the straight portion of the curve. For each
identified brain area, the mean grain density per unit area for each rat was calculated
and the group mean grain density per unit area calculated.
Specific radioactivity of labelled probes was ranged from 482.25 to 1753.13
Ci/mmol.
3.3.5 Statistical Analysis
All data are reported as means + S.E.M.. Data were analyzed statistically
using SigmaStat by a one-way repeated measures ANOVA for differences with time
and a two-way repeated measures ANOVA for differences between groups followed
by Dunnett's method, Bonferroni's method or Student-Newman-Keuls method. To
compare data between and after treatment within a group the paired t-test was used.
Differences between groups were compared using one way ANOVA followed by
Student-Newman-Keuls method. P< 0.05 was considered statistically significant.
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3.4 Results
1. Effect of NOS inhibitors on hypertonic saline- and CCK-stimulated oxytocin
release in virgin rats
In two series of experiments, rats received either the NOS inhibitor (L-NNA
or L-NAME) or isotonic saline followed by injections of CCK and hypertonic saline.
There was no difference in the basal plasma [Na+] or the basal plasma oxytocin
concentrations between groups (Fig. 5, 6). Therefore, L-NNA and L-NAME had no
significant effect on basal plasma [Na+] or on the basal release of oxytocin.
A significant increase in the plasma concentration of oxytocin occurred in all
rats 10 min after i.v. injection of CCK (P<0.05, Fig. 5, 6). In the first series of
experiments, after CCK injection, plasma oxytocin concentrations of L-NNA pre-
treated rats (n=8) and isotonic saline pre-treated rats (n=6) were increased by 30.15 ±
5.06 and 30.57 ± 6.14 pg/ml, respectively (not significantly different; Fig. 5). In a
separate series of experiments, a similar increase of plasma oxytocin concentration
after CCK injection was demonstrated. CCK increased the plasma oxytocin
concentration by 28.72 ± 3.85 pg/ml in L-NAME pre-treated rats (n=8) and 19.02 ±
5.19 pg/ml in isotonic saline pre-treated rats (n=8), respectively (Fig. 6). Again, there
was no significant difference in CCK-evoked oxytocin release between L-NAME
pre-treated rats and isotonic saline pre-treated rats.
In all rats, injection of hypertonic saline produced a significant increase of
plasma [Na+] (P<0.01). There was no significant difference between rats pre-treated
with isotonic saline and rats pre-treated with L-NNA or L-NAME following
hypertonic saline administration (Fig. 5, 6). In the first series of experiments, plasma
[Na+] increased by 23.25 ± 4.57 mM (L-NNA pre-treated rats, n=8) and 21.00 ± 3.91
mM (isotonic pre-treated rats, n=6). In separate experiments, plasma [Na+] increased
by 5.13 ± 1.37 mM (L-NAME pre-treated rats, n=8) and 4.63 ±1.17 mM (isotonic
pre-treated rats, n=8).
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A significant increase in the plasma concentration of oxytocin occurred in all
rats 30 min after i.p. injection of hypertonic saline (P<0.05, Fig. 5, 6). In the first
series of experiments, after hypertonic saline was administered, the plasma oxytocin
concentrations in L-NNA pre-treated rats (n=8) and isotonic saline pre-treated rats
(n=6) were increased by 190.46 ± 42.94 and 69.37 ±18.28 pg/ml, respectively. The
oxytocin release following hypertonic saline was significantly greater in L-NNA pre-
treated rats than in isotonic saline pre-treated rats (P<0.05, Fig. 5), despite similar
increases in plasma [Na+]. In a separate series of experiments, hypertonic saline
increased the plasma oxytocin concentration by 490.76± 144.70 in L-NAME pre-
treated rats (n=8) and by 163.68 ± 28.67 pg/ml in isotonic saline pre-treated rats
(n=8), respectively. Again, in L-NAME pre-treated rats the osmotically-induced
oxytocin release was significantly greater than in isotonic saline pre-treated rats
(P<0.05, Fig. 6), despite similar increases in plasma [Na+], Thus, both of the NOS
inhibitors (L-NNA and L-NAME) significantly potentiated the secretion of oxytocin
induced by i.p. hypertonic saline, but had no significant effect on CCK-evoked
oxytocin release.
2. Effect ofcentral administration ofa NO donor on oxytocin release in virgin rats
Urethane-anaesthetised rats were given an i.c.v infusion of 25 nmol SNP (10
nmol/pl) or isotonic saline (5 pi at 2 pl/min followed by 20 pi at 0.7 pl/min)
immediately after a hypertonic saline injection (4ml/kg 1.5 M NaCl, i.p.).
There were no differences in the basal plasma [Na+] and basal plasma
oxytocin concentrations between groups. A significant increase in plasma [Na+] upon
hypertonic saline injection was shown in all rats (P<0.01, Fig. 7). Plasma [Na+]
increased by 11.17 ± 1.30 and 10.43 ± 2.69 mM in SNP-infused rats (n=6) and
vehicle-infused rats (n=8), respectively; there was no significant difference in plasma
[Na+] between SNP-infused rats and vehicle-infused rats following hypertonic saline
administration.
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In all rats, i.p. injection of hypertonic saline induced a significant increase in
the plasma concentration of oxytocin (P<0.05, Fig. 7). In vehicle-infused rats, the
plasma concentration of oxytocin increased by 186.06 ± 45.00 pg/ml (n=8). In SNP-
infused rats, the plasma concentration of oxytocin increased by 71.65 ±27.33 pg/ml
(n=6). However, this increase was significantly less in SNP infused rats than in
vehicle-infused rats (P<0.05, Fig. 7), despite similar increases in plasma [Na+], Thus,
centrally administration of the NO donor SNP significantly attenuated hypertonic
saline-induced oxytocin release.
3. The effect of NOS inhibitor on hypertonic saline-stimulated, oxytocin release in
late pregnancy
Adult virgin rats and late-pregnant rats received either the NOS inhibitor (L-
NNA) or isotonic saline. There was no difference in the basal plasma [Na+] or the
basal plasma oxytocin concentrations among the groups (Fig. 8, 9). Therefore, L-
NNA had no effect on basal plasma [Na+] or basal oxytocin secretion in either virgin
or late-pregnant rats.
A significant increase in plasma [Na+] following hypertonic saline injection
was observed in all rats (P<0.005, f-test, Fig. 8, 9). The increase in plasma [Na+]
induced by i.p. injection of hypertonic saline in virgin rats pre-treated with L-NNA
(7.60 ± 1.27 mM) or isotonic saline (10.10 ± 2.00 mM) was not significantly
different from that in late-pregnant rats pre-treated with L-NNA (14.17 ± 1.31 mM)
or isotonic saline (12.00 ± 2.03 mM).
In all rats, oxytocin release was significantly increased 30 min after i.p.
injection of hypertonic saline. In virgin rats, this response was significantly greater in
rats pre-treated with L-NNA than in rats pre-treated with isotonic saline (P<0.05, Fig.
8). The plasma concentration of oxytocin increased at 30 min by 57.75 ± 12.02 pg/ml
and 30.93 ± 6.36 pg/ml in virgin rats pre-treated with L-NNA (n= 13) or isotonic
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saline (n=12), respectively. By contrast, in late-pregnant rats pre-treatment with L-
NNA had no significant effect on hypertonic saline-induced oxytocin release (Fig. 9).
Intravenous injection of naloxone significant enhanced osmotically-induced
oxytocin release in all rats. In virgin rats, this response was significantly greater in
rats pre-treated with L-NNA than in rats pre-treated with isotonic saline (P<0.05, Fig.
8). The plasma concentration of oxytocin increased by 709.37 ± 85.99 pg/ml and
388.82 ± 95.86 pg/ml in virgin rats pre-treated with L-NNA (n= 13) and virgin rats
pre-treated with isotonic saline (n=12), respectively. By contrast, in late-pregnant
rats pre-treatment with L-NNA had no significant effect compared to pre-treatment
with isotonic saline; in these groups the plasma oxytocin concentration was increased
by 658.15 ± 148.40 pg/ml and 556.54 ± 171.95 pg/ml, respectively (Fig. 9). Thus, in
virgin rats but not in late pregnant rats, pre-treatment with L-NNA resulted in a
significant enhancement of naloxone-evoked oxytocin release, following
hyperosmotic stimulation.
4. The effect ofNOS inhibitor on oxytocin release following intravenous infusion of
hypertonic saline in late pregnancy
There were no differences in the basal plasma [Na+] and basal plasma
oxytocin concentrations between virgin and late-pregnant rats that received either L-
NNA or isotonic saline (Fig. 10-12). Therefore, L-NNA had no effect on basal
plasma [Na+] and basal oxytocin secretion in either virgin or late-pregnant rats.
In all rats, plasma [Na+] gradually increased throughout the course of the
hypertonic saline i.v. infusion (Fig. 10, 11). A significant increase in plasma [Na+]
following hypertonic saline i.v. infusion was shown in all rats (P<0.05). The
increases in plasma [Na+] between the start and the end of the infusion were 25.75 ±
2.80 mM (virgin rats pre-treated with L-NNA, n=8), 21.25 ± 2.23 mM (virgin rats
pre-treated with isotonic saline, n=8), 20.63 + 1.78 mM (late-pregnant rats pre-
treated with L-NNA, n=8) and 18.13 ± 1.76 mM (late-pregnant rats pre-treated with
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isotonic saline, n=8) (Fig. 12B). There were no significant differences between
groups.
In all rats, the release of oxytocin was increased significantly in parallel with
the increase in plasma sodium concentration following hypertonic saline i.v. infusion
(P<0.05, Fig. 10, 11). The increase of plasma oxytocin concentration in L-NNA
treated virgin rats (673.98 ± 118.13 pg/ml, n=8) was significantly greater than in
isotonic saline treated virgin rats (408.03 ± 79.66 pg/ml, n=8) following i.v. infusion
of hypertonic saline for 50 min (P<0.05, Fig. 10). By contrast, in late-pregnant rats,
pre-treatment with L-NNA had no significant effect on oxytocin release in response
to i.v. infusion of hypertonic saline. (Fig. 11). The differences in plasma
concentrations of oxytocin following i.v. infusion of hypertonic saline between pre-
treatment with L-NNA and isotonic saline for virgin and pregnant rats are shown in
Fig. 12A. In virgin rats, but not in pregnant rats, L-NNA pre-treatment resulted in a
further increase in A plasma oxytocin concentration in parallel with the increase in
plasma sodium concentration following i.v. infusion of hypertonic saline.
5. NOS gene expression in the SON and PVN in pregnancy
There were strong hybridization signals for nNOS mRNA over the supraoptic
nucleus (SON), magnocellular region of the paraventricular nucleus (PVN),
subfornical organ (SFO) and medial amygdaloid nucleus (AMG). In the SON, a
decreased nNOS mRNA signal was revealed (Fig. 14C). The silver grain density over
the SON of 22-day pregnant rats was significantly less than in the other groups, with
no differences for the PVN, SFO or AMG (Fig. 13A). Neuronal NOS mRNA
expression measured as film density over the SON of 22-day pregnant rats (n=8)
significantly less than in the virgin rats (n=8) and 16-day pregnant rats (n=8) by
24.25 % and 25.47 %, respectively (P<0.05, Fig. 13A). The grain density
measurement of nNOS mRNA expression in the SON of parturient rats (n=9) was
significantly greater than in the 22-day pregnant rats (n=8) by 23.61 % (P<0.05, Fig.
13A). By contrast, the nNOS mRNA signal was unchanged in the SON and in other
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areas measured including the PVN, SFO and AMG of 16-day pregnant and parturient
rats compared to virgin rats (Fig. 14-16).
6. Oxytocin gene expression in the SON and PVN in pregnancy
Oxytocin gene expression in the SON and PVN was demonstrated using non¬
radioactive in situ hybridization. The signal for oxytocin mRNA was densely located
in the cytoplasm of neurones. Oxytocin mRNA containing neurones were markedly
located at the dorsal cap of the SON (Fig. 17A, B, C). The distribution of the
oxytocin gene expression in virgin, 22-day pregnant and parturient rats was evidently
similar in the SON. In the PVN, oxytocin mRNA-containing neurones were clearly
shown in the magnocellular part of the PVN (Fig. 17D, E, F) and the expression
pattern of the oxytocin gene in virgin, 22-day pregnant and parturient rats was
evidently similar. In the SON, double in situ hybridization revealed that nNOS
mRNA was present in both oxytocin and vasopressin neurones (Fig. 18). However,
the results are not consistent so we are unable to quantify the expression of nNOS
mRNA in oxytocin neurones compared to vasopressin neurones in different stages of
pregnancy.
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Figure 13. Neuronal NOS mRNA expression measured as film grain density over the
SON, PVN, SFO and AMG. A significant decrease in nNOS mRNA expression was
observed in late pregnant rats (day 22) compared to virgin rats in the SON (A) (*,
P<0.05, One Way ANOVA; Dunn's Method). There was no significant change in
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Figure 17. Photomicrographs showing oxytocin mRNA-containing neurones in the
SON and PVN of virgin (A, D), 22 day pregnant (B, E) and parturient rats (C, F).
Sections of the SON and PVN were hybridized with a digoxigenin-labelled probe
against rat oxytocin mRNA. OC; optic chiasm, V3; third ventricle. Bar=100 pm.
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A
Figure 18. Photomicrographs showing double in situ hybridization using a
radioactive labelled nNOS probe and a digoxigenin-labelled oxytocin probe.
Oxytocin mRNA-containing neurones in the SON were shown in A. Double-labelled
neurones (arrows) were shown in B and C. OC; optic chiasm. Bar=50 pm.
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3.5 Discussion
The role of NO in osmoregulation of oxytocin release in urethane-anaesthetised
virgin rats.
The present results demonstrated that the basal release of oxytocin and
plasma [Na+] were unaffected by systemic administration of either l-NNA or l-
NAME in urethane-anaesthetised rats (Fig. 5, 6), suggesting that, at least under
urethane anaesthesia, endogenous NO does not regulate the basal secretion of
oxytocin. Our results are consistent with previous findings in conscious normally
hydrated rats, in which systemic injection of l-NNA had no effect on the depletion of
oxytocin and vasopressin from the posterior pituitary (Kadowaki et al., 1994).
However, other authors have reported that centrally-produced NO inhibited basal
release of oxytocin but not vasopressin in conscious rats (Kadekaro et al., 1997, Liu
et al., 1997). By contrast, in pentobarbitone-anaesthetised rats, NO formed centrally
has been reported to stimulate basal vasopressin release (Cao et al., 1996). Two
possibilities may account for the discrepancies: first, the effect of L-NNA and L-
NAME on the basal release of oxytocin may be obscured by the effects of urethane.
Alternatively, we need to consider the route by which the NOS inhibitor was applied.
Although l-NNA and l-NAME are able to cross the blood-brain barrier (Dwyer et
al., 1991; Traystman et al., 1995) when administered systemically, l-NNA and l-
NAME could also have effects on the cardiovascular system, causing an increase in
blood pressure (Ishii et al., 1990). An increase of blood pressure (induced for
instance by i.v. administration of phenylephrine) transiently inhibits the neuronal
activity of vasopressin neurones in the SON, and generally has no effect on the firing
rate of oxytocin neurones in the SON, resulting in a decrease in vasopressin release
but little effect on oxytocin release (Harris, 1979). Vasopressin release, but not
oxytocin release, is potentiated by hypotension caused either by haemorrhage
(Wakerley et al., 1975) or in response to i.v. infusion of SNP, which does not cross
the blood-brain barrier (Cohen and Burke, 1979). Central inhibition of NOS inhibited
an increase of vasopressin secretion in response to SNP-induced hypotension (Cao et
Nitric oxide and osmoresponsiveness of the oxytocin system in pregnancy 120
al., 1996). It is not expected that any increase in blood pressure following systemic
administration of L-NNA and L-NAME will alter the basal release of oxytocin.
Interestingly, the present results in virgin rats showed that blockade of NOS
with systemic administration of either L-NNA or L-NAME further enhanced the
secretion of oxytocin induced by hypertonic saline, but had no effect on CCK-evoked
oxytocin release (Fig. 5, 6). These findings suggest that endogenous NO may
selectively inhibit the release of oxytocin in conditions of sustained intense
stimulation. It appears that there is a different effect of NO on CCK-induced oxytocin
release and oxytocin release evoked by hyperosmotic stimulation. However,
hypertonic stimulation is a much more effective stimulus than CCK; there is a
gradual and sustained increase in the firing rate of oxytocin neurones following
hyperosmotic stimulation (Brimble et al., 1978), whereas CCK evokes a rapid but
transient excitation of oxytocin neurones (Renaud et al., 1987). However, we cannot
distinguish whether NO directly inhibits oxytocin neurones, or acts indirectly by
affecting adjacent presynaptic terminals from the forebrain circuitry of fluid balance
and not on noradrenergic pathways from the nucleus tractus solitarii, a relay centre
for vagal afferents that are activated by systemic CCK.
Our observations on the effects of i.p. injection of L-NNA or L-NAME on the
oxytocin secretory response to hypertonic saline are similar to the results from i.p.
injection of L-NNA on the depletion of oxytocin in the posterior pituitary in response
to salt loading in conscious rats (Kadowaki et al., 1994), and of i.e.v. injection of L-
NMMA and L-NAME during dehydration in conscious rats (Summy-Long et al.,
1993). In addition, central blockade of NOS by L-NAME increased oxytocin release
in response to moderate, but not strong, hyperosmotic stimulation in conscious rats
(Kadekaro et al., 1997). The moderate hyperosmotic stimulus (15 ml/kg 0.45 M
NaCl, s.c.) used by Kadekaro et al. (1997) provided a similar Na+ load (6.75 mM/kg)
to the doses of hypertonic saline that we used in our experiments (4 ml/kg 1.5 M
NaCl, i.p.), 6 mM/kg. Further investigation in our studies demonstrated that i.e.v.
infusion of SNP also inhibited the secretion of oxytocin induced by hypertonic saline
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in urethane-anaesthetised rats (Fig. 7). Therefore, our findings support the hypothesis
that NO may play a role as a modulator in osmoregulation of oxytocin secretion. In
particular, NO may serve within a negative-feedback loop to restrain release of
oxytocin in conditions of intense stimulation.
It has been proposed that NO may originate from either oxytocin or
vasopressin neurones, as an increase in NADPH-diaphorase activity and an up-
regulation of NOS mRNA expression have been found in the SON and PVN during
dehydration induced by salt loading and water deprivation (Kadowaki et al., 1994;
O'Shea and Gundlach, 1996; Pow, 1992; Ueta et al., 1995b; Villar et al., 1994b).
Nitric oxide may also originate from the neurohypophysis, and from the forebrain
structures of the lamina terminalis (the subfornical organ, median preoptic nucleus
and organum vasculosum of the lamina terminalis) since an increase in number
and/or intensity of NADPH-diaphorase staining neurones in these areas was shown
after chronic salt loading and dehydration, respectively (Ciriello et al., 1996; Sagar
andFerriero, 1987).
Nitric oxide may inhibit the release of oxytocin in response to hyperosmotic
stimulation by acting at the SON, the PVN or at the axon terminals of magnocellular
neurones. Our findings in chapter 4 (Fig. 23) showed that NO can inhibit the activity
of the cell bodies of SON neurones. Another site of action of NO appears to be the
neurohypophysis since L-NAME appears to prevent the ultrastructural changes in the
neurohypophysis induced by injection of hypertonic saline (Beagley and Cobbett,
1997). Kadekaro et al. (1994) postulated that NO may act at axon terminals to inhibit
oxytocin release during dehydration since NO did not alter the increase in glucose
utilization in the SON, PVN and neurohypophysis, which indicates that NO did not
alter the metabolic/electrical activity of this system during dehydration. Furthermore,
NO increased the rate of glucose utilization in the subfornical organ and preoptic
nucleus, suggesting that NO may exert an inhibitory action on synaptic activation of
oxytocin neurones by increasing the firing rate of these neurones during water
deprivation. There may therefore be multiple sites of production and action of NO in
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the modulation of the responses of magnocellular oxytocin neurones to osmotic
stimulation.
Does the altered osmoresponsiveness of the oxytocin neurosecretory system in
pregnant rats reflect a change in the NOS system ?
In late pregnancy, plasma osmolality and plasma [Na+] are reduced (Barron et
ai, 1985; Durr et al., 1981) and the osmoresponsiveness of the oxytocin
neurosecretory system is also reduced (Russell et al., 1992). Therefore, we
investigated the influence of endogenous NO on the responsiveness of the oxytocin
system to osmotic stimulation in late pregnancy. We found that NO did not alter the
basal release of oxytocin in either virgin or pregnant rats under urethane anaesthesia.
To produce similar increases of plasma [Na+], pregnant rats were i.p. injected
with 2.5 M hypertonic saline while virgin rats received 1.5 M NaCl. Unlike previous
studies (Russell et al., 1992), in which oxytocin secretion was measured following
similar increases in plasma [Na+] in pregnant and virgin rats, in the present study
plasma [Na+] was increased to similar values in pregnant and virgin rats. The robust
oxytocin secretory responses in pregnant rats in the present study are likely to be a
consequence of the greater plasma [Na+] attained (Fig. 8, 9). A significant
enhancement of oxytocin release by L-NNA was shown in virgin rats, but not in late-
pregnant rats. Thus, the inhibitory influence of endogenous NO on hypertonic saline-
induced oxytocin release is down-regulated in late pregnancy. Reduced inhibition by
NO in late pregnancy reflects the reduced excitability of oxytocin neurones shown in
previous studies with less effective hyperosmotic stimulation (Russell et al., 1992),
or AY3V stimulation (Bull et al., 1994).
The similarity of the enhancement of oxytocin release in response to
hypertonic saline by blockade of NOS with L-NNA (Fig. 5, 6) or blockade of opioid
receptors with naloxone (Shibuki et al., 1988) prompted us to investigate the
relationship between these two mechanisms. In accord with previous studies
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(Douglas et al., 1993; Summy-Long et al., 1990), naloxone enhanced oxytocin
release in response to hyperosmotic stimulation in both virgin and late-pregnant rats
(Fig. 8, 9). Pre-treatment with L-NNA did not alter the increase in oxytocin release
after naloxone in late pregnancy, in contrast with a greater effect of naloxone on
oxytocin secretion after L-NNA in virgin rats. These differences between late-
pregnant and virgin rats suggest that the involvement of NO in osmoregulation of the
oxytocin system is not due to opioid inhibition, and vice versa. An opioid inhibition
of oxytocin release seems to amplify the inhibitory influence of NO on oxytocin
release in response to hypertonic saline. In agreement with our findings, the
preferential inhibition by NO of oxytocin release (Summy-Long et al., 1993) may be
an additional mechanism, but independent of an inhibitory effect of opioid peptide,
since oxytocin release induced by i.e.v. administration of L-NAME, but not by
naloxone, was attenuated by inhibition of prostaglandin production by the cyclo-
oxygenase inhibitor indomethacin (Summy-Long et al., 1996). Thus, an involvement
of NO in the osmoregulation of oxytocin system is independent of the inhibitory
influence of endogenous opioids.
In addition to elevating plasma osmolality (Dunn et al., 1973), i.p. injection
of hypertonic saline produces signs of visceral illness and pain (Verbalis et al.,
1986b). Therefore, the release of oxytocin induced by i.p. injected hypertonic saline
may result from activation of afferent neural pathways associated with nausea,
stimulated by either local peritoneal irritation or via chemoreceptors in the area
postrema (Verbalis et al., 1986a). Although our studies were in anaesthetised rats, to
avoid these effects we also administered hypertonic saline via i.v. infusion instead of
i.p. injection. Pregnant rats were i.v. infused with 2.6 M NaCl and virgin rats
received 2 M NaCl at the rate of 2 ml/h. Similar changes in plasma [Na+] were found
in both groups. In both virgin and late-pregnant rats, plasma concentration of
oxytocin increased in dose-dependent manner in parallel to the increase in plasma
[Na+] following i.v. infusion of hypertonic saline (Fig. 10, 11). Our results
demonstrated that L-NNA enhances the secretion of oxytocin in response to
hypertonic saline infusion, confirming that endogenous NO restraints oxytocin
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secretion stimulated by i.v. hypertonic saline infusion is attenuated in late pregnancy.
Similar to the findings in late-pregnant rats given the high dose of i.p. hypertonic
saline, L-NNA did not enhance the oxytocin response to i.v. hypertonic saline in late
pregnancy. Therefore, the osmoresponsiveness of the oxytocin neurosecretory system
in the pregnant rats is not restrained by the NOS system when driven by strong
osmotic stimulation. As a result, when appropriately and strongly stimulated the
oxytocin secretory response to osmotic stimulation in pregnant rats is at least as
great, and can be greater, in pregnant compared with virgin rats.
Our experiments provided additional evidence that nNOS mRNA expression
in the SON can be modulated by naturally-occurring changes in the reproductive
state, since the expression of nNOS mRNA in the SON was reduced at the end of
pregnancy and increased again during parturition (Fig. 13A). These findings are
consistent with the data reported by Okere and Higuchi (1996a) who found fewer
NADPH-diaphorase-positive cells in the SON and PVN together with a decrease in
the specific activity of NOS in the posterior pituitary in 19-21 day pregnant and
parturient rats, but not in mid-pregnant rats. By contrast, other authors have reported
that the number of NADPH-diaphorase positive cells in the SON and PVN is
increased in mid-pregnant rats (Popeski et al., 1999) and 22 day pregnant rats
(Popeski et al., 1999; Woodside and Amir, 1996). Another study demonstrated an
up-regulation of nNOS protein and nNOS mRNA expression in the hypothalamus of
20 day pregnant rats assessed by western blot and northern blot, respectively (Xu et
al., 1996). There are two possibilities to explain these discrepancies: first, there is
likely to be a delay between changes in nNOS mRNA expression and nNOS protein
expression. Second, expression of the nNOS mRNA, described as a late response
gene (Chapter 5), may vary over the last days of pregnancy, so selection of the time
points selected in each experiment may give different results. Alternatively, the
expression of nNOS mRNA may be regulated by nNOS protein in a negative
feedback way.
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No increase in nNOS mRNA expression was found in either the SON or the
PVN in mid-pregnancy (Fig. 13A, B), consistent with the findings of Luckman et al.
(1997). However, after a decrease in expression in late pregnancy, there was an acute
increase in expression in the SON during parturition (significant increase from late
pregnancy levels, Fig. 13A). This indicates that the activation of oxytocin neurones
during parturition may stimulate nNOS mRNA expression.
In conclusion, this study indicates a functional down-regulation of the
influence of endogenous NO on the excitability of oxytocin neurones to osmotic
stimulation during late pregnancy. In virgin rats, the endogenous NOS system has a
potent restraining influence on oxytocin cell excitability. Thus, the decrease in the
inhibitory effect of NO due to a down-regulation of the NOS system in the
magnocellular neurosecretory system and a decrease in NOS activity in the posterior
pituitary in late pregnancy (Okere and Higuchi, 1996a) may cause the oxytocin
system to become more excitable, resulting in the capacity for greater release of
oxytocin at term.
Down-regulation of the NOS system in the magnocellular neurosecretory
system at the end of pregnancy in the rat may play a physiological important role in
the timing of the onset and/or progress of parturition. During parturition NOS mRNA
expression is activated, possibly reflecting activity-dependent regulation of
expression at this time.
CHAPTER 4
NITRIC OXIDE SIGNALLING IN THE MAGNOCELLULAR
NEUROSECRETORY SYSTEM
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4.1 Introduction
Nitric oxide may regulate the release of oxytocin and vasopressin by acting on
either the cell bodies in the SON and PVN, or on their nerve terminals in the
neurohypophysis. Electrophysiology studies suggest that NO may modulate the
activity of SON neurones, since the activity of both phasic and non-phasic neurones
in the SON was inhibited by NO (Liu et al., 1997). However, the mechanisms
responsible for this inhibitory influence of NO are still unclear. Nitric oxide may
control the activity of the SON neurons through NMDA receptors at postsynaptic
sites, as NO suppressed NMDA-evoked depolarization (Cui et al., 1994).
Alternatively, NO may increase GABA release by acting at presynaptic terminals
rather than by a direct effect on SON neurones, since NO potentiated the spontaneous
inhibitory postsynaptic currents (IPSPs), but not excitatory postsynaptic currents
(EPSPs) recorded from SON neurones in vitro (Ozaki et al., 1999). In the PVN, NO
potentiated GABA inputs via postsynaptic as well as presynaptic mechanisms, since
NO evoked spontaneous IPSPs recorded from PVN neurones in vitro (Bains and
Ferguson, 1997b).
We therefore tested the hypothesis that the NO responsible for inhibition of
oxytocin release co-exists with either oxytocin or vasopressin, and that NO may be
involved in controlling the release of oxytocin and vasopressin by acting at the level
of the cell bodies of the magnocellular neurosecretory neurones and the terminals of
these neurones in the neurohypophysis.
4.2 Aims
This study examined the specific role of NO on the release of oxytocin from
the magnocellular neurosecretory system. We were particularly interested to
determine the involvement of NO in controlling neurohypophysial hormone release
at the level both of the cell bodies, and the nerve terminals. Furthermore, we also
investigated the expression of neuronal NOS gene in the hypothalamic magnocellular
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neurones of rats after prolonged electrical stimulation of the axons of magnocellular
neurosecretory neurones.
4.3 Materials and methods
4.3.1 Animals
Experiments were carried out on virgin female Sprague-Dawley rats,
weighing 250 to 300 g. They were housed under standard laboratory conditions (12-
hour: 12-h dark-light cycle, ambient temperature 20 ± 1 °C) with free access to food
and water.
4.3.2 Experimental procedure
1. The effect of the NOS inhibitor Nco-nitro-l-arginine. (l-NNA) on Fos expression in
the SON and PVN in rats treated with low doses ofhypertonic saline
Rats were anaesthetised with sodium pentobarbitone (Saggatal, Rhone
Merieux Ltd.) at a dose of 50 mg/kg, i.p.. They were treated with either the
irreversible NOS inhibitor A^-nitro-L-arginine (L-NNA, 10 mg/kg, i.p., Sigma,
(Dwyer et al., 1991)) or vehicle. After 4 h, rats received either hypertonic saline
solution (2 ml/kg 1.5 M NaCl, i.p.) or isotonic saline solution. Rats were decapitated
90 min later. Brains were removed, frozen with crushed dry ice and kept at -70°C.
Frozen brains were coronally sectioned (15 (im) through the SON and PVN on a
cryostat and processed for Fos immunocytochemistry using the indirect method.
2. The effect of the NOS inhibitor Nw-nitro-l-arginine (l-NNA) on Fos expression in
the SON and PVN in rats treated with high doses ofhypertonic saline
Sodium pentobarbitone anaesthetised rats were treated with either the
irreversible NOS inhibitor /V-nitro-L-arginine (L-NNA, 10 mg/kg, i.p., Sigma) or
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isotonic saline solution, then left for 4 h. Rats were then injected with hypertonic
saline solution (4 ml/kg 1.5 M NaCl, i.p.). Rats injected with isotonic saline solution
followed by 1.5 M NaCl were included as positive controls (Hamamura et al., 1992).
After 90 min, the rats were perfused transcardially with isotonic saline solution,
followed by fresh 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB). The
brains were removed, post-fixed 2-5 h in the same fixative, cryoprotected in 30%
sucrose in fixative overnight at 4°C and then left in phosphate-buffered 30% sucrose
(v/v) at 4°C until the brains sank. Brains were then coronally-sectioned (50 p,m)
through the SON and PVN on a freezing microtome and serially collected in PB.
Sections were processed for Fos immunocytochemistry using the ABC method.
3. The role ofNO in oxytocin release following electrical stimulation of the neural
stalk
Rats were anaesthetised with urethane to allow cannulation of femoral veins
and arteries on the day of the experiment (General Methods 2.2). The pituitary stalk
of each urethane-anaesthetised rats was exposed by the transpharyngeal approach as
described in General Methods 2.5. A stimulating electrode was placed on the neural
stalk of the pituitary gland to deliver biphasic pulses (10 Hz, 1 mA peak to peak).
The neural stalk was stimulated for 3 min before and 2, and 4 h after administration
of either L-NNA (Sigma, 10 mg/kg, i. p.) or isotonic saline solution. Blood samples
were taken from the left femoral artery before and immediately after stalk stimulation
O
and immediately centrifuged. The plasma was then separated and stored at -20 C
until assayed for oxytocin by specific RIA. The remaining blood cells were
resuspended in isotonic saline at the same volume as the plasma taken and returned
via the left femoral vein.
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4. NOS mRNA expression in the SON and PVN following prolonged
neurohypophysial stalk stimulation
Rats were anaesthetised with sodium pentobarbitone (Saggatal, Rhone
Merieux Ltd., 50 mg/kg, i.p.). A femoral artery and vein were cannulated for blood
sampling and reinfusion. Rats were divided into three groups; control, sham-
operation and stalk stimulated group. Control group: the skull was exposed only.
Sham-operation group: the pituitary stalk was approached dorsally and the electrode
was implanted in the stalk without current application. Stalk-stimulated group: the
pituitary stalk was approached dorsally and the electrode was implanted in the neural
stalk, and stimuli applied for 2 h (20 Hz, 10 s on, 10 s off, 1 mA peak to peak). The
surgical method is described in General Methods 2.4. After stimulation, the rats were
left a further 2 h before decapitation. Brains were removed and quickly frozen with
crushed dry ice and kept at -70°C. Frozen brains were then cryostat sectioned (15
pm) coronally and processed for study of the expression of nNOS mRNA by using
radioactive in situ hybridization histochemistry.
To verify the correct placement of the electrode, blood samples were
collected 5, 10 min before and 15, 20 min after the start of stalk stimulation. Plasma
samples were kept at -20°C until the day of oxytocin assay.
5. The role ofNO in the electrical activity ofoxytocin and vasopressin cells
The experiments were carried out on urethane-anaesthetised rats. A femoral
vein and the trachea were cannulated. The pituitary stalk and right SON were exposed
by a transpharyngeal surgery as described in General Methods 2.5. A combined
intrasupraoptic nucleus retrodialysis/m vivo extracellular recording technique
(Ludwig and Leng, 1997) was used to investigate the effect of local nitric oxide on
the activity of identified oxytocin- and vasopressin-cells. An in-house designed U-
shaped dialysis probe (total membrane length, 2.0 mm; Spectra/Por RC Hollow
Fibers®, Spectrum Med. Inc., (Ludwig et al., 1994a)) was bent to position the loop of
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the membrane flat onto the exposed ventral surface of the brain on the ventral glial
lamina of the supraoptic nucleus after removal of the meninges. A glass micropipette
(filled with 0.15 M NaCl, 20-40 MO resistance) was introduced into the centre of the
loop of the dialysis membrane to record the extracellular activity of single neurones in
the SON. A stimulating electrode (SNEX-200X, Clarke Electromedical) was placed
on the neural stalk of the pituitary gland and set to deliver single matched biphasic
pulses (1 ms duration, <1 mA peak to peak) for antidromic identification of SON
neurones. Oxytocin cells were distinguished from vasopressin cells by their firing
pattern and by their responses to i.v. injection of 20 ftg/kg cholecystokinin (CCK,
cholecystokinin-(26-33)-sulphated; Bachem Ltd). All continuously active neurones
were identified as oxytocin neurones by a transient excitation, and as vasopressin
neurones by no effect or short-term inhibition after CCK injection (Leng et al., 1991;
Renaud et al., 1987)).
Artificial cerebrospinal fluid (aCSF; pH 7.2, composition (mM): NaCl, 138;
KC1, 3.36; NaHC03, 9.52; Na2HP04, 0.49; urea, 2.16; MgCl2, 1.18) was dialysed
onto the SON at a flow rate of 3 |il/min throughout the experiment. Dialysis fluid
was changed to aCSF containing the NO donor sodium nitroprusside (SNP; lOmM,
100 mM, Sigma), the NO precursor L-arginine (100 mM, Sigma) or the NOS
inhibitor A^-nitro-L-arginine (L-NNA; 10 mM, Sigma). Dialysis was maintained until
a clear effect was observed, or for 30 min where no effect was seen.
The firing rates of identified oxytocin- and vasopressin-cells were recorded
using the Spike2 software package (Cambridge Electronic Design, Cambridge, UK).
The mean firing rate (spikes/s) of each cell and for phasic cells, the activity quotient,
were calculated for the 5 min period immediately before and for successive 5 min
periods after drug retrodialysis.
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4.3.3 Fos immunocytochemistry
The full methodology is described in General Methods 2.7.
Indirect method
Brains were cryostat sectioned coronally (15 |im) through the SON and PVN
guided by the stereotaxic atlas of Paxinos and Watson (1982) and thaw mounted on
chrome alum gelatine subbed slides. Sections were stored in desiccated slide boxes at
-70°C.
Cryostat sections were fixed in 4% paraformaldehyde in 0.1 M PB for 30 min
and washed in 0.1 M PB. Endogenous peroxidase was blocked with hydrogen
peroxide solution for 15 min. Slides were then washed with PB-T (0.1 M PB
containing 0.3% Triton X-100). Non-specific binding was blocked by preincubation
buffer containing 1% normal sheep serum for 1 h. Sections were incubated for 48 h
with a polyclonal antibody raised in rabbits against rat Fos (c-fos Ab-2; Oncogene
Sciences) at a dilution of 1:1000 in preincubation buffer containing 1% v/v normal
sheep serum. After 48 h, sections were washed with PB-T. Sections were then
incubated for 24 h with secondary antibody (goat anti-rabbit IgG-peroxidase
complex) at a dilution of 1:1000 in preincubation buffer containing 1% v/v normal
sheep serum. Sections were washed with PB-T and rinsed with 0.1 M acetate buffer
for 2 min. Sections were then incubated with the glucose oxidase-Ni DAB solution
until the reaction had worked and some nuclei appeared black. The reaction was
terminated with stop solution for 5 min, and then a rinse with PB for 5 min. Sections
were then dehydrated through serial concentrations of ethanol (70%, 90%, 95%,
100% and 100%) and then into xylene. Slides were finally coverslipped using DPX
mountant (BDH).
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ABC method
Paraformaldehyde fixed brains were coronally sectioned (50 |im) through the
SON and PVN using a freezing microtome. Sections were collected in 0.1 M PB and
processed for Fos immunonocytochemistry.
Free-floating sections were washed in PB-T (0.2% Triton X-100 in 0.1 M
PB). Endogenous peroxidase was then deactivated with hydrogen peroxide solution
for 15 min and washed off with PB-T. Non-specific staining was then blocked by
preincubation buffer containing 1% normal sheep serum for 30 min. After that the
sections were incubated for 48 h in Ab-2 Fos antibody (Rabbit polyclonal; Oncogene
Sciences), at a dilution of 1:1,000 in preincubation buffer. Slides were washed with
PB-T. The antibody-antigen complex was localized by incubating sections in
secondary antibody solution (1% biotinylated anti-rabbit immunoglobulin and 3%
normal goat serum in PB-T) for 1 h and washed in PB-T (3x10 min). Slides were
then left to incubate in ABC complex solution (2% Avidin DH and 2% Biotinylated
horseradish peroxidase in PB-T) for 1 h. Sections were washed in PB-T (2x10 min).
After that sections were rinsed with 0.1 M acetate buffer for 5 min. They were then
incubated with the glucose oxidase-Ni DAB solution for approximately 10 min until
some nuclei appeared black, the reaction was terminated with stop solution for 5 min,
and sections then rinsed with PB for 5 min. Sections were then mounted onto the
chrome alum gelatine subbed slides in serial order and left to dry overnight. Sections
were then dehydrated through serial concentrations of ethanol (70%, 90%, 95%,
100% and 100%) and then into xylene. Slides were finally coverslipped using DPX
mountant (BDH).
The number of neurones in the SON and PVN expressing Fos
immunoreactivity was counted under a light microscope (xlO objective lens).
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4.3.4 Radioimmunoassay
The full methodology for specific radioimmunoassay for oxytocin is
described in General Methods 2.6.
On the day of assay, plasma samples were thawed and centrifuged. Specific
anti-oxytocin antiserum (Higuchi et al., 1985) was added to triplicate aliquots of
standards (ranging from 2.4 to 2500 pg/ml) and duplicate aliquots of plasma samples.
Mixtures were left for 24 h before adding a fixed amount of 125I-oxytocin
(approximately 6-8,000 cpm) to all tubes. Mixtures were then left for 2-3 days.
Second antibody (Donkey anti-rabbit gammaglobulin) was added to all tubes and left
for 24 h. Standardized Pansorbin cells (Novabiochem (U.K.) Ltd., 0.1% w/v solution
in phosphate buffer) was added prior to centrifugation. Supernatants were then
aspirated before precipitates were counted in a gamma counter (LKB-Wallace 1272
Clinigamma). All samples in each experiment were measured in a single assay to
avoid interassay variance.
The concentration of oxytocin in the standard or plasma sample was inversely
proportional to the amount of 125I-oxytocin bound to the rabbit anti-oxytocin
antibody. Oxytocin concentration in the unknown samples was determined by
comparing the unknown precipitate radioactivity to that of known standard oxytocin
contents
4.3.5 In situ Hybridization
The full methodology is described in General Methods 2.8.
Brain sections
Brains were coronally sectioned (15 (im) through the hypothalamus at the
level of the SON and PVN using a cryostat and thaw-mounted onto gelatin-coated
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glass slides. Slides were then stored in desiccated slide boxes at -70°C before in situ
hybridization.
Probes
Three 45-mer antisense oligonucleotide probes complementary to bases 223-
267 (5'-noncoding region), 4714-4758 (3'-noncoding region) and 1662-1706 of the
rat neuronal NOS (nNOS) sequence (Bredt et al., 1991b) were used. Probes were
labelled at the 3' end with [a-35S]deoxy-ATP (NEN) using terminal
deoxynucleotidyltransferase (Pharmacia).
In situ hybridization
Sections were fixed with 4 % paraformaldehyde in 0.1 M PB (pH 7.4) for 30
min, then rinsed in 0.1 M PBS and washed in 0.1 M PBS (10 min), followed by
acetylation in triethanolamine solution (0.25% acetic anhydride in 0.1 M
triethanolamine-0.15 M NaCl) for 10 min. The sections were then dehydrated
through 70%, 80%, 95% and 100% ethanol (5 min each), delipidated in chloroform
for 10 min, and partially rehydrated in 95% ethanol (10 min). After air-drying the
slides were placed in a humidified chamber. The sections were covered with
hybridization buffer (4xSSC, 50% formamide, lxDenhardt's solution, 500 jig/ml
sheared salmon sperm DNA, 10% dextran sulphate and 0.3% mercaptoethanol)
containing the 35S-labelled NOS oligonucleotide probes at a concentration of 2500
dpm/|j,l and left to hybridize for 17 h at 37°C.
After the hybridization process, the excess hybridizing solution was drained
off. The slides were briefly rinsed three times in lxSSC at room temperature, washed
three times for 30 min in lxSSC and were washed for a further 1 h in lxSSC at room
temperature. The slides were air-dried and dipped in 300 mM ammonium acetate,
70% ethanol and then air-dried. The slides were then placed in autoradiographic
cassettes and exposed to Hyperfilm-Pmax autoradiography film (Amersham, UK)
together with brain paste standards. The film was left to expose for 3 weeks at 4°C.
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The films were developed in D19 developer (Kodak) and then fixed (Ilford Hypam
rapid fixer). After that, the sections were dipped in Ilford G-5 emulsion-coated slides
(Mobberley) diluted 1:1 with autoclaved water. The emulsion-coated slides were
exposed for a further 4-5 weeks to visualize the NOS cellular signal, and then
developed (Kodak D19 developer) for 5 min and fixed (Ilford Hypam rapid fixer
twice 5 min each). The developed sections were counterstained with cresyl violet,
dehydrated in a graded ethanol series, and coverslipped in DPX mountant.
Quantitative Analysis
The amount of nNOS mRNA in the SON and PVN was assessed by silver
grain density of autoradiographic films of the SON, PVN, SFO and AMG viewed
under the light microscope, with x5 and xlO objectives. Grain density was quantified
by the NIH Image analysis system version 1.58 on an Apple Mcintosh computer. The
value of silver grain density per unit area was obtained by subtracting background
measurements from each specific tissue measurement, and dividing by the area
measurements. Each brain paste standard was measured twice, and corresponding
background measurements taken. A logarithmic relationship was then plotted for
radioactivity against the grain density of the standards. Acceptable grain density
values lay on the straight portion of the curve. For each identified brain area, the
mean grain density per unit area for each rat was calculated and the group mean grain
density per unit area calculated.
Specific radioactivity of labelled probes was ranged from 536.82 to 866.42
Ci/mmol.
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4.3.6 Statistical Analysis
All data are reported as means + S.E.M.. Data were analysed statistically by t-
test, one-way ANOVA and two way ANOVA for comparison differences between
groups, a one-way repeated measures ANOYA for differences with time and a two-
way repeated measures ANOVA for differences between groups followed by
Dunnett's method or Student-Newman-Keuls method (SigmaStat). The parametric
paired r-test and the non-parametric Wilcoxon-Signed Rank test were used for
comparison differences between before and after treatment within group. P< 0.05
was considered statistically significant.
4.4 Results
1. The effect of the NOS inhibitor Nm-nitro-l-arginine (l-NNA) on Fos expression in
the SON and PVN in rats treated with low doses ofhypertonic saline
Fos was clearly localised in neuronal nuclei of magnocellular neurones in the
SON and PVN but not in surrounding areas. Compared to vehicle/isotonic saline-
injected controls (V/IS), there was a marked increase in Fos-immunoreactivity in the
SON and PVN 90 min after administration of low dose hypertonic saline (2 ml/kg,
1.5 M NaCl, i.p.) in isotonic saline pre-treated rats (V/HS)(Fig.21 A, B and Fig. 22A,
B). In rats pre-treated with the NOS inhibitor /V°-nitro-L-arginine (L-NNA, 10 mg/kg,
i.p.) followed by a low dose of hypertonic saline (L-NNA/HS), intense Fos-
immunoreactivity in the magnocellular neurones of the PVN was observed when
compared to vehicle/isotonic saline-injected rats (V/IS)(Fig.22A, D). Pre-treatment
with L-NNA did not significantly alter Fos-immunoreactivity in the magnocellular
neurones of the SON and PVN in response to systemic injection of either isotonic
saline or low dose hypertonic saline (Fig. 21C, D and Fig. 22C, D).
In vehicle pre-treated rats injected with a low dose of hypertonic saline
(V/HS, n=7) the mean number of Fos-positive neurones in the SON was significantly
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greater than in isotonic saline-injected rats (V/IS, n=6)(58.59 % increase; P<0.05,
Fig. 19). Significantly more Fos-positive cells were also found in the magnocellular
region of the PVN in response to the low-dose hypertonic saline (V/HS, n=7) than in
the V/IS group (n=7)(45.82 % increase; P<0.05, Fig. 20).
In rats pre-treated with L-NNA injected with a low dose of hypertonic saline
(L-NNA/HS, n=7) the mean number of the magnocellular neurones expressing Fos in
the PVN was significantly greater than in vehicle-injected rats (V/IS, n=7)(55.44 %
increase; P<0.05, Fig. 20). However, L-NNA pre-treatment did not alter the number
of magnocellular PVN neurones expressing Fos immunoreactivity in response to
low-dose hypertonic saline since there was no significant difference between the
number of Fos-positive neurones after L-NNA pre-treatment (L-NNA/HS, n=7) and
vehicle pre-treatment (V/HS, n=7) (Fig. 20). The number of Fos-positive neurones in
the SON from L-NNA-pre-treated rats that were injected with a low dose of
hypertonic saline (L-NNA/HS, n=6) was increased, but not significantly different,
compared with V/IS rats (n=6, 61.07 % increase). Pre-treatment with L-NNA did not
significantly alter the mean number of Fos-positive cells in the SON in response to
low-dose hypertonic since there was no significant difference between rats pre-
treated with L-NNA (L-NNA/HS, n=6) and rats pre-treated with vehicle (V/HS, n=7)
(Fig. 19).
The mean number of Fos-positive nuclei in the SON and the magnocellular
PVN of L-NNA pre-treated rats injected with isotonic saline (L-NNA/IS, n=7) was
not significantly increased compared with V/IS rats (n=7). There was no significant
difference in the mean number of Fos-positive neurones in the SON and
magnocellular part of the PVN between the L-NNA/HS group and the L-NNA/IS
group (Fig. 19, 20).
Thus, pre-treatment with L-NNA did not significantly alter the basal number
of Fos-positive cells in the SON or in the magnocellular part of the PVN, and had no
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effect on the number of magnocellular neurones of the SON and PVN expressing Fos
immunoreactivity in response to a low dose of hypertonic saline.
2. The effect of the NOS inhibitor Fff-nitro-L-arginine (L-NNA) on Fos expression in
the SON and PVN in rats treated with high doses ofhypertonic saline
Extensive immuno-staining for Fos was seen in neuronal nuclei of
magnocellular neurones of the SON and PVN 90 min after i.p. injection of 1.5 M
NaCl (4 ml/kg) in both NOS inhibitor pre-treated (10 mg/kg L-NNA, i.p.) and vehicle
pre-treated rats (Fig. 24). Significantly more magnocellular neurones in the SON
expressed Fos in L-NNA pre-treated rats (n=8) than in vehicle-injected positive
control rats (n=8)(23.77 % increase; P<0.05, Fig. 23). The number of Fos-positive
cells in the magnocellular part of the PVN of rats pre-treated with L-NNA followed
by a high dose of hypertonic saline was not significantly increased compared with
control rats (Fig. 23).
Thus, pre-treatment with L-NNA enhanced the expression of Fos in the SON
of rats given a high dose of hypertonic saline, suggesting an inhibitory action of NO
on the activation of the neurones following strong hypertonic stimuli. No significant
effect of pre-treatment was observed in rats given a lower dose of hypertonic saline.
3. The role of NO in oxytocin release following electrical stimulation of the neural
stalk
In this experiment, the neural stalk of urethane-anaesthetised rats was
stimulated for 3 min (10Hz, 1 mA) before, 2 and 4 h after administration of either the
L-NNA or vehicle. Pre- and post-stimulation samples for oxytocin RIA were taken
immediately before and after stalk stimulation. In all rats, the plasma oxytocin
concentration in pre-stimulation samples did not alter following L-NNA or vehicle
administration, suggesting that NO had no effect on the basal release of oxytocin. In
vehicle pre-treated rats (n=5), stalk stimulation induced an increase in plasma
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oxytocin concentration by 2.12-, 1.75- and 1.93-fold before, 2 h and 4 h after vehicle
administration. The increases in plasma oxytocin release following stalk stimulation
were significant before and 2 h after vehicle administration (P<0.05, Fig. 25A). There
was no statistically significant difference between pre- and post-stimulation samples
taken 4 h after vehicle administration. In L-NNA pre-treated rats (n=7), stalk
stimulation increased plasma oxytocin concentration by 2.69-, 3.52- and 2.86-fold
before, 2 h and 4 h after L-NNA administration, which were all significant increases
(P<0.01, Fig. 25B). The oxytocin concentration in the post-stimulation sample 4 h
after administration of L-NNA, was significantly greater than in the post-stimulation
samples taken before and 2 h after L-NNA administration (P<0.05, Fig. 25B).
In control rats (n=5), the increase in oxytocin release following stalk
stimulation at 2 and 4 h was not significantly altered by vehicle administration (Fig.
26). By contrast, in L-NNA treated rats (n=7), the stimulated oxytocin release
increased progressively following L-NNA treatment. The stimulation of oxytocin
release was significantly enhanced 4 h after L-NNA administration compared to the
control group (P<0.05, Fig. 26).
L-NNA did not affect basal oxytocin release. L-NNA enhanced oxytocin
release evoked by electrical stimulation of the axons of magnocellular neurosecretory
neurones, suggesting an inhibitory action of NO on the release of oxytocin following
action potentials propagated along the axons. Thus NO, generated in an activity-
dependent manner, appears to act as a feedback inhibitor of oxytocin release at the
terminals of oxytocin neurones.
4. NOS mRNA expression in the SON and PVN following prolonged
neurohypophysial stalk stimulation
To verify the position of the stimulating electrode and to establish the
effectiveness of stalk stimulation, plasma oxytocin concentrations were measured
before and after the start of stalk stimulation. The basal oxytocin release in control,
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sham-operated and stalk-stimulated rats were not significantly different from each
other (Fig. 27).
Under sodium pentobarbitone anaesthesia, neurohypophysial stalk stimulation
(20 Hz, 10 s on, 10 s off, 1 mA peak to peak) for 15 min caused a dramatic increase
in the plasma oxytocin concentration from basal by 46.44-fold (P<0.05, n=8, Fig.
27). In control and sham-operated rats, the plasma concentration of oxytocin did not
significantly change.
Strong nNOS mRNA hybridization signals were observed in the SON, the
magnocellular region of the PVN, SFO and AMG. A decreased nNOS mRNA signal
was revealed by silver grain density in the SON of prolonged stalk-stimulated rats
(Fig. 29C). The nNOS mRNA signal in the magnocellular part of the PVN, SFO and
AMG of prolonged stalk-stimulated rats was not significantly different from control
rats (Fig. 30, 31).
Prolonged stalk stimulation (n=8) resulted in a significant decrease in silver
grain density (nNOS mRNA) in the SON compared to sham-operated rats
(n=7)(28.88 % increase; P<0.05, Fig. 28A). By contrast, there was no change in
nNOS gene expression in the PVN, SFO and AMG after prolonged stalk stimulation.
5. The role ofNO in the electrical activity ofoxytocin and vasopressin cells
The firing rates of oxytocin cells and continuously firing vasopressin cells
were increased after local administration of the NOS inhibitor L-NNA, and were
reduced after local administration of the NO donor SNP or the NO precursor L-
arginine (Fig. 32, 33). L-arginine similarly tended to inhibit the spontaneous activity
of both types of cell. L-NNA had a significant excitatory effect on the spontaneous
activity of both oxytocin cells and vasopressin cells (P<0.05 and P<0.0005 vs basal,
respectively, Fig. 34). The mean spontaneous firing rate of five oxytocin cells tested
increased by 0.83 ± 0.20 spikes/s and the mean spontaneous firing rate of twelve
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vasopressin cells tested increased by 1.78 ± 0.36 spikes/s following retrodialysis of
10 mM L-NNA. In addition, the spontaneous firing rate of both oxytocin cells and
vasopressin cells was inhibited by SNP in a dose-dependent way (Fig. 35). The firing
rate of oxytocin cells and vasopressin cells was significantly inhibited after 100 mM
SNP administration (P<0.05, P<0.0001, respectively). The mean spontaneous firing
rate of the four oxytocin cells decreased by 3.01 ± 1.11 spikes/s and the mean
spontaneous firing rate of the twelve continuously firing vasopressin cells decreased
by 7.01 ± 0.63 spikes/s following retrodialysis of 100 mM SNP.
In each of four phasic vasopressin cells, 100 mM SNP retrodialysis onto the
SON for 45 min caused a significant decrease of activity quotient, firing rate and
mean burst length (P<0.05, Fig. 36). After 45 min of 100 mM SNP administration,
the activity quotient of phasic vasopressin cells decreased by 0.58 ± 0.20, the mean
spontaneous firing rate decreased by 4.38 ± 1.62 spikes/s and the mean burst length
decreased by 115.01 ±65.16 s. Three phasic cells were recorded during retrodialysis
of 10 mM L-NNA onto the SON for 40 min. No significant change in neuronal
activity was observed (Fig. 37).
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Figure 22. Photomicrographs of Fos expression in the magnocellular neurones of the
PVN. A, rats were pre-treated with vehicle followed by isotonic saline (V/IS). B, rats
were pre-treated with vehicle followed by hypertonic saline injection (2 ml/kg 1.5 M
NaCl, i.p.) (V/HS). C, rats were pre-treated with V-nitro-L-arginine (L-NNA)
followed by isotonic saline (L-NNA/IS). D, rats were pre-treated with L-NNA
followed by hypertonic saline (L-NNA/HS). Sections from V/HS (B) and L-NNA/HS
rats (D) showed more Fos-positive cells than sections from V/IS rats (A). Mp; medial
parvocellular, Pm; posterior magnocellular. Bar=100 pm.
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Figure 24. Photomicrographs of Fos expression 90 min after hypertonic saline
injection (4ml/kg 1.5 M NaCl, i.p.) in the SON (A, B) and PVN (C, D). A and C
were pre-treated with vehicle; B and D were pre-treated with L-NNA. In the SON,
there was more Fos-positive cells from rats pre-treated with L-NNA (B) than from
rats pre-treated with vehicle (A). Mp; medial parvocellular, Pm; posterior
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Figure 28. Neuronal NOS mRNA expression measured as film grain density over the
SON, PVN, SFO and AMG. A significant decrease of nNOS mRNA expression was
observed in the SON after prolonged stalk stimulation compared to control with
implanted electrode (*, P<0.05, /-test). There was no significant change in NOS
mRNA expression in the PVN (B), SFO (C) and AMG (D). Values are means ±
SEM.
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Figure 29. Film autoradiographs of sections hybridized with a S oligonucleotide probe
against rat neuronal NOS mRNA in the SON. Neuronal NOS mRNA signal in the SON
in prolonged neurohypophysial stalk stimulated rats (C) was lower than in control rats
with an implanted electrode (B). PVN; paraventricular nucleus, SON; supraoptic nucleus.
Bai^l mm.
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Figure 30. Film autoradiographs of sections hybridized with a S oligonucleotide probe
against rat neuronal NOS mRNA in the PVN. Neuronal NOS mRNA signal in the PVN
in prolonged neurohypophysial stalk stimulated rats (C) was similar to control rats with
and without an implanted electrode (B, A). PVN; paraventricular nucleus, SON;
supraoptic nucleus. Bar=500 pm.
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Figure 31. Film autoradiographs of sections hybridized with a S oligonucleotide
probe against rat neuronal NOS mRNA in the SFO. Neuronal NOS mRNA signal in
the SFO in prolonged neurohypophysial stalk stimulated rats (C) was similar tc
control rats with and without implanted electrode (B, A). Bar=500 pm.
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4.5 Discussion
The effect of the NOS inhibitor N®-nitro-L-arginine (L-NNA) on Fos expression in the
SON and PVN in hypertonic saline treated rats
In the present experiments, expression of Fos was studied in the SON and
PVN following intraperitoneal injection of hypertonic saline in rats pre-treated with
L-NNA. In addition to inhibiting NOS activity (Dwyer et al., 1991), L-NNA may
reduce NO formation by inhibiting re-uptake of L-arginine (Westergaard et al.,
1993). The result of both actions would be reduce the availability of NO. In this
study, systemic administration of L-NNA alone did not alter significantly the
expression of Fos in either the SON or PVN in pentobarbital-anaesthetised rats (Fig.
19, 20), suggesting that NO does not regulate basal Fos expression in the SON and
PVN. By contrast, other authors have recently reported that i.p. injection of L-NAME
reduced urethane-induced Fos expression in the SON and PVN (Woodside and
Popeski, 1999). Urethane dehydrates the rat by elevating plasma osmolality (Hartman
et al., 1987), and urethane induced more Fos-positive neurones than pentobarbitone
(Takayama et al., 1994). Therefore, Fos expression in the SON and PVN following
osmotic stimuli is modulated by NO.
Corresponding to previous findings (Giovannelli et al., 1992; Hamamura et
al., 1992), injection of either 2 ml/kg 1.5 M NaCl or 4 ml/kg 1.5 M NaCl but not
isotonic 0.15 M NaCl, caused increased Fos expression in the SON and PVN in a
dose-dependent manner. We chose 90 min after hypertonic saline administration to
assess Fos expression (Hamamura et al., 1992) as this time point gives that maximal
number of Fos-positive neurones (Giovannelli et al., 1992). Interestingly, Fos
expression in the SON induced by high doses of hypertonic saline (4 ml/kg 1.5 M
NaCl, i.p.) but that not induced by low doses of hypertonic saline (2 ml/kg 1.5 M
NaCl, i.p.) was enhanced by systemic administration of L-NNA (Fig. 19, 23),
suggesting an inhibitory effect of NO on the activity of the SON neurones at high
levels of activity. This finding parallels our previous results in Chapter 3 that the
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release of oxytocin induced by high doses of hypertonic saline (4 ml/kg 1.5 M NaCl,
i.p.) was enhanced by the NOS inhibitor, L-NNA and L-NAME (Fig. 5, 6), whereas
CCK-induced oxytocin release was not altered by L-NNA and L-NAME. These data
are in accord with the findings of Kadekaro et al. (1997) who demonstrated that
plasma oxytocin release in response to similar doses of hypertonic saline was
potentiated by L-NAME in conscious rats. Other authors have demonstrated an
inhibitory role of NO on KCl-evoked vasopressin release by acting directly on the
cell bodies in the SON and PVN in vitro (Yasin et al., 1993). Thus, NO exerts a
predominantly inhibitory effect directly on the cell bodies in the SON and PVN, and
may serve within a negative-feedback loop to restrain the production and release of
oxytocin in condition of intense stimulation.
The role ofNO in oxytocin releasefollowing electrical stimulation of the neural stalk
The present experiments provide the first evidence for an inhibitory effect of
NO on the release of oxytocin at the nerve terminals of magnocellular neurones in
vivo. Systemic administration of L-NNA did not alter the basal release of oxytocin
(Fig. 25). As expected, electrical stimulation of the axons of magnocellular neurones
caused an increase in the plasma concentration of oxytocin before drug treatment but
also 2 h after administration of either vehicle or L-NNA (Fig. 25). At 4 h after pre-
treatment with either vehicle or L-NNA, a significant increase in evoked oxytocin
release was found in rats pre-treated with L-NNA. Our results parallel the previous in
vitro study of Lutz-Bucher and Kuch (1994) who reported that NO attenuated KCl-
evoked the release of vasopressin from pituitary explants.
Application of high frequency electrical stimuli to the neural stalk of the
pituitary evokes action potentials conducted antidromically to the cell bodies and
conducted orthodromically to the nerve terminals (Dyball et al., 1988). An influx of
calcium into the nerve terminals following orthodromically action potentials causes
an increase of intracellular calcium, which will activate NOS enzyme to promote the
production of NO. Once released, NO is thought to act by stimulating cytoplasmic
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guanylate cyclase, resulting in the elevation of cGMP (Southam and Garthwaite,
1993; Wood and Garthwaite, 1994), with a half life of a few seconds. Cyclic GMP
can regulate physiological events by interaction with target proteins, including
cGMP-gated ion channels and cGMP-dependent protein kinases and cGMP-regulated
cyclic nucleotide phosphodiesterases (Garthwaite, 1991; Garthwaite and Boulton,
1995; Lincoln and Cornwell, 1993; McDonald and Murad, 1996). This means that
cGMP can alter cell function both through protein phosphorylation and through
mechanisms not directly related to protein phosphorylation. It has been shown
recently that cGMP and NO itself directly inactivated NOS activity in medial basal
hypothalamus explants and homogenates, providing an ultra-short loop negative
feedback (Canteros et al., 1996).
Depolarization induced by high concentration of potassium chloride (KC1)
also stimulates the release of oxytocin, vasopressin and co-exiting neuropeptides
from hypothalamic explants and isolated neural lobe (Cazalis et al., 1987). Vale and
Hope (1982) demonstrated that the release of cGMP, cAMP and vasopressin from the
rat isolated neural lobe was evoked by high concentration of KC1, suggesting that
KC1 probably enhanced the production of NO, which in turn binding to the target
molecule sGC resulting in an increase of cGMP (Moncada et al., 1989; Southam and
Garthwaite, 1993; Wood and Garthwaite, 1994).
Consistent with our functional studies, Beagly et al. (1997) have postulated
that NO may play a role in the maintenance of structural relations in the
neurohypophysis. Neurohypophysis of rats injected with l-NAME and hypertonic
saline had significantly less contact between the basal lamina and the membrane of
axon terminals and a significantly larger number of axonal profiles enclosed within
piuicytes than those of rats injected only with hypertonic saline. The activation of the
magnocellular neurones caused increased NO production and that NO generated by
these neurones activates sGC in the pituicytes to initiate altered pituicyte morphology
through cGMP dependent processes.
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NOS mRNA expression in the SON and PVN following prolonged neurohypophysial
stalk stimulation
The present study showed for the first time that prolonged electrical
stimulation of the axons of the magnocellular neurones for 2 h (20 Hz, 10 s on, 10 s
off, 1 mA peak to peak) significantly down-regulated the expression of nNOS mRNA
in the rat SON (Fig. 28A). However, the NOS mRNA expression in the PVN, SFO
and AMG did not change after prolonged neural stalk stimulation (Fig. 28B, C, D).
Down-regulation of nNOS mRNA following prolonged neural stalk stimulation in
the present study was unexpected as an increase of NOS mRNA expression and
NADPH-diaphorase staining in the SON and PVN has been demonstrated following
hyperosmotic stimulation (Kadowaki et al., 1994; Pow, 1992). Thus, although NOS
expression is up-regulated in conditions where there is a chronic demand for oxytocin
secretion (Kadowaki et al., 1994; Ueta et al., 1995b; Villar et al., 1994b), the present
experiments indicate that this does not reflect a coupling of spike activity to
increased NOS mRNA expression.
Application of electrical stimuli to the neural stalk of the pituitary evoked the
release of oxytocin as expected (Fig. 25A, 27), and this was enhanced by inhibition
of NO production (Fig. 26). The physiological circumstances in which NO inhibits
oxytocin secretion from the neurohypophysial nerve terminals are not yet clear,
although recent evidence suggests that this system may be activated during
conditions of chronic demand for oxytocin secretion such as dehydration. However,
this is not the case during prolonged neural stalk stimulation. The important point is
that increased spike activity in the cell bodies alone (from antidromic stimulation)
did not stimulate the nNOS gene, but instead decreased nNOS mRNA content. Up-
regulation of nNOS gene may therefore be stimulated by pathways activated through
synapses on the neurones, and not as a consequence of electrical activity. The
changes of nNOS mRNA expression in the SON indicate that the NOS system in the
SON plays a long term as well as an acute neuromodulatory role in the rat
magnocellular neurosecretory system.
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It has been shown recently that a high concentration of SNP directly
inactivates NOS activity when added to medial basal hypothalamus explants and
homogenates, providing an ultra-short loop negative feedback on the activity of NOS
(Canteros et al., 1996). As in the case of SNP, cGMP also blocked NOS activity
when incubated with medial basal hypothalamus explants and homogenates. Nitric
oxide activated sGC in the SON, PVN and neurohypophysis, leading to the
production and liberation of cGMP (Snyder and Bredt, 1991), mediates many of the
actions of NO. This cGMP might diffuse within the NOS-containing neurones and
reduce the activity of NOS. Therefore, high concentrations of NO evoked by
prolonged electrical stimulation of the axons of the magnocellular neurones may
block NOS activity in the NOS-containing neurones. Nitric oxide itself probably
inhibits NOS activity by changing the conformation of the heme group in NOS
(Canteros et al., 1996). Therefore, high concentrations of produced NO could
suppress the release of NO from NOS-containing neurones. Furthermore, high
concentrations of cGMP released by NO may be taken up by NOS-containing
neurones and suppress NOS activity.
The role ofNO in the electrical activity ofoxytocin and vasopressin cells
Application of intra-supraoptic nucleus retrodialysis of SNP, L-arginine and
L-NNA coupled with the single cell recording technique provided the first
information of the effect of local NO on the activity of oxytocin and vasopressin
neurones in vivo. The present results demonstrate an inhibitory effect of NO on the
neuronal activity of both oxytocin and vasopressin neurones in urethane-
anaesthetised rats. Both oxytocin and vasopressin neurones increased their firing rate
in response to L-NNA (Fig. 34). The firing rate of oxytocin and vasopressin neurones
was decreased by SNP but not significantly decreased by L-arginine (Fig. 35). Our
present results are consistent with the in vitro electrophysiological study of Liu et al.
(1997) who reported inhibitory effects of NO on neuronal activity of both phasic and
non-phasic firing neurones in the SON.
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There are two mechanisms that may explain the inhibitory action of NO on
oxytocin and vasopressin neurones; first, NO inhibits NMDA receptor-mediated
glutamatergic excitatory inputs by acting at postsynaptic sites of the SON neurones.
Cui et al. (1994) has reported that NO suppressed the membrane depolarization
evoked by the glutamate receptor agonist NMDA in SON neurones in vitro.
Alternatively, NO may potentiate inhibitory synaptic inputs to SON neurones by
acting at presynaptic GABA neurones. Nitric oxide increased the frequency, but not
the amplitude, of spontaneous inhibitory postsynaptic currents (IPSPs) recorded from
the SON neurones in vitro, representing presynaptic GABA release, while NO had no
effect on excitatory postsynaptic currents (EPSPs), representing presynaptic glutamate
release (Ozaki et al, 1999). These two mechanisms are mediated via cGMP-
independent pathways. The mechanism that may explain the inhibitory action of NO
on PVN neurones may be different from those of the SON neurones. In the rat PVN,
NO potentiated GABA inputs via postsynaptic as well as presynaptic mechanisms,
since NO increased both the amplitude and the frequency of spontaneous IPSPs
recorded from the PVN type I neurones (putative vasopressin or oxytocin) in vitro
(Bains and Ferguson, 1997b).
In conclusion, the results from this chapter provide information about the
mechanisms by which NO influences oxytocin and/or vasopressin secretion. Nitric
oxide exerts a predominantly inhibitory effect on the neuronal activity of oxytocin
and vasopressin neurones in the SON. Endogenous NO inhibits oxytocin release, and
nNOS co-existing with either oxytocin or vasopressin generates NO in an activity-
dependent manner. NO may serve within a negative feedback loop to control the
production and release of oxytocin by acting at both the cell bodies and the nerve
terminals of oxytocin neurones to prevent over stimulation of oxytocin. However,
although NOS expression is up-regulated in conditions of chronic demand for
oxytocin secretion, the present experiments indicate that this does not reflect a
coupling of spike activity to increased NOS mRNA expression.
CHAPTER 5
nNOS mRNA EXPRESSION IN THE MAGNOCELLULAR
NEUROSECRETORY SYSTEM AFTER ACUTE HYPERTONIC
STIMULATION AND CHRONIC SALT LOADING
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5.1 Introduction
The hypothesis that NO plays an important role in osmoregulation of
vasopressin and oxytocin release was initiated by the study of Sagar and Ferriero in
1987. They found an increase of NADPH-diaphorase staining in the rat posterior
pituitary gland after 8-days of salt loading. Up-regulation of nNOS mRNA
expression was also found in the SON and PVN after chronic salt loading (Kadowaki
et al., 1994; Villar et al., 1994b). Dehydrated rats also show an increase of NADPHd
activity in the SON (Pow, 1992) and nNOS mRNA expression in the SON and PVN
(Ueta et al., 1995b), however, it is not clear that acute hypertonic administration can
regulate nNOS gene expression as chronic salt loading and dehydration do. The
anatomical findings of changes of NOS system within the magnocellular
neurosecretory system during chronic hyperosmotic stimulation are complemented by
functional studies. An increase in NO-forming activity in the posterior pituitary gland
has been reported after chronic osmotic stimulation (Kadowaki et al., 1994). Under
normal salt-water balance conditions, endogenous NO tonically inhibits secretion of
vasopressin and oxytocin (Kadekaro et al., 1997; Liu et al., 1997; Liu et al., 1998).
Centrally-produced NO selectively inhibits oxytocin release in response to a painful
stimulus (needle prick) and moderate osmotic stimulation (Kadekaro et al., 1997), in
dehydrated rats (Summy-Long et al., 1998; Summy-Long et al., 1993) and in
angiotensin Il-treated rats (Liu et al., 1997). In parallel, systemic inhibition of NOS
enhanced oxytocin and vasopressin release in salt-loaded rats (Kadowaki et al.,
1994). Furthermore, NO inhibits stimulated vasopressin secretion from rat
hypothalamic explants in vitro, without affecting basal secretion (Yasin et al., 1993).
Nitric oxide also inhibits the basal release of vasopressin from the pituitary gland in
vitro (Lutz-Bucher and Koch, 1994). However, the effect of NO on vasopressin
release remains controversial since there is also evidence that centrally produced NO
can stimulate vasopressin secretion in rats in vivo (Ota et al., 1993).
Although many studies have demonstrated that osmotic stimuli cause a
marked increase in NOS activity and in the expression of nNOS mRNA in the PVN
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and SON (Kadowaki et al., 1994; Pow, 1992; Ueta et al., 1995b; Villar et al.,
1994b), there is no direct evidence about whether the expression of nNOS mRNA in
the PVN, SON and structures of the laminae terminalis is modulated by acute
hypertonic saline administration In the present study we examined the time course
changes in nNOS mRNA in the SON, PVN and structures in the laminae terminalis
following acute hypertonic administration using in situ hybridization histochemistry.
5.2 Aims
-To consider the possible role of NO in osmoregulation.
- To investigate the up-regulation of NOS gene expression in the SON and PVN after
chronic salt loading.
-To examine whether acute hypertonic saline administration has a rapid effect on the
expression of the NOS gene in the SON, PVN and structures of the lamina
terminalis.
5.3 Materials and Methods
5.3.1 Animals
Female Sprague-Dawley rats, weighing 250-300 g, were used throughout the
experiments. Before the experimental manipulation, all rats were housed under
standard laboratory conditions (12:12 h dark-light cycle, ambient temperature 20 ±
1°C) with free access to food and water, or otherwise, as stated in the experiments.
5.3.2 Experimental procedure
1. Neuronal NOS gene expression in the SON, PVN and SFO in salt-loaded rats
Rats were divided into two groups. The control group received food and
water ad libitum. The salt loading group received free access to food and 2% NaCl
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solution as the only source of water. After four days of salt loading, rats were
decapitated, their brains were rapidly removed and frozen on dry ice, before storing
at -70°C and processing for in situ hybridization histochemistry.
2. Time course of the effects ofacute hypertonic saline administration on nNOS gene
expression in the SON, PVN, and structures of the lamina terminalis.
Rats were given hypertonic saline (4 ml/kg 1.5 M NaCl; i.p.) or isotonic
saline. They were decapitated after 2h, 4h or 6h. and the brains were rapidly
removed. The brains were then frozen on dry ice and kept at -70°C and processed for
in situ hybridization histochemistry.
5.3.3 In situ Hybridization
The full methodology is described in General Methods 2.8.
Brain sections
Brains were coronally sectioned (15 |im) on a cryostat through the level of the
structures of the lamina terminalis (the OVLT, MnPO and SFO), SON and PVN,
using the stereotaxic atlas of Paxinos and Watson (1982) and thaw-mounted onto
gelatin-coated glass slides. Slides were then stored in desiccated slide boxes at -70°C
before in situ hybridization.
Probes
Three 45-mer antisense oligonucleotide probes for nNOS which were
complementary to bases 223-267 (5'-noncoding region), 4714-4758 (3'-noncoding
region) and 1662-1706 of the rat nNOS sequence (Bredt et al., 1991b) were used.
Probes were labelled at the 3' end with [a-35S]deoxy-ATP (NEN) using terminal
deoxynucleotidyltransferase (Pharmacia).
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In situ hybridization
Sections were fixed with 4 % paraformaldehyde in 0.1 M PB (pH 7.4) for 30
min, then rinsed in 0.1 M PBS and washed in 0.1 M PBS (10 min), followed by
acetylation in triethanolamine solution (0.25% acetic anhydride in 0.1 M
triethanolamine-0.15 M NaCl) for 10 min. The sections were then dehydrated
through 70%, 80%, 95% and 100% ethanol (5 min each), delipidated in chloroform
for 10 min, and partially rehydrated in 95% ethanol (10 min). After air-drying the
slides were placed in a humidified chamber. Sections were covered with
hybridization buffer (4xSSC, 50% formamide, lxDenhardt's solution, 500 pg/ml
sheared salmon sperm DNA, 10% dextran sulphate and 0.3% mercaptoethanol)
containing the 35S-labelled NOS oligonucleotide probes at a concentration of 2500
dprn/pl and left to hybridize for 17 h at 37°C.
After the hybridization process, excess hybridizing solution was drained off.
Slides were briefly rinsed three times in lxSSC at room temperature, washed three
times for 30 min lxSSC and were washed for a further 1 h in lxSSC at room
temperature. Slides were air-dried and dipped in 300 mM ammonium acetate, 70%
ethanol and then air-dried. Slides were placed in autoradiographic cassettes and
exposed to Hyperfilm-(3max autoradiography film (Amersham, UK) together with
brain paste standards. The film was left to expose for 3 weeks at 4°C. The films were
developed in D19 developer (Kodak) and then fixed (Ilford Hypam rapid fixer). After
that, sections were dipped in Ilford G-5 emulsion-coated slides (Mobberley) diluted
1:1 with autoclaved water. Emulsion-coated slides were exposed for a further 4-5
weeks to visualize NOS cellular signal, and then developed (Kodak D19 developer)
for 5 min and fixed (Ilford Hypam rapid fixer twice 5 min each). Developed sections
were counterstained with cresyl violet, dehydrated in a graded ethanol series, and
coverslipped in DPX mountant.
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Quantitative Analysis
The amount of nNOS mRNA in the regions of interest was assessed by silver
grain density of autoradiographic films of the SON, PVN, SFO and AMG viewed
under the light microscope, x5 and xlO objective. Grain density was quantified by
NIH Image analysis system version 1.58 on an Apple Mcintosh computer. The value
of silver grain density per unit area was obtained by subtracting background of each
specific tissue measurement, and dividing by the area measurements. Each brain
paste standard was measured twice, and also corresponding background
measurements. A logarithmic relationship was then plotted for radioactivity against
the grain density of the standards. Acceptable grain density values lay on the straight
portion of the curve. For each identified brain area, the mean grain density per unit
area of each rat was calculated and the group mean grain density per unit area
calculated.
Specific radioactivity of labelled probes was ranged from 367.01 to 1457.18
Ci/mmol.
5.3.4 Statistical Analysis
Data are expressed as means ±SEM. Groups were compared using the t-test
(SigmaStat). P< 0.05 was considered statistically significant.
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5.4 Results
1. Neuronal NOS gene expression in the SON, PVN, and SFO in salt-loaded rats
At the end of the experiment, the rats given 2% NaCl for 4 days had a mean
body weight (n=8) of 243.46 ± 2.60 g, while the mean body weight of control rats
(263.88 ± 2.79 g, n=8) was significantly greater (P=0.0001, t-test).
Strong hybridization signals for nNOS mRNA were observed in the SON, the
magnocellular region of the PVN, the SFO and the medial amygdaloid nucleus
(AMG). An increase of NOS mRNA signal was apparent as an increase in silver
grain density in the SON and the magnocellular part of the PVN of chronically
salted-loaded rats (Fig. 39A, C). The neuronal NOS mRNA signal was unchanged in
the SFO (Fig. 39E) and AMG of chronic salt loaded rats compared to control rats.
Up-regulated nNOS mRNA expression was revealed as a significant increase
in mean silver grain density per unit area, in the SON and magnocellular region of
the PVN compared to their respective controls after 4 days of salt loading (n=8 in
each group, P<0.05 and P<0.005, t-test, respectively, Fig. 38). After 4 days of salt
loading (n=8), there was a significant 1.53-fold and 1.61-fold increase in the
expression of nNOS mRNA in the SON and magnocellular region of the PVN,
respectively. There was no significant change in nNOS gene expression in other areas
measured after 4 days salt loading, including the SFO and AMG at this time (Fig.
38).
2. Time course of the effects of acute hypertonic saline administration on nNOS gene
expression in the SON, PVN, and structures of the lamina terminalis.
At the end of the experiment, the rats given 1.5 M NaCl (i.p.) 2h, 4h and 6h
previously had mean body weights of 240.38 ± 3.35, 243.13 ± 3.44 and 242.50 ±
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3.77 g, respectively (n=8 for each group). There was no significant difference when
compared to the mean body weight of control rats (241.40 ± 1.91 g, n=15).
Hybridization signals for nNOS mRNA were intense in the OVLT, MnPO,
SFO, SON, PVN and AMG. An increase of NOS mRNA signal was revealed by
analysis of silver grain density in the SON, and in the magnocellular part of the PVN
6 h after administration of 1.5 NaCl (Fig. 41D, 42D) and in the MnPO 4h following
administration of hypertonic saline, but not after 6 h (Fig. 43C). Neuronal NOS
mRNA signal was similar in the OVLT, SFO and AMG 2h, 4h and 6h after
hypertonic saline administration (Fig. 44-45).
Up-regulation of nNOS mRNA expression was evident as a significant
increase in mean silver grain density per unit area, in the SON and magnocellular
region of the PVN 6 h after hypertonic saline administration and in the MnPO after 4
h compared to isotonic saline administration (P<0.05, t-test, Fig. 40). Quantitation of
the autoradiographic image analysis obtained from the SON and magnocellular part
of the PVN 6 h after 1.5 NaCl (i.p.) showed a significant 1.21-fold and 1.16-fold
increase in nNOS mRNA expression in the SON and magnocellular region of the
PVN, respectively (n=8, Fig. 40A, B). The expression of nNOS in the MnPO showed
a significant 1.25-fold increase following 4 h administration of hypertonic saline
(n=7, Fig. 40D). In the OVLT, we were unable to demonstrate a significant up-
regulation of nNOS gene 2 h, 4h and 6 h after hypertonic saline administration.
However, the expression of nNOS mRNA in the OVLT does increase (not
significantly) 4h after hypertonic saline injection (n=8, Fig. 40E). There was no
change in nNOS gene expression in the SFO and AMG 2, 4 and 6 h after hypertonic
saline administration.
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Figure 40. Neuronal NOS mRNA expression measured as film grain density over the
SON, PVN, SFO, MnPO, OVLT and AMG. Significant increases in nNOS mRNA
expression were observed in both the PVN and SON 6h after hypertonic saline
administration (4 ml/kg, 1.5 M NaCl, i.p.) and in the MnPO 4 h after hypertonic
saline administration compared to the control group (* P<0.05 vs control, t- test).
There was no significant change in nNOS mRNA expression in the OVLT, SFO or
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35
Figure 43. Film autoradiographs of sections hybridized with a S oligonucleotide
probe against rat neuronal NOS mRNA in the MnPO. Neuronal NOS signal in the
MnPO of 4 h hypertonic saline treated rats (C) was greater than in control rats (A).
Neuronal NOS signal in the MnPO of 2h and 6h hypertonic saline treated rats (B, D)
was similar to control rats (A). MnPO; median preoptic nucleus, AC; anterior
commissure. Bar=l mm.
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5.5 Discussion
Dehydration may be produced by either chronic salt-loading (giving a 2%
NaCl solution in place of drinking water) or water deprivation. Dehydration produces
an increase in plasma osmolality which leads to depletion of oxytocin and
vasopressin from the neural lobe, and elevation of plasma oxytocin and vasopressin
concentrations (Balment et al., 1980; George, 1976; Jones and Pickering, 1969; Shoji
et al., 1994; Van Tol et al., 1987). A number of studies have demonstrated that
dehydration can up-regulate the expression of vasopressin and oxytocin mRNA in the
SON and PVN (Amaya et al., 1999; Ding et al., 1994; Herman et al., 1991;
Lightman and Young, 1987; McCabe et al., 1990; Meister et al., 1990a; Suemaru et
al., 1990; Van Tol et al., 1987). Dehydration also up-regulates the expression of
tyrosine hydroxylase, galanin, dynorphin, cholecystokinin and nitric oxide synthase
mRNAs in the SON and PVN (Kadowaki et al., 1994; Lightman and Young, 1987;
Meister et al., 1990a; Sherman et al., 1988; Villar et al., 1994b; Young, III et al.,
1987). Translated peptides from these genes co-localize with oxytocin and
vasopressin in the SON and PVN (Brownstein and Gainer, 1977; Brownstein and
Mezey, 1986; Brownstein et al., 1980; Meister et al., 1990b; Mezey and Kiss, 1985;
Sawchenko et al., 1984; Vanderhaeghen et al., 1981; Villar etal., 1990).
As expected, the expression of nNOS mRNA in the rat SON and PVN was
up-regulated after 4 days of salt loading (Fig. 38). However, nNOS mRNA
expression in the SFO was not significantly altered after 4 days of salt loading. In the
present study, we observed a 1.53-fold and 1.61-fold increase in nNOS mRNA
expression in the SON and PVN, respectively, after 4 days of salt loading, indicating
that magnocellular neurones of the SON and PVN respond similarly to the elevated
plasma osmolality. This indicates that the expression of the nNOS gene is sensitive to
a chronic osmotic stimulus.
An up-regulation of nNOS gene expression in the SON and PVN following
chronic salt loading has been previously demonstrated by Kadowaki et al. (1994) and
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Villar et al. (1994b). Villar and his colleagues demonstrated an increase of nNOS
expression and NOS-immunoreactive cells in the SON and PVN after 5 days and 14
days of salt loading, and the expression of nNOS mRNA in the SON and PVN
appeared to reach a peak after 5 days of salt loading (Villar et al., 1994b). Kadowaki
and her colleagues showed an up-regulation of nNOS mRNA in the SON and PVN
after 4 days of salt loading, which was accompanied by an increase in NADPH-
diaphorase activity in the SON and PVN, and NO-forming activity in the posterior
pituitary (Kadowaki et al., 1994). Water deprivation induced an increase in NADPH-
diaphorase activity in the SON (Pow, 1992) and in the expression of nNOS mRNA in
the SON and PVN (O'Shea and Gundlach, 1996; Ueta et al., 1995b). In addition, it
has been reported that NADPH-diaphorase activity is increased in the posterior
pituitary after chronic salt loading (Sagar and Ferriero, 1987). In rats with inherited
diabetes insipidus, which are chronically stimulated by a hyperosmotic condition due
to a deficiency in the secretion of vasopressin, an increase in the number of nNOS-
immunopositive cells (Wang and Morris, 1996) and an up-regulation of nNOS gene
expression in the SON and PVN (Yamamoto et al., 1997) have been reported. The
up-regulation of NOS activity, nNOS-immunopositive cells and the expression of
nNOS mRNA in the SON and PVN, and increase of NO-forming activity in the
posterior pituitary following chronic hyperosmotic stimulation, which is expected to
cause an increase in local NO concentration, may serve as a negative-feedback loop
to prevent overstimulation of oxytocin and vasopressin secretion following the
prolonged elevation of osmolality. Therefore, local NO may provide "fine tuning" in
the control of oxytocin and vasopressin release by acting either at the posterior
pituitary or at the level of the SON and PVN.
The present study has shown that acute administration (i.p.) of hypertonic
saline resulted in an increase in nNOS expression in the SON and PVN 6 h later (Fig.
40A,B). There was also an up-regulation of nNOS mRNA expression in the MnPO 4
h after administration of hypertonic saline (Fig. 40D). Acute hypertonic saline
administration causes rapid and transient increases in plasma osmolality and plasma
vasopressin and oxytocin (Brimble and Dyball, 1977; Dunn et al., 1973). These
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results indicate that an acute osmotic challenge has a stimulatory effect on nNOS
gene expression, but, the nNOS mRNA response was 4 to 6 h later than the plasma
oxytocin and vasopressin response. Although the nNOS gene is of the constitutive
type, several studies have revealed that nNOS gene expression is regulated by
physiological manipulations including chronic osmotic stimuli (Kadowaki et al.,
1994; Ueta et al., 1995b; Villar et al., 1994b) and non-osmotic stimuli (Ueta et al.,
1998). The late response of the nNOS gene suggests the complexity of the
mechanisms underlying the induction of nNOS gene transcription, which include the
second messenger system, primary and secondary gene transcriptions, and the
maturation process of nNOS mRNA. On the other hand, the time delay for the
response of the nNOS gene might merely reflect the difficulties in measuring a small
increase in a large pool of mRNA, inasmuch as the larger the pool size, the longer it
takes to double in size.
The involvement of NO within central osmoresponsive neurones during a
hyperosmotic challenge has been demonstrated in the present study as an increase in
nNOS mRNA expression in the MnPO 4 h after administration of hypertonic saline
(Fig 40D). We also found that the expression of the nNOS gene in the OVLT was
increased (but not significantly), while the expression of nNOS mRNA in the SFO
was not altered 4 h after administration of hypertonic saline (Fig. 40E, C). In
addition, nNOS gene expression in the SFO was not altered by 4 days of salt loading
(Fig. 38) and 48 h water deprivation (Ueta et al., 1995b). Nonetheless, nNOS mRNA
was strongly expressed in the SFO, so we cannot exclude the possibility that
induction of NOS expression that was not detected because of the difficulties in
measuring a small increase in a large pool of nNOS mRNA in the SFO.
Ciriello and his co-workers found increased NADPH-diaphorase activity in
the SFO, OVLT and MnPO following 3 days of water deprivation (Ciriello et al.,
1996). Nitric oxide is believed to be synthesized within these structures since NOS
protein and NADPH-diaphorase positive cells have been identified in these areas
(Bredt et al., 1991a; Vincent and Kimura, 1992). The SFO, MnPO and OVLT are
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interconnected and form a local neural circuit for the processing of afferent
information regarding plasma osmolality and the plasma concentration of angiotensin
II (AH), which play a major role in body fluid and electrolyte balance (see Johnson
and Thunhorst, 1997 and McKinley et al., 1996 for reviews). Central NO inhibits the
basal release of oxytocin and vasopressin and selectively inhibits oxytocin release
following All administration (Liu et al., 1997). Nitric oxide is thought to be related
to All-induced drinking since All-induced drinking was significantly attenuated by a
NOS inhibitor (Liu et al., 1997; Liu et al., 1998). The neurones of the SFO and
OVLT send direct and indirect (via the MnPO) connection to the SON and PVN
(McKinley et al., 1990). Luckman and colleagues have recently shown that some
neurones of the lamina terminalis (the OVLT, MnPO and SFO) that send afferent
projections to the SON contain nNOS (Luckman et al., 1997).
An up-regulation of nNOS mRNA in the MnPO following acute hypertonic
administration observed in the present study may reflect the function of NO as a
neuromodulator within the central osmoresponsive circuitry that controls the release
of oxytocin and vasopressin. Some neurones in the OVLT and SFO that project to the
MnPO are activated, as identified by Fos expression, after systemic osmotic
stimulation (Oldfield et al., 1994). The increase in the activity of presynaptic
neurones in the SFO and OVLT may evoke NO release from the postsynaptic MnPO
neurones, which in turn, release NO to inhibit further release of specific




This thesis described investigations of the physiological role of endogenous
NO in the magnocellular neurosecretory system in vivo. The thesis aimed to
determine the role of NO in osmoregulation of oxytocin release, to investigate the
sites of action of NO in controlling oxytocin release, to address the question of
whether the changes in the NOS system may reflect the reduction of
osmoresponsiveness in late pregnancy, and to examine the expression of nNOS
mRNA in the SON and PVN during late pregnancy, and after prolonged stalk
stimulation and hypertonic stimulation.
Nitric oxide has been shown to be involved in the physiological regulation of
oxytocin secretion during water deprivation and salt loading in conscious rats
(Kadowaki et al., 1994; Summy-Long et al., 1993). The involvement of NO in
osmoregulation of oxytocin release in virgin rats under urethane anesthesia was
confirmed in this thesis. Systemic blockade of NOS by either L-NNA or L-NAME
did not alter the basal release of oxytocin. However, endogenous NO may
preferentially inhibit the release of oxytocin in conditions of intense stimulation, as
systemic administration of the NOS inhibitors L-NNA and L-NAME enhanced
hypertonic saline-induced oxytocin release, but did not alter CCK-evoked oxytocin
release (Chapter 3). Further support for the role of NO in inhibiting oxytocin release
in response to hypertonic saline was found where i.e.v. administration of the NO
donor SNP resulted in decreased oxytocin release induced by hypertonic saline. The
inhibitory influence of endogenous NO on osmoregulation of oxytocin release is
independent of the inhibitory effect of endogenous opioids, as the non-selective
opioid receptor antagonist naloxone enhanced oxytocin release in urethane-
anaesthetized rats pre-treated with either L-NNA or vehicle. Systemic administration
of L-NNA increased the expression of Fos protein in the SON in pentobarbital-
anaesthetized rats after high doses of hypertonic saline, but not after low doses of
hypertonic saline (Chapter 4). Thus, this thesis provides additional evidence of an
inhibitory effect of NO on neuronal activity of the SON neurones at high levels of
activity in a manner that is independent of endogenous opioids, which in turn
determines the amount of oxytocin release. This postulate is supported by the
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experiments in conscious rats where central blockade of NOS by L-NAME
potentiated oxytocin release in response to moderate hypertonic saline (similar doses
of hypertonic saline to those used in this thesis), but not strong hypertonic saline
(Kadekaro et al., 1997). However, the mechanisms by which NO influence oxytocin
release and the sites of action of NO are still unclear.
Elevation in plasma osmolality following acute hypertonic saline
administration, salt loading or water deprivation dramatically increases the firing rate
of oxytocin and vasopressin neurones (for reviews see Renaud and Bourque, 1991),
and subsequently increases the release of oxytocin, vasopressin and probably NO. As
mentioned before, up-regulation of NOS protein, NADPH-diaphorase staining and
NOS mRNA in the SON and PVN was found in these conditions leading to increase
in local NO concentration in the SON and PVN (Kadowaki et al., 1994; Ueta et al.,
1995b; Villar et al., 1994b). Additionally, NADPH-diaphorase also increased in the
SFO, OVLT and MnPO (Ciriello et al., 1996), and the neurohypophysis under
conditions of dehydration (Sagar and Ferriero, 1987). Dehydration causes
morphological changes in the axonal processes of the magnocellular neurones
(Beagley and Hatton, 1992; Dellmann et al., 1988). Nitric oxide plays a potential role
in morphological plasticity of the neurohypophysis in response to fluctuations of
fluid balance (Beagley and Cobbett, 1997). It has been reported that NO is involved
in two major forms of long-lasting neuronal plasticity; long-term potentiation in the
hippocampus (Bon et al., 1992; Haley et al., 1992) and long-term depression in the
cerebellum (Daniel et al., 1993; Shibuki and Okada, 1991). Thus, a similar function
in morphological plasticity in these areas may be attributed to NO and may explain
the observed effects of NO on the release of oxytocin. In general, locally produced
NO may diffuse out of the magnocellular neurones in the SON and PVN and act
retrogradely on presynaptic terminals to modulate the release of oxytocin and
vasopressin in response to hypertonicity. It is possible that NO modulates the release
of oxytocin and vasopressin from neurones that are activated in response to an
elevation in plasma tonicity. Nitric oxide may participate in the autocrine or paracrine
regulation of oxytocin and vasopressin production by acting on target molecule sGC
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in the same cells or neighboring cells. Thus, the production of NO is increased in the
SON and PVN in order to mediate the physiological response required to re-establish
homeostatic balance.
The response of oxytocin neurones to changes in systemic osmolality is a
result of the combination between excitatory synaptic drive from the osmosensitive
neurones in the AV3V region and endogenous osmosensitivity of oxytocin neurones
(Bourque et al., 1994). Since the overall effect of NO on hormone release is thought
to be inhibitory, it is possible that NO may act throughout the AV3V region to
modulate the sensitivity of the magnocellular neurosecretory system. This is
suggested by the increase of NADPH-diaphorase expression in the SFO, OVLT and
MnPO that has been shown in dehydrated rats (Ciriello et al., 1996). In accord with
the findings in the thesis, nNOS mRNA expression in the MnPO was up-regulated 4
h after hypertonic saline administration, although there was no change in the OVLT
and SFO after hypertonic saline injection. From the previous findings, dehydration
did not alter the expression of nNOS mRNA in the SFO (Ueta et al., 1995b).
The sites of action of NO to exert an inhibitory effect on oxytocin release
have been described in this thesis. Nitric oxide may serve as an important
intermediary in the regulation of neuronal excitability of oxytocin and vasopressin
neurones in the SON and NO may serve as an inhibitory regulator on oxytocin
release by acting at the nerve terminals. This thesis provides the first evidence in vivo
that NO may potentially play an important role in modulating the electrical activity of
oxytocin and vasopressin neurones in the SON. Local application of L-NNA
increased the electrical activity of oxytocin and vasopressin neurones in the SON
(Chapter 4). In addition, local production of NO by SNP inhibited neuronal activity
of both types of cells in vivo. Indeed, the ability of NO to inhibit neuronal activity of
oxytocin and vasopressin neurones in the SON has been demonstrated previously in
the slice preparation (Liu et al., 1997). Therefore, the release of oxytocin and
vasopressin is attenuated by NO, since the amount of oxytocin and vasopressin
release can be determined by the rate and pattern of firing of oxytocin and
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vasopressin neurones (Bicknell, 1988). Furthermore, NO has been found to inhibit
vasopressin release from hypothalamus explants (Yasin et al., 1993). The possible
mechanisms responsible for this inhibition have been examined by in vitro
electrophysiological studies. Nitric oxide inhibits the electrical activity of SON
neurones, probably by acting at postsynaptic sites of SON neurones, since NO
suppressed NMDA-evoked membrane depolarization of SON neurones in vitro (Cui
et al., 1994), and also by acting at presynaptic GABA neurones, as the frequency of
IPSPs, but not EPSPs, recorded from the SON neurones in vitro was increased by NO
(Ozaki et al., 1999). In magnocellular neurones of the PVN, NO modulates inhibitory
transmission in response to NMDA receptor activation, as NO stimulates GABA
release and also increases GABA's postsynaptic efficacy (Bains and Ferguson,
1997b). Supporting these possibilities are the findings that local administration of
NO via microdialysis caused an increase of GABA and glutamate release within the
PVN (Horn et al., 1994). The excitation of inhibitory GABA neurones, the increased
postsynaptic efficacy of GABA in the PVN, the excitation of GABA release, and the
inhibition of postsynaptic efficacy for NMDA in the SON, may help to explain
earlier observations where NO exerts an inhibitory action on oxytocin release in
response to hyperosmotic stimulation.
Nitric oxide may also act at the nerve terminals of oxytocin neurones.
Systemic administration of L-NNA enhanced stalk stimulation-evoked oxytocin
release in vivo (Chapter 4). Furthermore, NO inhibited vasopressin release from
neurohypophysis explants (Lutz-Bucher and Koch, 1994). Thus, the NO responsible
for inhibition of oxytocin and vasopressin release co-exists with either oxytocin or
vasopressin and is generated in an activity-dependent manner. Nitric oxide thus
appears to act as a feedback inhibitor of oxytocin release at the terminals of oxytocin
neurones.
Although nNOS is thought to be a constitutively expressed enzyme, recent
data suggest that nNOS mRNA expression in the SON and PVN is dynamically
regulated in conditions of chronic demands of oxytocin e.g. water deprivation and
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salt loading (Kadowaki et al., 1994; Ueta et al., 1995b; Villar et al., 1994b). We have
found that the nNOS gene is a late response gene, as an up-regulation of NOS mRNA
expression in the SON and PVN was found 6 h after acute hypertonic saline
administration (Chapter 5). Furthermore, nNOS mRNA expression in the MnPO was
increased 4 h after hyperosmotic stimulation. However, an increase of nNOS
expression in the SON does not reflect a direct coupling to spike activity, since the
expression of nNOS mRNA in the SON was reduced after prolonged stalk
stimulation (Chapter 4). Moreover, down-regulation of nNOS mRNA expression in
the SON has been found during late pregnancy (Chapter 3). Thus, nNOS mRNA
expression in the SON and PVN can be regulated under some circumstances, but the
molecular mechanisms responsible for the dynamic regulation of nNOS transcription
are poorly understand.
We have found for the first time that NO activity is reduced during late
pregnancy in a manner that is independent of endogenous opioids. The potentiation
of oxytocin release stimulated by a high dose of hypertonic saline by systemic
blockade of NOS by L-NNA disappeared in late-pregnant rats, while naloxone
enhanced oxytocin release in rats pre-treated with either L-NNA or vehicle.
Furthermore, the expression of nNOS mRNA is reduced during late pregnancy and
increased during parturition (Chapter 3). An attenuation of physiological function of
NO during late pregnancy coincides with a time when oxytocin neurones are quiet
(for reviews see Leng et al, 1999). Thus, reduced NO activity may be a consequence
of reduced activity in oxytocin neurones at this time. In other words, oxytocin
neurones are quiet but have a reduced amount of NOS protein at term so when they
are excited there is no restraint, resulting in an enhanced secretory capacity of the
oxytocin system at term. Moreover, the NOS system present in the uterus may be
important in maintaining uterine quiescence during pregnancy. Nitric oxide
production is decreased in the uterus and increased in the cervix at term. Since NO
relaxes smooth muscle this results in a coordinated increased excitability of the
uterus, and changes in the cervix leading to dilation, essential for the process of
labour (Garfield et al., 1998a). A down-regulation of NOS system in the SON and in
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the uterus at term may initiate labour. By the end of pregnancy, inhibitory influences
onto oxytocin neurones are also decreased, as a down-regulation of GABAa subunit
receptor mRNA in oxytocin neurones of the SON and PVN has been revealed and the
potentiation of GABA actions via allopregnanolone diminishes with the collapse of
progesterone secretion (Brussaard et al., 1997; Fenelon and Herbison, 1996).
Oxytocin nerve terminals in the neural lobe become desensitized to endogenous
opioid restraint and the electrical activity of oxytocin neurones is reduced by a
separate endogenous opioid system, acting upon |4-receptors (Russell et al., 1995).
These changes in inhibitory components during late pregnancy may contribute to the
increase of electrical activity of oxytocin neurons at the time of parturition
(Summerlee, 1981) and facilitate the release of oxytocin with a bursting pattern of
firing of oxytocin neurones during parturition (Bicknell et al., 1988). The changes in
afferent inputs to cell bodies and nerve terminals of oxytocin neurones in virgin, late-
pregnant and parturient rats are summarized in figure 46.
In summary, a physiological role of NO in regulating the functional activity of
the magnocellular neurosecretory system has been established. The plasticity of the
NOS system in the SON and PVN has been demonstrated following both artificial
stimuli e.g. hyperosmotic stimulation and electrical stimulation of the neural stalk,
and physiological stimuli e.g. reproductive state. It is likely that NO is produced
locally at the SON and PVN and at the neurohypophysis, when oxytocin and
vasopressin neurones are activated by either artificial stimuli or physiological stimuli.
Endogenously generated NO may function in a negative feedback loop to inhibit
electrical activity of oxytocin and vasopressin neurones, and to restrain the release of
oxytocin. Evidence presented in this thesis indicates that endogenously generated NO
participates in the regulation of oxytocin release in response to hyperosmotic
stimulation in a manner that is independent of opioid inhibition. Furthermore, the
functional down-regulation of endogenous NO action due to a reduction of nNOS
system activity in the SON in late pregnancy has been demonstrated, which may
increase the excitability of the oxytocin system, resulting in the capacity for greater
release of oxytocin at term. The findings presented in this thesis contribute to
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understanding the function of endogenous NO in the magnocellular neurosecretory
system during hyperosmotic stimulation and pregnancy.
Virgin Late pregnancy Parturition
Figure 46. Schematic representing changes in afferent input to cell bodies and nerve
terminals of oxytocin neurones in virgin, late-pregnant and parturient rats. Nitric
oxide, produced by oxytocin neurones, has a potent inhibitory influence on oxytocin
release in virgin rats. During late pregnancy, the inhibitory effect of NO on oxytocin
release is decreased, in parallel with a desensitization of K-poioid restraint in
oxytocin nerve terminals and a reduction of the electrical activity of oxytocin
neurones by (l-opioid, causing less oxytocin release. During parturition, these
inhibitory components are decreased while the excitatory influence onto oxytocin
neurones becomes more active, causing a large amount of oxytocin release.
Abbreviations: NTS, nucleus tractus solitarius; NO, nitric oxide; GABA, gamma-
aminobutyric acid; NA, noradrenaline.
General Discussion 196
Further studies:
As mentioned above, nNOS mRNA expression in the SON and PVN is up-
regulated following hyperosmotic stimulation. In parturient rats, an up-regulation of
nNOS mRNA expression in the SON was demonstrated in this thesis. During
lactation, the expression of nNOS mRNA in the PVN (Ceccatelli and Eriksson, 1993)
and in the structures of the lamina terminalis including the SFO, MnPO and OVLT
has been revealed (Luckman et al., 1997). Neuronal NOS mRNA expression
increased in oxytocin neurones, but not vasopressin neurones, in the SON in lactating
rats (Luckman et al., 1997). Hyperosmotic stimuli cause a sustained continuous firing
pattern of oxytocin cell activity, inducing continuous release of oxytocin. Conversely,
suckling evokes a bursting pattern of oxytocin cell activity, and a comparable activity
has been reported during parturition, causing pulsatile release of oxytocin (for
reviews see Poulain and Wakerley, 1982). Milk ejection is related to this bursting
activity of oxytocin neurones and a sudden but transient rise in intramammary
pressure, which indicates oxytocin release. Since NOS co-exists with oxytocin, if the
bursting activity activated nNOS to produce NO, the pattern of the release of
endogenous NO should be similar to that of oxytocin secretion. In contrast, NO is
likely to be produced continuously during hyperosmotic stimulation while release of
NO may be found during parturition and suckling. The inhibitory effect of locally
produced NO on oxytocin release induced by hyperosmotic stimulation is clearly
demonstrated in this thesis and other authors' findings (Kadowaki et al., 1994;
Summy-Long et al., 1993). In contrast, locally-produced NO may not affect the
pulsatile release of oxytocin evoked by suckling, since an increase of endogenous NO
may occur following the burst during the background non-burst activity of oxytocin
cells; however, NO may contribute to the post-burst quiescence. Furthermore,
chronic systemic or acute central administration of L-NNA had no effect, while
exogenous NO produced by SNP reduced milk transfer from mother rats to pups,
which was reversed by systemic injection of oxytocin (Okere et al., 1996). Central
administration of L-NNA permitted, while SNP inhibited the induction of neuronal
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burst activity recorded from SON oxytocin neurones and intramammary pressure
during suckling (Okere et al., 1996).
During lactation, the sensitivity of oxytocin neurones and vasopressin
neurones to osmotic stimuli is reduced, although the plasma osmolality and the
threshold for oxytocin and vasopressin release return to control levels (Higuchi et al.,
1988; Koehler et al., 1993). The reduction of osmosensitivity of the oxytocin system
during lactation corresponds to an up-regulation of nNOS expression in the SON,
PVN and lamina terminalis. Thus, endogenous NO within these areas may be
involved in the reduced osmosensitivity during lactation. Further studies of the
physiological role of endogenous NO during parturition and lactation may explain the
importance of endogenous NO in the magnocellular neurosecretory system.
Further issues raised by this thesis need to be investigated. First, NO inhibits
neuronal activity of both oxytocin and vasopressin neurones in vivo, but the
mechanisms of this inhibition are unclear. To gain a better understanding of the
mechanisms of the inhibitory actions of NO we need to investigate the involvement
of NO in the modulation of inhibitory transmission resulting from the activation of
GABA neurones, the increase of the efficacy of the GABAa receptors or the decrease
of the efficacy of glutamate NMDA receptors at postsynaptic sites using in vivo
electrophysiology. Second, studies of the osmoregulation of oxytocin release in
nNOS gene knockout mice may give a better idea of the mechanisms that control
nNOS transcription and subsequent protein levels. These studies may provide further
details for the mechanisms of the inhibitory role of NO on oxytocin and vasopressin
neurones. Third, although we have shown that nNOS mRNA expression in the SON
is down-regulated during late pregnancy, we do not know whether this down-
regulation is preferentially found in oxytocin neurones or vasopressin. This question
can be addressed by using double in situ hybridization. The results from this
investigation may indicate which types of SON cells produce less NO during
parturition. Lastly, the causes of the changes in nNOS expression in magnocellular
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15.08 DOWN-REGULATION OF NITRIC OXIDE SIGNALLING IN THE
SUPRAOPTIC NUCLEUS (SON) IN LATE PREGNANCY.
R. Srisawat*, P.M. Bull A.J. Douglas. J.A. Russell and G. Lena,
Department of Physiology, University Medical School,
Edinburgh, EH8 9AG, Scotland
We examined the expression of nNOS mRNA in the rat SON
using in situ hybridization. A significant decrease of nNOS mRNA
expression was observed in late pregnant rats (day 22) compared to
virgin rats (late pregnancy: 0.23+0.009 mean grain density/unit area,
n=8, virgin: 0.30±0.024, n=8, p<0.05, one way ANOVA; Dunn's
method). We also investigated the influence of endogenous NO on
the responsiveness of the oxytocin system to osmotic stimulation.
The NOS inhibitor, Nco-Nitro-L-Arginine (L-NA; 10 mg/kg i.p) or
saline was administered to urethane-anaesthetized virgin and late
pregnant rats. After 4 h, rats were injected with hypertonic saline
(virgin:4 ml/kg 1.5 M NaCl, late pregnant: 5 ml/kg 2 M NaCl, i.p.).
Plasma oxytocin concentration was measured by specific
radioimmunoassay. In all rats, oxytocin release was significantly
increased by injection of hypertonic saline. In virgin rats, this
response was significantly elevated in rats pre-treated with L-NA,
whereas in pregnant rats pre-treatment with L-NA had no significant
effect. The study demonstrates down-regulation of nNOS activity in
the magnocellular system of the SON in late pregnancy.
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